tsawon lokacin da wadannan alamun suka kasance?
kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar musamman da shekarunka
kuma tare da zazzabi
kuma kuma ya kamata a duba yawan cholesterol da kake da shi a cikin jini
kuma kana da zazzabi yanzu?
kuma kana da wannan ciwon kirji yanzu?
kuma banda haka kana da wahalar numfashi
kuma za ku iya gaya mini waɗanne wasu alamu kuke da su tare da wannan?
kuma yaya zafin jikinka ya kasance
Ni ma ina da tari
Kuma ina da ɗan sanyi da tari
kuma ina da ciwon kirji mai tsanani a yau
Kuma wannan ne lokacin da ya dace don hay zazzabin
kuma yana samun ciwon kirji
Kuma ina ganin ina da kadan daga zazzabi
kuma ina son ka bayyana inda ciwon kirji yake
kuma suna da wasu zazzabi ma
da kuma tarihin ciwon sukari
Kuma ka san yana jin kamar kirji na kamar zai murkushe
Kuma ka san mutane suna ta yin tari a kaina a koyaushe
kuma kana da ciwon kirji
kuma ka ce wannan matsin lamba ne a cikin kirjinka
wani a cikin iyali yana da matsalar zuciya ciwon zuciya ciwon zuciya high cholesterol high blood pressure
wani wasu alamun ko matsaloli da kuka lura da su a ciwon tsoka?
akwai wasu mutane da suka kamu da cutar kamar ku a gida da suke da irin wannan alamun?
kuna da wasu alamun cutar?
kana da wani numfashi?
har yanzu kana da ciwon kirji
saboda wannan lokacin mura ne
amma kuma bai kamata mu bar zuciya ba zuciya asalin ciwon kirji
amma matsala mafi muhimmanci yanzu ita ce wannan ciwon kirji
amma ina da wahalar numfashi
Amma na san mutane da yawa suna tari a kaina
amma muna bukatar mu bi da kowane ciwon kirji da matuƙar tsanani
Amma kana numfashi daidai yanzu, ko ba haka ba?
Saboda wannan ciwon kirji na manta kwata-kwata
kana jin kamar wani yana matse kirjinka
har yanzu ina jin kamar na shan numfashi
suna gunaguni na rashin lafiya irin wannan cututtuka?
Kuna da wani ciwon hawan jini ko wani abu makamancin haka?
kuna da wasu cututtuka na rashin lafiya na kullum kamar su ciwon sukari?
Kuna da wani numfashi tare da wannan ciwon kirji?
kana da hawan jini?
Shin kana da wani numfashi mai wuya da ke tare da wannan?
kin san wane irin alamun da take da su?
kin ga hoton?
sha ruwa mai yawa yau
duk da haka na yi gwaje-gwaje don ciwon sukari
Duk da haka tana da alamun da suka yi kama da nawa
Yaya zafin zafin jikinka yake?
Yaya hawan jini?
idan har yanzu kana da zazzabi mai yawa
idan kuna da zazzabi na 100 ko sama da haka
idan ka yi tunanin cewa alamun ko matsalolinka sun bukaci a duba ka sosai
Na yi zazzabi jiya
Ina da zazzabi ma
Ina da zazzabi jiya
Ina da ciwo mai zafi a nan a cikin kirji
Ni ma ina da wahalar numfashi
Zan aiko maka da hoto
Ina da ciwon kirji a yau
Ina da ciwon kai da zazzabi a yau
A ganina mura ce
A ganina wannan ɗan mura ne
Shin kamar wani mutum mai nauyi ne a kan kirjinka?
Duk ya fara ne da ciwon kai da zazzabi a daidai lokacin
Yana ci min ciwo a tsakiyar kirji na
matsi ne kamar ciwon kirji
Yana cikin ƙirjina
Yana tsakiyar kirjina
yana tsakiyar kirji
Ina da ciwo a cikin kirji
Ina matukar damuwa da wannan ciwon kirji
Ina so ka gaya mini a kwatanta wannan kirji zafi
kamar hawan jini ko ciwon sukari
kamar a tsakiyar kirji
Yanzu don zazzabi zaka iya shan tachipirina mai dadi
Yanzu Mary kwana nawa kuka yi da alamun
yanzu ka ce kana da ciwon kirji
wani lokacin ina da wani ciwon kirji
ok kana da wasu alamun cutar tare da wannan banda kawai ciwo
ko kuma wani yana zaune a kan kirjinka?
daidai yake da zazzabi da tari da ciwon kai da ciwon tsoka
daidai a tsakiyar kirji na
Ka nuna mini a wannan hoton inda kake jin ciwo
tun da kana da zazzabi
To, kana tsammanin wasu daga cikin wadannan alamun za su iya danganta da kasancewa cikin ciki?
to yaranka suna da wasu daga cikin alamun?
Ka gaya mini game da ciwon kirjinka
zazzabi yana ƙaruwa da dare
zazzabin da nake da shi a cikin kwanaki biyu da suka gabata
zazzabin ya fara ƙaruwa a daren jiya
Wannan shi ne Dr. Porter daga cibiyar tantancewa ta gaggawa
To za ki iya gaya mani kadan game da ciwon kirjinki?
To ina jin ciwo a gaban jikina a nan a kirjina
To ina da ciwo mai tsanani a cikin ƙirjina
To, idan ina da wannan ciwo a cikin ƙirjina
wane irin ciwo kake da shi a cikin kirjinka?
lokacin da wannan ciwon kirji ya fara?
Ina kake da ciwon kirji?
inda ka ji wannan kirji ciwo eel wannan kirji t
kana jin kamar ka na da tsananin damuwa a kirjinka
Ka sani ina da ciwon sukari da sauran abubuwa
Ka ce kana da wannan ciwon kirji
Haɗakar yawan kamuwa da cutar coronavirus (COVID-19) cikin sauri a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya, daga 1 ga Janairu zuwa 15 ga Maris 2020
Adadin masu kamuwa da cutar coronavirus (COVID-19) yana nuna irin wannan yanayin a cikin Tarayyar Turai / ƙasashen Yankin Tattalin Arzikin Turai da Burtaniya, wanda ke tabbatar da cewa, yayin da a wani mataki daban dangane da ƙasar, annobar COVID-19 tana ci gaba cikin sauri a duk ƙasashe.
Dangane da kwarewar Italiya, ƙasashe, asibitoci da rukunin kulawa mai mahimmanci ya kamata su haɓaka shirye-shiryen su don ƙaruwar marasa lafiya tare da COVID-19 waɗanda zasu buƙaci kulawar lafiya, musamman kulawa mai mahimmanci.
A ranar 31 ga Disamba, 2019, an ba da rahoton tarin cututtukan ciwon huhu na rashin sananne a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin ta ba da rahoton cewa mai haifar da cutar sabon coronavirus ne wanda yanzu ake kira da cutar coronavirus 2 mai tsanani mai saurin numfashi (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
Shaida har zuwa yau ita ce kusan kashi 80% na mutanen da ke da COVID-19 suna da rashin lafiya, watau kamuwa da cuta ta hanyar numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin waɗannan suna murmurewa.
A cikin kusan kashi 14 cikin ɗari, COVID-19 yana ci gaba zuwa wata cuta mai tsanani da ke buƙatar asibiti yayin da sauran kashi 6 cikin ɗari ke fuskantar mummunan cuta da ke buƙatar kulawa mai tsanani.
Mutuwar marasa lafiya da aka kwantar a asibiti saboda COVID-19 kusan 4%.
A cikin wannan binciken, mun kimanta yanayin tarin kamuwa da cutar COVID-19 a kowace ƙasa ta Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da kuma Burtaniya (UK) kuma mun kwatanta su da na lardin Hubei, China.
Mun kuma kwatanta adadin masu kamuwa da cutar COVID-19 a yanzu a cikin ƙasashen EU/EEA da Burtaniya da na Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris 2020.
Al'amuran COVID-19 a ƙasashen EU/EEA da Burtaniya
Bayan China, COVID-19 ya ci gaba da yaduwar yanki kuma yanayin annobar COVID-19 a sauran duniya a halin yanzu ya bi na wannan ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri da sauransu sun ba da rahoton farkon mutanen Turai da aka tabbatar da cutar COVID-19 bisa ga ma'anar yanayin WHO.
A cikin EU/EEA, Faransa ta ba da rahoton farkon mutane uku da aka tabbatar da su a ranar 24 ga Janairu 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris 2020, an gano shari'o'in COVID-19 a duk ƙasashe 30 na EU / EEA da United Kingdom (UK), inda tsakanin 31 ga Disamba 2019 da wannan kwanan wata, an ba da rahoton shari'o'i 39,768 da mutuwar 1,727, tare da shari'o'i 17,750 da mutuwar 1,441 a Italiya kadai.
Samun adadin masu kamuwa da cutar COVID-19 da kuma yawan kamuwa da su
A Cibiyar Tsaro da Kula da Cututtuka ta Turai (ECDC), ana sabunta adadin masu kamuwa da cutar COVID-19 da aka sanar a kowace kasa a duniya, wanda aka samu ne kawai daga tushen hukuma kamar ma'aikatar lafiya ta ƙasashen, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, kowace rana da karfe 8:00 na safe.
An yi amfani da waɗannan bayanan don kimanta yanayin COVID-19 a EU / EEA da Burtaniya, da kuma kwatanta su da na Italiya.
A matsayin wakilcin yaduwar masu cutar COVID-19, mun lissafta adadin adadin masu cutar COVID-19 na kwanaki 14, ta haka ne la'akari da yanayin COVID-19, a kowace ƙasa ta EU / EEA da Burtaniya, a lokacin 1 ga Janairu zuwa 15 ga Maris 2020.
Mun kuma gabatar da adadin adadin masu kamuwa da cutar da aka sanar a kowace kasa a ranar 15 ga Maris 2020 da karfe 8:00 na safe idan aka kwatanta da na Italiya a tsawon 31 ga Janairu zuwa 15 ga Maris 2020.
Yanayin COVID-19 a ƙasashen EU/EEA da Burtaniya
Yanayin a cikin kwanaki 14 na tarin adadin masu kamuwa da cutar COVID-19 a cikin ƙasashen EU / EEA da Burtaniya gabaɗaya sun bi na lardin Hubei (China) (Hoto 1).
Ga EU/EEA da Burtaniya gabaɗaya, tarawar cutar COVID-19 ta fara ƙaruwa a kusa da 21 ga Fabrairu sannan ta ƙaru sosai a kusa da 28 ga Fabrairu 2020 (Karin bayani).
Wannan ya kasance galibi saboda saurin karuwar adadin masu kamuwa da cutar daga Italiya, amma duk sauran ƙasashen EU / EEA da Burtaniya sun nuna irin wannan yanayin karuwar tarin cutar ta COVID-19 (Karin bayani).
Shafi na 2 ya nuna adadin adadin masu kamuwa da cutar COVID-19, a cikin ƙasashen EU/EEA da Burtaniya idan aka kwatanta da na Italiya a cikin 31 ga Janairu zuwa 15 ga Maris 2020.
Ya nuna cewa a ranar 15 ga Maris da karfe 8:00 na safe, wasu ƙasashe 15 na EU/EEA da Burtaniya sun riga sun ba da rahoton jimillar adadin masu cutar da za a iya kwatanta su da na Italiya makonni 3 da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin waɗanda aka sanar da su na COVID-19 yana ƙaruwa cikin sauri a EU / EEA da Burtaniya.
Yanayin da aka lura a cikin tarin kamuwa da cutar COVID-19 ya nuna cewa annobar tana ci gaba da irin wannan saurin a dukkan ƙasashe.
Wannan duk da cewa ƙasashe suna cikin matakai daban-daban, bambance-bambance a cikin martani na lafiyar jama'a na ƙasa, kuma mai yiwuwa ma'anoni daban-daban a cikin ƙasashe da ladabi daban-daban don zaɓar marasa lafiya waɗanda dole ne a gwada su don tabbatar da COVID-19, gami da gwajin kamawa.
A farkon Maris 2020, likitoci a yankunan da cutar ta shafa na Italiya sun bayyana halin da ake ciki wanda kusan kashi 10% na marasa lafiya da ke da COVID-19 ke buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da rukunin kulawa mai tsanani a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai kan shigar da masu cutar COVID-19 a asibiti da/ko sashen kulawa mai tsanani a halin yanzu ana samun su a matakin EU/EEA ne kawai na kashi 6% da 1% na masu cutar, bi da bi (ba a nuna bayanai ba).
Duk da haka, ya kamata a tattara su ta hanyar da ta dace don a kara wa bayanan sa ido na yanzu da suka maida hankali kan adadin wadanda aka ruwaito da kuma adadin mutuwar.
Wani bincike da aka gudanar a 201011 ya nuna bambancin da ke tsakanin samun gadajen kulawa mai tsanani da na kulawa ta tsakiya a Turai, daga 29.2 a Jamus zuwa 4.2 gadaje ga kowane mutum 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙasa da albarkatu fiye da Italiya (12,5 gadajen kulawa mai zurfi da kulawa ta tsakiya a kowace mutane 100,000 a 201011).
An bayar da yanayin ƙira da ya shafi wadatar ƙarfin kiwon lafiya, tare da kimantawa ga kowace ƙasar EU / EEA da Burtaniya na yawan waɗanda ke cikin asibiti na COVID-19 da ke da alaƙa da &gt; 90% haɗarin wucewar ƙarfin gado mai kulawa mai mahimmanci a cikin sabuntawa ta shida na ECDC mai saurin kimanta haɗarin COVID-19.
Tunda har zuwa yanzu an tattara masu kamuwa da cutar a wasu yankuna a cikin kasashen EU/EEA da Burtaniya, kuma asibitoci da rukunin kulawa mai mahimmanci galibi suna ba da sabis ga ƙididdigar ƙididdigar yankin yankin, ya kamata a samar da bayanai game da masu kamuwa da cuta da gadajen kulawa mai mahimmanci a matakin Nomenclature of territorial units for statistics 2 (NUTS-2).
Kwarewar Italiya da yanayin da ake ciki a yanzu a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ci gaba cikin sauri a EU / EEA da Burtaniya.
Kasashe, asibitoci da rukunin kulawa mai mahimmanci ya kamata su shirya kansu don yanayin ci gaba da watsa SARS-CoV-2 a cikin al'umma da haɓaka yawan marasa lafiya tare da COVID-19 waɗanda ke buƙatar kulawa ta lafiya, musamman kulawa mai mahimmanci, kamar wanda ke faruwa a yankunan da cutar ta shafa na Italiya.
Kamar yadda aka nuna a cikin rahoton ECDC na kwanan nan, hanzarin tantance hadarin, hanzarin, da kuma cikakkiyar hanya yana da mahimmanci don jinkirta yaduwar SARS-COV-2, tare da sauyawa daga hanawa zuwa hanyar ragewa, saboda saurin karuwar da ake tsammani a cikin adadin shari'o'in na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da daidaita martani daidai idan ba a aiwatar da su ba a gaba.
Binciken hadarin cikin sauri ya kuma lissafa matakan kiwon lafiyar jama'a don rage tasirin annobar.
Akwai ɗan gajeren lokacin da ƙasashe ke da damar ƙara ƙoƙarin sarrafawa don rage yaduwar SARS-CoV-2 da rage matsin lamba kan kiwon lafiya.
Idan ba haka ba, yana yiwuwa tsarin kiwon lafiya na sauran ƙasashen EU / EEA zai fuskanci hauhawar marasa lafiya waɗanda ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Barkewar cutar Coronavirus ta 2019 (COVID-19), wadda cutar coronavirus 2 (SARS-CoV-2) ta haifar, ta kashe mutane sama da 3,000 kuma ta kamu da mutane sama da 80,000 a China da sauran wurare a duniya, wanda hakan ya haifar da bala'i ga mutane.
Kamar kwayar cutarta ta homologous, SARS-CoV, wanda ya haifar da SARS a dubban mutane a 2003, SARS-CoV-2 kuma ana iya watsa shi daga bat kuma yana haifar da irin wannan bayyanar ta hanyar irin wannan tsari.
Koyaya, COVID-19 yana da ƙarancin tsanani da mutuwar fiye da SARS amma yana da yaduwa sosai kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
A amsa ga yawan littattafan da ke ƙaruwa da sauri game da cutar da ke tasowa, wannan labarin yana ƙoƙari ya ba da cikakken nazari game da batun bincike mai saurin tasowa.
Za mu rufe abubuwan da suka shafi ilimin cututtuka, ilimin cututtuka, ilimin kwayar cuta, ganewar asali, magani, tsinkaya, da rigakafin cutar.
Ko da yake tambayoyi da yawa suna bukatar amsa, muna fatan cewa wannan bita zai taimaka wajen fahimtar da kuma kawar da wannan cuta mai barazana.
Bikin bazara a ranar 25 ga Janairu, 2020 ya zama abin tunawa da ba a taba gani ba ga duk Sinawa wadanda aka bukaci su zauna a gida a duk lokacin hutu da kuma makonni da yawa bayan haka saboda barkewar sabuwar cutar kwayar cuta.
Kwayar cutar tana da kamanceceniya sosai da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar mai saurin numfashi (SARS) a 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta sanya mata sunan SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma cutar da ke da alaƙa da ita an sanya mata sunan CoV Disease-19 (COVID-19).
Annobar ta fara ne a Wuhan, China, kuma da sauri ta bazu a duk faɗin ƙasar da kusan wasu 50 a duk faɗin duniya.
Ya zuwa ranar 2 ga Maris, 2020, kwayar cutar ta haifar da sama da 80,000 da aka tabbatar da cutar ta COVID-19, tare da sama da marasa lafiya 40,000 da aka sallama kuma sama da marasa lafiya 3,000 da suka mutu.
WHO ta yi gargadin cewa COVID-19 shine abokin gaba na 1 kuma mai yuwuwar zama mafi iko fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga takardu sama da 200 akan COVID-19 gami da ilimin ƙwayoyin cuta, ilimin cututtukan cuta, ilimin asali, ganewar asali, da magani tun daga rahoton farko a ranar 7 ga Janairu, 2020 wanda ya ƙayyade jerin ƙwayoyin cuta da aka ware daga marasa lafiya da yawa.
Wannan bita na ƙoƙari ne don taƙaita ci gaban bincike a cikin sabon yanki da ke ci gaba da sauri.
A duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da wani cuta da CoV ke haifarwa, ciwon numfashi na Gabas ta Tsakiya (MERS, barkewar cutar a shekarar 2012).
Za mu kuma tattauna abin da muka koya har zuwa yanzu game da rigakafin cutar da kuma yadda za a gane ta da kuma wasu tambayoyi da suka rage da suke da gaggawa.
CoVs an yi la'akari da su a matsayin cututtukan da ba sa kashe mutane, galibi suna haifar da kusan kashi 15% na yawan sanyi 4.
Koyaya, a cikin wannan karni, mun haɗu da CoVs na ɗan adam sau biyu, watau SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar cutar a China a 2003 da Saudi Arabiya a 2012, bi da bi, kuma ba da daɗewa ba suka bazu zuwa wasu ƙasashe da yawa tare da mummunan rashin lafiya da mutuwa.
Saboda haka, cutar COVID-19 ta yanzu ita ce annoba ta uku ta CoV a tarihin mutane.
Kamar yadda aka nuna a Fig. Fig.1,1, an fara bayar da rahoton tarin ciwon huhu wanda ba a san asalinsa ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta China.
Kwana bakwai bayan haka an saki jerin CoV.
A ranar 15 ga Janairu, 2020 ne aka ba da rahoton farkon cutar mutuwa daga Wuhan.
A wannan lokacin, annobar ta bazu cikin sauri zuwa birane, larduna, da kuma ƙasashe da ke kewaye da ita.
A ranar 20 ga watan Janairu, an bayar da rahoton kamuwa da ma'aikatan kiwon lafiya, wanda ke nuna cewa ana iya yaduwa daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an kulle birnin Wuhan tare da dakatar da duk hanyoyin sufuri na jama'a.
A ranar 24 ga Janairu binciken farko na asibiti kan cutar ya ruwaito cewa, daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar abincin teku ta Wuhan wanda aka yi la'akari da wurin fara kamuwa da cutar daga asalin dabba da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa ta duniya.
A lokacin da ake rubuta wannan rahoto, cutar ta riga ta bazu a duk fadin kasar Sin da kuma kusan wasu kasashe 50 a duk faɗin duniya (Hoto. (Hoto.2).2).
Tunda halin da ake ciki yana ci gaba da sauri, har yanzu ba a tantance ƙarshen yaduwar cutar da kuma tsananin cutar ba.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyi da yawa akan marasa lafiya 8,866 gami da 4,021 da aka tabbatar da marasa lafiya COVID-19 sun gabatar da ƙarin hoto na yau da kullun na annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane na kowane zamani, amma galibi a shekarun 30-65.
Kusan rabin (47.7%) na mutanen da suka kamu da cutar sun haura shekaru 50, kaɗan ne kawai ke da shekaru 20 a karkashin, kuma mutane 14 ne kawai suka kamu da cutar da shekarunsu ba su kai 10 ba.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya faɗaɗa a cikin rukuni galibi a cikin Hubei da kewaye.
COVID-19 ya ɗauki matsakaicin kwanaki 5 (2-9) daga farawa zuwa ganewar asali.
Matsakaicin lokacin hawan shine kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga farawa zuwa mutuwa ya kasance kwanaki 9.5 (4.8-13).
Lambar haifuwa ta asali (R0) ta kasance 3.77 (95% CI: 3.51-4.05) kuma daidaitaccen R0 ya kasance 2.23-4.82.
Adadin mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin manyan sufuri kafin bikin bazara a China.
Mutuwar marasa lafiya tare da tabbatar da shari'o'i ya kasance 1.44% (95% CI: 1.10-1.86%), kuma daidaitaccen mutuwar dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Manyan abubuwan haɗari guda uku don COVID-19 sune jinsi (maza), shekaru (≥60), da mummunar cutar huhu.
CoVs wani yanki ne na manyan ƙwayoyin cuta masu rufi waɗanda ke ƙunshe da zaren RNA guda ɗaya.
Ana iya raba su zuwa nau'i huɗu, watau, alpha, beta, gamma, da delta, wanda aka san cewa alpha da beta-CoVs suna cutar da mutane.
Glycoprotein na envelope spike (S) yana ɗaure ga masu karɓar kwayoyinta na angiotensin-converting enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan kuma haɗuwa da membrane yana faruwa.
Ana sakin kwayar RNA ta kwayar cutar zuwa cikin cytoplasm; bayan kwayar kwayar cutar ta kwayar cutar, RNA ta kwayar halitta tare da glycoproteins da nucleocapsid sun hada da kwayar virion, wanda daga baya ya hade da membrane na plasma don sakin kwayar cutar.
An ba da rahoton jerin kwayoyin farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV tare da fiye da 99.98% asalin kwayar halitta tsakanin samfuran 10 da aka tattara daga asalin wurin ɓarkewar cutar, Kasuwar Abinci na teku na Huanan a Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV a cikin kwayoyin halitta fiye da MERS-CoV.
Ta hanyar microscopy na watsa lantarki, an sami SARS-CoV-2 a cikin sassan ultrafin na epithelium na numfashin mutum.
An gano cewa ACE2 na mutum mai karɓar SARS-CoV-2 ne da kuma SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana ɗaure ga ACE2 na ɗan adam da rauni fiye da na SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta mai tsanani a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 kuma na iya samar da sabon gajeren furotin da aka tsara ta hanyar orf3b da kuma furotin da aka ɓoye wanda aka tsara ta hanyar orf8.
Orf3b na SARS-CoV-2 na iya taka rawa a cikin cutar kwayar cuta ta kwayar cuta kuma yana hana bayyanar IFNβ; duk da haka, orf8 ba shi da wani sanannen yanki ko dalili.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., sun ba da rahoton tsarin cryo-EM na cikakken tsawon mutum ACE2 a ƙuduri 2.9 Å a cikin hadaddun tare da mai ɗaukar amino acid B0AT1.
Sun gano cewa hadadden, wanda ke da bude da rufe, an haɗa shi azaman dimer kuma ACE2-B0AT1 hadadden na iya ɗaure sunadarai biyu na S, wanda ke ba da tabbaci don ganewar CoV da kamuwa da cuta.
B0AT1 na iya zama makasudin magani don gwajin magani don hana kamuwa da cutar SARS-CoV-2.
Asalin da kuma mai watsa shiri na tsakiya
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga bat kuma an watsa su ga mutane ta hanyar kuliyoyi da rakuma, bi da bi.
Ta hanyar kwatanta phylogenetic na SARS-CoV-2 tare da sauran CoVs, an dauki bat a matsayin asalin bakuncin SARS-CoV-2 kamar yadda sabon kwayar cutar ta kasance kashi 96% daidai da CoVs biyu masu kama da SARS daga bat da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, wane mai watsa shiri na tsakiya ya taimaka wa kwayar cutar ta tsallaka shingen nau'in don kamuwa da mutane har yanzu ba a sani ba, kuma hanyar watsawa har yanzu ba a bayyana ba.
Ji, et al., sun ba da shawarar macizai a matsayin mai ɗaukar kwayar cutar daga bat zuwa ɗan adam wanda ya haɗa da sake haɗuwa a cikin furotin S.
Dangane da wani bincike, masu bincike a Guangzhou, China sun ba da shawarar cewa pangolins - dogon-hanci, dabbobi masu shayar da dabbobi masu shayarwa da ake amfani da su a cikin maganin gargajiya na kasar Sin - sune masu iya daukar bakuncin SARS-CoV-2 bisa ga 99% na daidaiton kwayoyin halitta a cikin CoV da aka gano a cikin pangolins da SARS-CoV-2.
Duk da haka, bambancin 1% da aka rarraba a kan dukkanin kwayoyin halitta biyu har yanzu babban bambanci ne; saboda haka ana jiran sakamako mai mahimmanci don shaida na ainihi (Hoto.
Abubuwan jiki da sinadarai na SARS-CoV-2 ba a san su ba tukuna.
SARS-CoV da MERS-CoV na iya rayuwa a cikin vitro na tsawon sa'o'i 48 a cikin bushewar yanayi kuma har zuwa kwanaki 5 a ƙarƙashin 20 °C da 40%-50% danshi.
SARS-CoV-2 na iya samun irin wannan kaddarorin.
An bayar da rahoton cewa SARS-CoV-2 yana da saukin kamuwa da hasken ultraviolet da zafi a 56 °C na tsawon minti 30; ether, 75% ethanol, maganin kashe cuta mai dauke da chlorine, peracetic acid, chloroform, da sauran mai narkewa, amma ba chlorhexidine ba, na iya kashe kwayar cutar yadda ya kamata.
Dukan al'ummar dan adam gabaɗaya ba su da rigakafi ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, ba a bayar da rahoton cikakken bincike game da amsawar rigakafin cutar SARS-CoV-2.
Don haka, za mu iya komawa ga binciken da aka yi a baya kan wasu CoVs, musamman SARS-CoV da MERS-CoV (Hoto (Hoto.4).4).
Gabaɗaya, bayan kwayar cutar ta mamaye mai masaukin, tsarin garkuwar mahaifa na farko ya fara gane ta ta hanyar masu karɓar tsarin ganewa (PRRs) gami da masu karɓar nau'in C-type lectin-like, mai karɓar mai kama da Toll (TLR), mai karɓar NOD-like (NLR), da mai karɓar RIG-I-like (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar abubuwan kumburi, balagawar ƙwayoyin dendritic, da kuma hadawar nau'in interferons na I (IFNs) wanda ke iyakance yaduwar kwayar cutar da kuma hanzarta macrophage phagocytosis na kwayoyin cutar.
Koyaya, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta tsere daga martani na rigakafi.
Ba da daɗewa ba, rigakafin jiki mai daidaitawa ya shiga yaƙi da kwayar cutar.
Kwayoyin lymphocytes na T ciki har da CD4 + da CD8 + T sun taka muhimmiyar rawa a cikin kariya.
Kwayoyin CD4+ T suna motsa kwayoyin B su samar da ƙwayoyin cuta na ƙwayoyin cuta, kuma kwayoyin CD8+ T kai tsaye suna kashe kwayoyin da suka kamu da cutar.
Kwayoyin T masu taimakawa suna samar da cytokines masu hana kumburi don taimakawa kwayoyin karewa.
Koyaya, CoV na iya hana ayyukan ƙwayoyin T ta hanyar haifar da apoptosis na ƙwayoyin T.
Tsaron jiki gami da abubuwan da ke karawa kamar C3a da C5a da kuma kwayoyin cutar ma yana da mahimmanci wajen yaki da kamuwa da kwayar cutar.
Misali, ƙwayoyin cuta da aka ware daga mai haƙuri da ya warke sun kawar da MERS-CoV.
A wani ɓangare kuma, idan jikin mutum ya yi amfani da ƙwayar cuta fiye da yadda ya kamata, hakan zai sa a samu ƙwayoyin cuta masu yawa da za su iya lalata huhu da sauran gabobin jiki, kuma a mafi munin yanayi, zai iya sa mutum ya rasa gabobin jiki da yawa har ma ya mutu.
Cutar SARS-CoV-2, wacce ke nuna ta hanyar tarin cututtuka, tana iya shafar tsofaffi da ke da cututtukan da ke tattare da su da mata masu juna biyu.
Abu ne na kowa cewa ga mutanen da suka kamu da ƙwayoyin cuta da yawa ko kuma waɗanda aikin garkuwar jikinsu ya lalace, suna da damar kamuwa da cutar fiye da wasu.
Kimanin matsakaicin lokacin haɓakawa na SARS-CoV-2 shine kwanaki 1-14, galibi kwanaki 3-7 bisa ga binciken farkon shari'o'i 425 a Wuhan.
Koyaya, nazarin kan shari'o'i 1,099 ya nuna cewa lokacin haɓakawa ya kasance kwanaki 3 a matsakaici kuma ya kasance daga kwanaki 0 zuwa 24.
Wani bincike na baya-bayan nan, kamar yadda aka bayyana a sama, ya nuna cewa lokacin da aka yi a cikin cutar ya kai kwanaki 4.8 (3.0-7.2) bisa alƙaluma na mutane 8,866.
Yana da matukar muhimmanci ga hukumomin kiwon lafiya su daidaita lokacin keɓewa bisa ga mafi ƙarancin lokacin ɗorawa, don haka hana mutane da ke kamuwa amma ba su da alamun cutar daga watsa kwayar cutar ga wasu.
A matsayin al'ada, ana buƙatar mutane da suka kamu da cutar, ko kuma suka kamu da ita, a keɓe su na tsawon kwanaki 14.
Shin ya kamata a tsawaita lokacin keɓewa zuwa kwanaki 24?
Zazzabi galibi shine babban alama na farko na COVID-19, wanda ba shi da wata alama ko wasu alamomi kamar tari mai bushe, rashin numfashi, ciwon tsoka, zazzaɓi, ciwon kai, ciwon makogwaro, rhinorrhea, ciwon kirji, zawo, tashin zuciya, da zubar da ciki.
Wasu marasa lafiya sun sami dyspnea da/ ko hypoxemia mako guda bayan fara cutar.
A cikin mawuyacin yanayi, marasa lafiya da sauri sun ci gaba zuwa ciwon cututtukan numfashi mai tsanani, tashin hankali, acidosis na metabolism, da kuma coagulopathy.
Ya kamata a bincika marasa lafiya da ke da zazzabi da/ ko alamun numfashi da kuma zazzabi mai tsanani, koda kuwa ba tare da rashin daidaito na hoton huhu ba, don gano cutar da wuri.
Wani binciken alƙaluma a ƙarshen Disamba na 2019 ya nuna cewa yawan alamun cutar ya kasance 98% don zazzabi, 76% don tari mai bushe, 55% don dyspnea, da 3% don zawo; 8% na marasa lafiya suna buƙatar tallafin iska.
An bayar da rahoton irin wannan binciken a cikin binciken biyu na kwanan nan na tarin iyali da kuma tarin da ya haifar da watsawa daga mutum mara alamun.
Hakazalika, binciken alƙaluma a cikin 2012 ya nuna cewa marasa lafiyar MERS-CoV suma suna da zazzabi (98%), tari mai bushe (47%), da dyspnea (55%) a matsayin manyan alamun su.
Koyaya, 80% daga cikinsu sun buƙaci tallafin iska, fiye da marasa lafiyar COVID-19 kuma daidai da mutuwar MERS fiye da COVID-19.
An kuma lura da zawo (26%) da ciwon makogwaro (21%) a cikin marasa lafiyar MERS.
A cikin marasa lafiya na SARS, an nuna cewa zazzabi (99% - 100%), tari mai bushe (29% - 75%), dyspnea (40% - 42%), zawo (20-25%), da ciwon makogwaro (13-25%) sune manyan alamun cutar kuma ana buƙatar tallafin iska a kusan 14% - 20% na marasa lafiya.
Zuwa 14 ga Fabrairu, mutuwar COVID-19 ta kai kashi 2 lokacin da waɗanda aka tabbatar da su suka kai 66,576 a duniya.
Hakazalika, mutuwar SARS a watan Nuwamba 2002 ya kasance 10% na 8,096 da aka tabbatar da su.
Don MERS, bisa ga binciken alƙaluma a watan Yunin 2012, mutuwar ta kasance 37% na 2,494 da aka tabbatar da su.
Wani binciken da ya gabata ya ruwaito cewa R0 na SARS-CoV-2 ya kai 6.47 tare da 95% na lokacin amincewa (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya kasance daga 2 zuwa 4.
An gabatar da kwatancen SARS-CoV-2 tare da MERS-CoV da SARA-CoV dangane da alamun su, mutuwarsu da R0 a cikin Table Table1.1.
Adadin da ke sama ya nuna cewa SARS-CoV-2 yana da mafi girman ikon yaduwa fiye da MERS-CoV da SARS-CoV, amma ba shi da kisa fiye da na biyun.
Saboda haka, ya fi ƙalubale a sarrafa annobar SARS-CoV-2 fiye da na MERS-CoV da SARS-CoV.
Sau da yawa ana samun tarin cutar a cikin iyali ɗaya ko daga taro ɗaya ko abin hawa kamar jirgin ruwa.
Marasa lafiya galibi suna da tarihin tafiya ko zama a Wuhan ko wasu yankunan da cutar ta shafa ko hulɗa da mutane ko marasa lafiya masu kamuwa a cikin makonni biyu da suka gabata kafin farawar cutar.
Koyaya, an bayar da rahoton cewa mutane na iya ɗaukar kwayar cutar ba tare da alamun cutar ba fiye da makonni biyu kuma marasa lafiya da aka warkar da su daga asibitoci na iya sake ɗaukar kwayar cutar, wanda ke aika da ƙararrawa don ƙara lokacin keɓewa.
Marasa lafiya suna da adadin ƙwayoyin farar jini na waje (musamman lymphocytes) na al'ada ko raguwa a farkon matakin.
Misali, an sami cutar lymphopenia tare da ƙididdigar ƙwayoyin jini &lt; 4×109/L ciki har da ƙididdigar lymphocyte &lt; 1×109/L, da kuma ƙaruwar matakan aspartate aminotransferase da viremia a cikin marasa lafiya 1,099 na COVID-19.
An ƙara matakan hanta da ƙwayoyin ƙwayoyin cuta da myoglobin a cikin jinin wasu marasa lafiya, kuma an ƙara C-reactive protein da kuma ƙwayoyin erythrocyte a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya masu mawuyacin hali, matakin D- dimer, samfurin lalacewar fibrin da ke cikin jini, ya tashi, kuma ƙididdigar lymphocyte ya ragu a hankali.
An gano rashin daidaito a cikin hotunan kirji a yawancin marasa lafiyar COVID-19 kuma ana nuna su ta hanyar inuwa mai banƙyama ta bangarorin biyu ko kuma gilashin da aka niƙa a cikin huhu.
Marasa lafiya galibi suna samun ciwon huhu mara kyau, raunin huhu mai tsanani, da kuma ciwon numfashi mai tsanani (ARDS).
Sa'ad da ARDS ta faru, kumburi da ba a iya sarrafawa, tarin ruwa, da kuma ci gaba da ciwon fibrosis suna sa musayar gas ya yi muni sosai.
Rashin aiki na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Saboda haka, sakamakon radiography na kirji mafi muni sau da yawa yana daidai da mafi tsanani na cutar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna ɓarkewar ƙwayoyin cuta, samuwar membrane na hyaline, da kuma shiga cikin ƙwayoyin cuta na interstitial, da ƙwayoyin syncytial masu ƙwayoyin cuta masu yawa a cikin huhu na mai haƙuri wanda ya mutu daga cutar, daidai da yanayin kamuwa da kwayar cutar ta kwayar cuta da ARDS kuma yayi kama da na SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar jujjuya-transcriptase polymerase chain reaction (RT-PCR) a matsayin babban ka'ida don ganewar asali na COVID-19.
Koyaya, saboda yawan ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Hakanan lamarin ya faru da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwajen dakin gwaje-gwaje, da binciken radiology yana da mahimmanci kuma yana da mahimmanci don yin ganewar asali.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana yarjejeniya ta amfani da fasahar SHERLOCK mai tushen CRISPR don gano SARS-CoV-2, wanda ke gano ɓangarorin SARS-CoV-2 RNA na roba a 20 × 10-18 mol / L zuwa 200 × 10-18 mol / L (10-100 kwafi a kowace microliter na shigarwa) ta amfani da dipstick a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai mahimmanci ba.
Da fatan, sabuwar hanyar na iya inganta ƙwarewa da dacewa idan an tabbatar da shi a cikin samfuran asibiti.
Saboda rashin gogewa da sabon CoV, likitoci na iya ba da kulawa mai goyan baya ga marasa lafiyar COVID-19 yayin ƙoƙarin magunguna iri-iri waɗanda aka yi amfani da su ko aka ba da shawarar a baya don maganin sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table (Table2).2).
Wadannan hanyoyin sun hada da maganin da ake yi yanzu da kuma na iya zuwa da magungunan rigakafin cutar, magungunan hana kamuwa da cuta, magungunan steroid, jini daga marasa lafiya da suka warke, maganin kasar Sin, da kuma tallafin tunani.
Ko da jini daga marasa lafiya da suka warke an ba da shawarar a yi amfani da shi don magani.
Kamfanonin magunguna suna gaggawar samar da kwayoyin cutar da kuma allurar rigakafi da za su iya kawar da cutar.
SARS-CoV-2 ya fi kaiwa huhu hari a farko kuma mai yiwuwa kuma ya kai hari, a ƙaramin mataki, wasu gabobin da ke bayyana ACE2, kamar tsarin gastrointestinal da koda.
Duk da haka, rashin aiki da gazawar numfashi sune babbar barazana ga marasa lafiya kuma babban dalilin mutuwa.
Don haka, tallafin numfashi yana da mahimmanci don sauƙaƙe alamun cutar da ceton rayuka kuma ya haɗa da maganin oxygen na gaba ɗaya, iskar oxygen mai ƙarfi, iska mai iska, da iska mai iska mai ƙarfi dangane da tsananin cutar.
Marasa lafiya da ke da cututtukan numfashi masu tsanani dole ne a tallafa musu da oxygenation membrane na waje (ECMO), wani gyaran hanyar bypass na zuciya da huhu da ake amfani da shi don maganin rashin ƙarfi na zuciya ko na numfashi mai barazana ga rayuwa.
Bugu da kari, kiyaye daidaiton lantarki, rigakafi da maganin kamuwa da cuta na biyu da kuma girgizar kasa, da kuma kare ayyukan gabobin rayuwa ma na da muhimmanci ga marasa lafiya da SARS-CoV-2.
An san cewa guguwar cytokine sakamakon wuce haddi ne na tsarin garkuwar jiki a cikin marasa lafiya na SARS da MERS.
Cytokine hadari wani nau'i ne na amsawar kumburi ta tsarin da aka nuna ta hanyar sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna haifar da kwayoyin garkuwar jiki don sakin adadi mai yawa na 'yanci wanda shine babban dalilin ARDS da gazawar gabobin jiki da yawa.
Immunosuppression yana da mahimmanci a cikin maganin guguwar cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da maganin corticosteroids da tocilizumab, wanda shine anti-IL6 monoclonal antibody, don magance cutar cytokine.
Sauran magungunan hana rigakafi don guguwar cytokine sun haɗa da daidaitawar amsawar rigakafin da aka tsara ta kwayar T; toshewar IFN-γ, IL-1, da TNF; hana JAK; blinatumomab; mai hana siginar cytokine 4; da masu hana HDAC.
Ana amfani da steroids, a matsayin maganin hana rigakafi, a cikin maganin SARS don rage tsananin lalacewar kumburi.
Koyaya, steroids a cikin manyan allurai ba su da fa'ida ga mummunan raunin huhu a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako na gefe, musamman avascular osteonecrosis, wanda ke shafar yanayin cutar sosai.
Duk da haka, an ba da shawarar a yi amfani da gajeren lokacin shan maganin corticosteroids a ƙananan zuwa matsakaici don masu cutar COVID-19 masu tsanani.
A lokacin rubuta wannan, babu wani maganin cutar da ya tabbatar da inganci.
Koyaya, an gano cewa maganin intravenous tare da remdesivir, kwatankwacin nucleotide, yana da tasiri a cikin wani mara lafiyar Amurka tare da COVID-19.
Remdesivir wani sabon magani ne na rigakafin cutar da Gilead ta haɓaka da farko don maganin cututtukan da ƙwayoyin cuta na Ebola da Marlburg ke haifarwa.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta na RNA guda ɗaya ciki har da ƙwayoyin cuta na MERS da SARS.
Dangane da waɗannan, Gilead ta samar da mahaɗin zuwa China don gudanar da gwaje-gwaje biyu akan mutanen da ke dauke da cutar SARS-CoV-2, kuma ana tsammanin sakamakon.
Bugu da kari, baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin an ba da shawarar a matsayin magunguna masu yuwuwa ga marasa lafiya da ke da cututtukan numfashi mai tsanani.
Cutar shan inna, tashin zuciya, amai, lalacewar hanta, da sauran halayen cutarwa na iya faruwa bayan hada maganin lopinavir/ ritonavir.
Ya kamata a lura da hulɗar waɗannan magunguna tare da sauran magungunan da ake amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma samar da kwayoyin cutar
Tattara jini daga marasa lafiya da suka warke daga wata cuta mai saurin yaduwa don a kula da wasu marasa lafiya da suke fama da wannan cuta ko kuma a kāre mutane masu lafiya daga kamuwa da cutar tana da tarihi mai tsawo.
Hakika, marasa lafiya da suka warke sau da yawa suna da matakan rigakafi da yawa a cikin jinin su da ke yaƙi da kwayar cutar.
Kwayoyin rigakafi sune immunoglobulin (Ig) da kwayoyin B ke samarwa don yaƙar ƙwayoyin cuta da sauran abubuwa na waje kuma suna gane ƙwayoyin ƙwayoyin cuta na musamman a cikin ƙwayoyin cuta kuma suna kawar da su kai tsaye.
Dangane da wannan, an tattara jini daga jinin rukunin marasa lafiya waɗanda suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 da ke da mummunan cuta allura.
Alamun su sun inganta cikin awanni 24, tare da rage kumburi da nauyin kwayar cuta da ingantaccen iskar oxygen a cikin jini.
Duk da haka, ana bukatar tabbatarwa da bayyanawa don ba da shawarar hanyar don amfani mai yawa kafin a ci gaba da takamaiman hanyoyin magani.
Bugu da ƙari, saboda tasirin maganin, wasu rashin amfani da ke tattare da jini ya kamata a yi la'akari da su a hankali.
Misali, ƙwayoyin cuta na iya tayar da amsawar rigakafi kuma su haifar da ciwon cytokine, wanda zai iya zama haɗarin haɗari.
Yawan rigakafin a cikin jini yawanci ba shi da yawa, kuma ana bukatar jini mai yawa don a kula da marasa lafiya masu ciwo mai tsanani.
Yana da wuya a samar da takamaiman ƙwayoyin cuta da sauri don yaƙi da annobar duniya.
Don haka, ya fi mahimmanci da kuma amfani a ware ƙwayoyin B daga marasa lafiya da suka warke kuma a gano lambobin ƙwayoyin halitta waɗanda ke yin kwafin ƙwayoyin cuta masu tasiri ko kuma a bincika ƙwayoyin cuta masu tasiri akan mahimman sunadarai na kwayar cutar.
Ta wannan hanyar, za mu iya ƙara yawan samar da ƙwayoyin cuta.
An yi amfani da TCM don magance cututtuka daban-daban a China na dubban shekaru.
Koyaya, tasirinsa ya dogara ne da haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da ganewar asali na cutar bisa ka'idodin TCM.
Yawancin abubuwan da ke aiki ba a san su ba ko kuma ba su da ma'ana saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwan ko kuma haɗuwa da su.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin magani na madadin ga marasa lafiya tare da haske zuwa matsakaiciyar bayyanar cututtuka ko kuma ga waɗanda suka murmure daga matakai masu tsanani.
Misali, Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules an gano cewa suna da tasiri don maganin COVID-19.
An lura da mafi girman adadin warkarwa a cikin maganin marasa lafiyar COVID-19 a larduna da dama a China waɗanda suka yi amfani da TCM a cikin kashi 87% na marasa lafiyar su, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ya yi amfani da TCM a cikin kusan kashi 30% na marasa lafiyar COVID-19 nasa, yana da mafi ƙarancin adadin warkarwa (13%).
Koyaya, wannan kwatancen ne mai ɗan taushi saboda yawancin sauran abubuwan tasiri kamar su yawan marasa lafiya da tsananin cutar ya kamata a haɗa su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike don kwatanta maganin maganin yamma (WM) shi kaɗai tare da haɗin maganin WM da TCM.
Sun gano cewa lokutan da ake buƙata don farfado da zafin jiki, ɓacewar bayyanar cututtuka, da kuma asibiti sun kasance masu gajarta sosai a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai.
Mafi ban sha'awa, yawan cutar ta cutar (daga mai sauƙi zuwa mai tsanani) ya kasance ƙasa da yawa ga ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (7.4% vs. 46.2%) kuma mutuwar ta kasance ƙasa a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (8.8% vs. 39%).
Duk da haka, inganci da amincin TCM har yanzu suna jiran ƙarin gwaji mai kyau a manyan sikelin da kuma a cikin cibiyoyi da yawa.
Hakanan zai zama mai ban sha'awa don bayyana yanayin aikin kuma a bayyana abubuwan da ke cikin maganin TCM ko haɗuwa da su idan ya yiwu.
Marasa lafiya da ake zargi ko kuma aka tabbatar da cutar COVID-19 galibi suna fuskantar babban tsoro na cutar mai saurin yaduwa har ma da kisa, kuma mutanen da ke keɓewa suma suna fuskantar rashin jin daɗi, kaɗaici, da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, hypoxia, da tari da kuma mummunan tasirin jiyya kamar rashin bacci da aka haifar da maganin corticosteroids na iya haifar da ƙarin damuwa da damuwa ta hankali.
A farkon farkon barkewar cutar ta SARS, an ba da rahoton wasu cututtukan kwakwalwa ciki har da ciwon bakin ciki na dindindin, damuwa, hare-haren tsoro, tashin hankali na kwakwalwa, alamun cutar ta kwakwalwa, hauka, har ma da kashe kansa.
Binciken tuntuɓar wajibi da keɓewa, a matsayin wani ɓangare na martani na lafiyar jama'a ga ɓarkewar COVID-19, na iya sa mutane su ƙara damuwa da laifi game da tasirin kamuwa da cuta, keɓewa, da kuma ƙyama a kan danginsu da abokansu.
Don haka, ya kamata a samar da kulawar lafiyar kwakwalwa ga marasa lafiyar COVID-19, mutanen da ake zargi, da mutanen da ke hulɗa da su da kuma jama'a da ke da bukata.
Tallafin halayyar dan adam ya kamata ya hada da kafa kungiyoyin kiwon lafiya na hankali masu fannoni daban-daban, sadarwa mai ma'ana tare da sabuntawa na yau da kullun da kuma daidai game da barkewar cutar SARS-CoV-2 da tsare-tsaren magani da kuma amfani da na'urorin lantarki da aikace-aikacen ƙwararru don kauce wa kusanci da juna.
Alurar riga kafi mai inganci tana da mahimmanci don katse layin watsawa daga wuraren ajiyar dabbobi da mutane masu kamuwa da cuta zuwa masu karɓar bakuncin da ke da saukin kamuwa da cuta kuma galibi suna dacewa da maganin antiviral a cikin sarrafa annobar da ƙwayoyin cuta ke haifar.
An yi ƙoƙari don haɓaka alluran rigakafi na tushen furotin S don samar da tsayayyun ƙwayoyin cuta masu tsawo da ƙarfi da / ko rigakafin kariya daga SARS-CoV.
An kimanta allurar rigakafin rayayyu a kan ƙirar dabbobi don SARS.
Koyaya, ingancin in vivo na waɗannan masu neman allurar rigakafi a cikin tsofaffi da samfuran ƙalubalen mutuwa da kariya daga kamuwa da kwayar cutar zoonotic har yanzu ba a ƙaddara ba kafin a fara gwajin asibiti.
Wannan wataƙila saboda SARS ya mutu shekaru 17 da suka gabata kuma ba a ba da rahoton sabon yanayin ba tun daga lokacin.
Akasin haka, lokuta da tarin MERS na ci gaba da faruwa a Gabas ta Tsakiya kuma sun bazu zuwa wasu yankuna saboda ci gaba da tushen zoonotic a yankunan da ke da cutar.
An tsara dabarun allurar rigakafi don MERS ta hanyar amfani da kwayar cutar da ba ta da aiki, plasmids na DNA, masu ɗaukar kwayar cutar, nanoparticles, ƙwayoyin cuta masu kama da kwayar cuta da ƙananan ƙwayoyin cuta masu haɗuwa kuma an kimanta wasu a kan ƙirar dabbobi.
Ci gaban rigakafin SARS-CoV-2 mai lafiya da tasiri ga mutanen da ba su da rigakafi aiki ne mai gaggawa da mahimmanci don sarrafa annobar da ke gudana.
Koyaya, yana da ƙalubale a shawo kan wahalar saboda dogon lokaci (talakawa watanni 18) da ake buƙata don haɓaka allurar rigakafi da kuma canji mai ƙarfi na CoVs.
A matsayin sabon cuta, COVID-19 ya fara bayyana cikakkiyar hanyarsa ta asibiti a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya na iya samun sauki a hankali ba tare da wani ciwo ba.
Koyaya, kamar SARS da MERS, COVID-19 kuma yana da alaƙa da babban rashin lafiya da mutuwa a cikin marasa lafiya tare da mawuyacin hali.
Saboda haka, gina samfurin tsinkaya don cutar yana da mahimmanci ga hukumomin kiwon lafiya don fifita ayyukansu, musamman a yankunan da ke da iyakantaccen albarkatu.
Dangane da binciken asibiti da aka ruwaito ya zuwa yanzu, abubuwan da ke gaba na iya shafar ko kuma suna da alaƙa da hangen nesa na marasa lafiyar COVID-19 (Table (Table33)):
Shekara: Shekara ita ce muhimmiyar mahimmanci don sanin cutar SARS, wanda hakan ma ya shafi COVID-19.
COVID-19 ya faru ne da farko a cikin shekaru 30-65 tare da kashi 47.7% na waɗannan marasa lafiya sama da shekaru 50 a cikin binciken shari'o'i 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun fi saurin samun cututtukan da ke tattare da cuta da kuma tsufa fiye da waɗanda ba su da (a matsakaicin shekaru 66 da 51), yana nuna shekaru a matsayin abin da ke haifar da sakamakon marasa lafiyar COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka bayyana a sama.
Cutar da rikice-rikice: Marasa lafiya da ke da COVID-19 waɗanda ke buƙatar kulawa mai tsanani suna iya shan wahala daga raunin zuciya mai tsanani da arrhythmia.
Abubuwan da ke faruwa a zuciya kuma sune babban dalilin mutuwa a cikin marasa lafiya na SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya ɗaurewa ga ACE2-positive cholangiocytes, wanda zai iya haifar da rashin aiki na hanta a cikin marasa lafiyar COVID-19.
Ya kamata a lura cewa shekaru da ciwon da ke saurin faruwa suna da nasaba sosai kuma suna iya shafan juna.
Abubuwan da aka gano na asibiti: Matsayin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko raunin nama kuma an ba da shawarar zama mai yuwuwar yanayin cutar, amsawa ga magani, da warkewa ta ƙarshe.
An kuma ba da shawarar alaƙar matakin CRP da tsananin cutar COVID-19 da kuma hangen nesa.
Bugu da kari, hawan lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan enzymes suna bayyana sosai a cikin gabobin da yawa, musamman a zuciya da hanta, kuma ana sakin su yayin lalacewar nama.
Saboda haka, su ne alamun gargajiya na rashin aiki na zuciya ko hanta.
Babban alamun asibiti: Ya kamata a yi la'akari da daukar hoton kirji da ci gaban alamun asibiti na lokaci tare da sauran batutuwa don hango sakamakon da rikitarwa na COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune maganin rigakafi wanda ake amfani dashi a matsayin magani na ƙarin cututtuka don rage tsananin lalacewar kumburi.
Tunda ana amfani da babban sashi na corticosteroids a cikin marasa lafiya masu cutar SARS mai tsanani, yawancin waɗanda suka tsira sun sha wahala daga avascular osteonecrosis tare da nakasa tsawon rai da ƙarancin ingancin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroids a ƙananan allurai kuma na ɗan gajeren lokaci a cikin marasa lafiyar COVID-19.
Damuwa ta hankali: Kamar yadda aka bayyana a sama, a lokacin barkewar COVID-19 marasa lafiya da yawa sun sha wahala daga matsanancin damuwa kamar yadda sau da yawa suna jure tsawon lokacin keɓewa da matsanancin rashin tabbas kuma sun ga mutuwar dangi na kusa da abokan su marasa lafiya.
Yana da mahimmanci a samar da shawara ta tunani da tallafi na dogon lokaci don taimakawa waɗannan marasa lafiya su murmure daga damuwa kuma su koma rayuwa ta al'ada.
Dangane da binciken alƙaluma ya zuwa yanzu, COVID-19 da alama yana da halaye daban-daban na annoba daga SARS.
Baya ga yin kwafi a ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin kwafi cikin inganci a cikin hanyoyin numfashi na sama kuma yana haifar da laushi ko babu alamun a farkon matakin kamuwa da cuta, kama da sauran CoVs waɗanda ke haifar da sanyi na yau da kullun.
Saboda haka, marasa lafiya da suka kamu a farkon lokaci ko lokacin hawan za su iya samar da adadin kwayar cutar mai yawa yayin ayyukan yau da kullun, wanda ke haifar da babbar wahala ga sarrafa annobar.
Koyaya, ana ɗaukar watsa SARS-CoV ya faru lokacin da marasa lafiya ke da mummunan rashin lafiya, yayin da yawancin watsawa ba ya faruwa a farkon matakin.
Saboda haka, barkewar COVID-19 na yanzu ya fi tsanani kuma yana da wahalar sarrafawa fiye da barkewar SARS.
Ana kokarin yin manyan ayyuka a yanzu a China ciki har da kulle Wuhan da biranen da ke kewaye da shi da kuma ci gaba da keɓewar kusan dukkan jama'a da fatan dakatar da yaduwar SARS-CoV-2.
Kodayake waɗannan ayyukan sun yi mummunan lalacewa ga tattalin arziki da sauran ɓangarorin ƙasar, adadin sabbin marasa lafiya yana raguwa, yana nuna jinkirin annobar.
Kimanin mafi kyawun fata shine cewa barkewar cutar zata ƙare a watan Maris kuma lokacin raguwa zai ɗauki watanni 3-4.
Amma, wasu masana ba su da irin wannan bege.
Paul Hunter, et al., sun kiyasta cewa COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare ba a shekarar 2020.
Ira Longini, et al., sun kafa wani tsari don hango sakamakon annobar kuma sun ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan jama'ar duniya.
Wata ƙungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin swabs na tsakiya da makogwaro na marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon ƙwayar cutar da aka gano na iya zama yanayin sake zagayowar kama da mura.
Koyaya, alamun da ke ba da bege sun faru a China bisa raguwar adadin sabbin shari'o'in, wanda ke nuna cewa dabarun yanzu na iya yin aiki.
A farko an yi hasashen cewa cutar Ebola za ta iya kaiwa miliyan daya tare da mutuwar mutane miliyan daya da rabi.
Duk da haka, ta hanyar tsauraran tsare-tsare da keɓewa, an sami nasarar sarrafa cutar a ƙarshe.
Yana yiwuwa, kamar SARS-CoV, cewa SARS-CoV-2 na iya zama mai rauni a cikin kamuwa da cuta kuma daga ƙarshe ya mutu ko ya zama ƙarancin kwayar cuta mai cuta tare da mutane.
An ba da kwatancen annobar COVID-19 da na SARS da MERS a ƙasa (Hoto na 55).
SARS-CoV-2 yana yaduwa sosai ta hanyar tari ko tari, kuma mai yiwuwa kuma ta hanyar hulɗa kai tsaye da kayan da cutar ta gurɓata.
An kuma gano kwayar cutar a cikin kwari, wanda ke haifar da sabon yiwuwar yaduwar kwari zuwa baki.
Wani binciken da aka yi kwanan nan kan mutane 138 ya ruwaito cewa kashi 41% na masu cutar na iya haifar da kamuwa da cuta ta hanyar asibiti, ciki har da marasa lafiya 17 da ke da wasu cututtuka da suka gabata da kuma masu ba da kiwon lafiya 40.
Saboda haka, ya kamata a yi amfani da tsauraran matakai don kare mutane, musamman masu kula da lafiya, ma'aikatan zamantakewa, 'yan iyali, abokan aiki, har ma da masu kallo da ke hulɗa da marasa lafiya ko mutanen da ke da cutar.
Layin farko na kariya wanda za a iya amfani da shi don rage haɗarin kamuwa da cuta shine ta hanyar sanya abin rufe fuska; duka amfani da abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 (jerin # 1860s) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata na hana saukad da ruwa daga mai yiwuwar kamuwa da cutar daga tafiya ta iska ko mannewa a saman kayan, inda za a iya watsa su ga wasu.
Koyaya, kawai N95 (jerin # 1860s) masks na iya karewa daga numfashin virions kamar ƙananan 10 zuwa 80 nm, tare da 5% na virions kawai suna iya shiga gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a girma kuma duka suna kusan 85 nm.
Tunda ƙwayoyin cuta na iya shiga cikin masks biyar na tiyata da aka ɗora tare, masu ba da kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya dole ne su sa N95 (jerin # 1860s) masks amma ba masks na tiyata ba.
Baya ga abin rufe fuska, ya kamata masu kula da lafiya su sanya rigunan keɓewa don rage hulɗa da ƙwayoyin cuta.
Ƙwayoyin cuta kuma za su iya kamuwa da mutum ta idanu.
A ranar 22 ga Janairu, 2020, likita ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; cutar ta iya shiga jikinsa ta hanyar idanunsa masu kumburi.
Saboda haka, masu kula da lafiyar ya kamata su saka abin rufe fuska ko kuma tabarau sa'ad da suke aiki da marasa lafiya.
Ga jama'a a yankunan da cutar ta shafa ko kuma wanda za ta iya shafawa, an ba da shawarar sosai cewa kowa ya wanke hannayensa da sabulu mai kashe ƙwayoyin cuta fiye da yadda aka saba, yi ƙoƙarin kasancewa a cikin gida don keɓewa da iyakance hulɗa da mutanen da ke iya kamuwa da cutar.
An dauki nisan kafa uku a matsayin mai kyau ga mutane su nisanta daga mai haƙuri.
Waɗannan ayyuka hanyoyi ne masu tasiri don rage haɗarin kamuwa da cuta da kuma hana yaduwar kwayar cutar.
Kodayake SARS-CoV-2 ya zo a matsayin sabon kwayar cutar ga duniyar ɗan adam, babban daidaituwa da SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu 2020 ya kamata ya haifar da babban faɗakarwa ga China bisa la'akari da ƙwaƙwalwar ƙwaƙwalwar cutar SARS a 2003.
Koyaya, ba sai ranar 19 ga Janairu 2020 ne daraktan Cibiyar Kula da Cututtuka ta Wuhan ya ta'azantar da 'yan ƙasa ta hanyar cewa sabon kwayar cutar tana da ƙarancin yaduwa da iyakantaccen haihuwa daga mutum zuwa mutum kuma cewa ba matsala ce don hanawa da kuma hana cutar.
Wannan sakon ya kwantar da hankalin jama'a, musamman lokacin da duk kasar ke shirin bikin bazara, kuma an rasa lokaci mai mahimmanci don hana cutar a ƙaramar sikelin ta a Wuhan.
Hukumomin kula da cututtuka a China na iya ɗaukar wannan darasi mai wuya kuma suyi ci gaba mai mahimmanci a nan gaba.
Alal misali, waɗannan hukumomin ya kamata (1) su kasance masu taka tsantsan yayin yin sanarwar jama'a kamar yadda kowace kalma ke da mahimmanci ga 'yan ƙasa kuma suna iya canza halinsu da yanke shawara; (2) mafi mahimmanci da kuma amsawa ga bayanai marasa kyau daga asibitoci maimakon jiran rahotanni na hukuma daga likitoci ko jami'ai; (3) mafi ƙuntatawa don hana yiwuwar annobar a farkon matakin ta maimakon ƙoƙarin ta'azantar da jama'a; da kuma (4) mafi sau da yawa don bayar da manufa da kuma tasiri don ƙara wayar da kan jama'a game da cututtukan annoba da kuma gwadawa da inganta tsarin amsawa na al'umma lokaci-lokaci.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya bazu ko'ina cikin China da kusan wasu kasashe 50 a duniya a lokacin rubuta wannan.
Tunda kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar ma sun yi kama da COVID-19 da SARS, barkewar COVID-19 ta haifar da jin cewa SARS na sake dawowa.
Koyaya, akwai wasu bambance-bambance masu ban mamaki tsakanin COVID-19 da SARS, waɗanda suke da mahimmanci don hana annobar da kuma kula da marasa lafiya.
COVID-19 na shafar tsofaffi fiye da matasa da maza fiye da mata, kuma tsananin cutar da yawan mutuwa ma sun fi na tsofaffi fiye da na matasa.
SARS tana da yawan mutuwa fiye da COVID-19 (10.91% vs 1.44%).
Marasa lafiya na COVID-19 suna yada kwayar cutar ko da ba su da alamun cutar yayin da marasa lafiya na SARS ke yin hakan a lokacin da suke da ciwo mai tsanani, wanda ke haifar da matsala mafi girma wajen hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wani ɓangare dalilin da yasa SARS-CoV-2 ya bazu da sauri da yawa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiyar COVID-19.
A gefe guda kuma, marasa lafiya da suka warke na iya sake nuna cewa suna da kwayar cutar.
Wadannan binciken sun kara hadarin yaduwar kwayar cutar sosai.
Ganin irin wannan saurin ci gaba a cikin bincike kan COVID-19, akwai wasu mahimman batutuwa da ke buƙatar warwarewa, kamar haka:
Daga ina SARS-CoV-2 ya fito?
Kodayake an sami kashi 96% na kwayoyin halittar tsakanin SARS-CoV-2 da CoVs biyu masu kama da SARS, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 daga bat ne ba.
Wane dabba ne ya kai cutar daga mahaifar da ta fara, wato, barewa, zuwa ga mutane?
Ba tare da sanin amsoshin 1 da 2 ba, ba za mu iya yanke watsawar yadda ya kamata ba, kuma annobar na iya sakewa a kowane lokaci.
Kodayake samfurin kwayoyin halitta da gwajin kwayoyin sun nuna cewa SARS-CoV-2 yana ɗaure zuwa ACE2, ta yaya ainihin kwayar cutar ta shiga cikin ƙwayoyin hanyar numfashi kuma ta haifar da canje-canje na pathological na gaba?
Shin kwayar cutar tana ɗaure ƙwayoyin ACE2 a wasu gabobin?
Idan ba mu sami amsoshi masu kyau ga waɗannan tambayoyin ba, ba za mu iya samun ganewar asali da kuma magani mai kyau ba.
Har yaushe za a ci gaba da annobar?
Ta yaya kwayar cutar take juyawa a lokacin da take yaduwa tsakanin mutane?
Shin zai zama annoba a duniya, ya mutu kamar SARS ko kuma ya sake dawowa kamar mura?
Yana da muhimmanci amma zai ɗauki lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Duk da haka, ko da menene kudin da zai iya bukata, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu dawo da rayuwarmu yadda ta kasance.
Tushen kwayar cutar korona ta mutum
Juyin halittar halitta da daidaitawa sun haifar da juyin halittar kwayar cutar corona (CoVs) da kuma masu masaukinsu, gami da mutane, tsawon dubban shekaru.
Kafin 2003, an san cewa CoVs biyu na mutum (HCoVs) suna haifar da rashin lafiya mai sauƙi, kamar sanyi na yau da kullun.
Barkewar cutar ta mummunar cutar numfashi (SARS) da cutar numfashi ta Gabas ta Tsakiya (MERS) sun juyar da tsabar kudi don bayyana yadda cutar HCoV za ta iya zama mai hallaka da barazana ga rayuwa.
Bayyanar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake tura CoVs cikin hasken rana kuma ya ba mu mamaki da yawan yaduwar sa amma rage cutar idan aka kwatanta da 'yar'uwar sa SARS-CoV.
Cutar HCoV cuta ce ta dabbobi kuma fahimtar asalin dabbobi na HCoVs zai amfane mu sosai.
Yawancin HCoVs sun samo asali ne daga batutuwan da ba su da cutar.
Hakanan an san matsakaitan masu riƙe da wasu HCoVs.
Gano masu ba da izinin dabbobi yana da tasiri kai tsaye a cikin rigakafin cututtukan mutane.
Binciken hulɗar CoV-host a cikin dabbobi na iya samun muhimmiyar fahimta game da cutar CoV a cikin mutane.
A cikin wannan bita, mun gabatar da bayyani na ilimin da ake da shi game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da kuma asalin su na dabbobi da kuma watsawa tsakanin jinsuna.
Abu mai mahimmanci, muna kwatanta da kuma bambance-bambancen HCoVs daban-daban daga hangen nesa na juyin halitta na kwayar cuta da kuma sake haɗuwa da kwayoyin halitta.
An tattauna game da annobar cutar CoV ta 2019 (COVID-19) a wannan mahallin.
Bugu da kari, an kuma nuna bukatun sauya mai masaukin da ya yi nasara da kuma tasirin juyin halittar kwayar cutar kan tsananin cutar.
Coronaviruses (CoVs) na cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na ɓoye, mai kyau-sensing, ƙwayoyin cuta na RNA guda ɗaya.
Wadannan ƙwayoyin cuta masu babban kwayar halitta na kilobases 26 zuwa 32 a tsakanin ƙwayoyin cuta na RNA an kira su CoVs saboda yanayin halittarsu kamar kambi a ƙarƙashin microscope na lantarki.
A tsarin, CoVs suna da kwayoyin halittar da ba su da rarrabuwa waɗanda ke da irin wannan ƙungiyar.
Kimanin kashi biyu bisa uku na kwayoyin sun ƙunshi manyan manyan sararin karatu biyu (ORF1a da ORF1b), waɗanda aka fassara zuwa pp1a da pp1ab polyproteins.
Ana ƙara sarrafa polyproteins don samar da sunadarai 16 marasa tsari, waɗanda aka sanya nsp1 ~ 16.
Sauran ɓangaren kwayoyin sun ƙunshi ORFs don sunadarai na tsari, ciki har da ƙugiya (S), envelope (E), membrane (M) da nucleoprotein (N).
Hakanan wasu ƙwayoyin cuta na musamman na ƙwayoyin cuta suna yin lambar ta hanyar nau'ikan CoV daban-daban.
Dangane da bambancin jerin sunadarai, ana rarraba CoVs zuwa nau'i huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), daga cikinsu nau'in beta-CoV ya ƙunshi yawancin HCoVs kuma an rarraba shi zuwa jinsi huɗu (A, B, C da D).
Shaidar ilimin halittu ta nuna cewa batsa da masu naman gwari sune tushen kwayoyin halittar mafi yawan alpha-CoVs da beta-CoVs, yayin da tsuntsaye su ne babban wurin ajiyar gamma-CoVs da delta-CoVs.
Shekaru dubbai, CoVs koyaushe suna ƙetare shingen nau'in kuma wasu sun fito a matsayin mahimman ƙwayoyin cuta na ɗan adam.
Zuwa yau, an san mutane bakwai na CoVs (HCoVs).
Daga cikinsu HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, coronavirus mai tsanani na cututtukan numfashi (SARS-CoV), coronavirus na cututtukan numfashi na Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun rashin lafiya, kamar sanyi da / ko zawo.
Akasin haka, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 da aka gano suna da cututtuka sosai, suna haifar da kamuwa da cuta mai tsanani a ƙananan hanyoyin numfashi a cikin marasa lafiya da yawa tare da babban damar samun ciwon ciwon numfashi mai tsanani (ARDS) da bayyanar extrapulmonary.
An ware kwayar HCoV-229E ta farko, B814, daga fitowar hanci na marasa lafiya da sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an tara ƙarin ilimi ta hanyar bincike mai zurfi akan HCoV-229E da HCoV-OC43, dukansu suna haifar da alamun da ke iyakance kansu.
Tabbas, an yarda da ra'ayin cewa kamuwa da HCoVs gabaɗaya ba shi da lahani har zuwa barkewar SARS.
Barkewar SARS da ta faru a 2003 na ɗaya daga cikin mafi muni a tarihin yanzu, ta kamu da mutane sama da 8,000 tare da mutuwar kusan kashi 10%.
Shekaru goma bayan haka, annobar cutar numfashi ta Gabas ta Tsakiya (MERS) ta haifar da wata annoba mai ci gaba a yankin Larabawa tare da yaduwa zuwa sauran duniya.
Sabuwar cutar HCoV (2019-nCoV) ta 2019, wacce daga baya aka sake masa suna SARS-CoV-2, ita ce mai haifar da annobar cutar coronavirus ta 2019 (COVID-19), wacce ta kashe mutane sama da 3,120 kuma ta kamu da mutane sama da 91,000 har zuwa ranar 3 ga Maris, 2020.
An yi gargadin kuma duniya dole ta shirya don annobar SARS-CoV-2 mai zuwa.
Dukkanin kwayar cutar HCoVs bakwai suna da asalin zoonotic daga bat, beraye ko dabbobin gida.
Layin shaidu da yawa suna tallafawa asalin juyin halitta na duk HCoVs daga bat, inda ƙwayoyin cuta suka dace da kyau kuma ba su da cutar amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta gabatar da kalubale masu yawa na likita, kimiyya, zamantakewa da ɗabi'a ga Sin da duniya.
Binciken asalin kwayar cutar HCoVs na samar da tsari don fahimtar tarihin halitta, motsa jiki da abubuwan da ke hana nau'in tsalle.
Wannan kuma na iya jagorantar ko sauƙaƙa bincike don mai riƙewa, matsakaici da haɓaka mai masaukin dabba na SARS-CoV-2, tare da mahimman abubuwan da ke tattare da hana ɓarkewar nan gaba.
A cikin wannan bita mun gabatar da bayyani game da asalin zoonotic, watsawa tsakanin jinsuna da kuma cutar HCoVs.
Musamman, muna nunawa da tattauna batun gama gari cewa ƙwayoyin cuta na HCoVs yawanci ba su da cutar a cikin masu masaukin su na halitta amma sun zama masu cutar bayan watsawa tsakanin nau'ikan zuwa sabon mai masauki.
Hakanan muna nazarin yanayin juyin HCoV wanda yawanci ƙaruwar yaduwar cuta ke zuwa tare da raguwar cutar.
An kuma tattauna sakamakon barkewar cutar SARS-CoV-2 a wannan mahallin.
An san CoVs na dabbobi tun daga ƙarshen 1930s.
Kafin warewar farko na HCoV-229E nau'in B814 daga fitar hanci na marasa lafiya waɗanda suka kamu da mura, an ware CoVs daban-daban a cikin dabbobi daban-daban da suka kamu da cutar, gami da turkey, linzamin kwamfuta, shanu, alade, cat da kare.
A cikin shekarun da suka gabata, an gano HCoVs bakwai.
Takaitaccen tarihin gano HCoV cikin tsari na lokaci (Table 1) zai kasance mai bayani da kuma koyarwa.
An ware kwayar HCoV-229E ta farko daga hanyoyin numfashi na marasa lafiya tare da kamuwa da cutar ta sama a cikin shekarar 1966, kuma daga baya aka daidaita shi don girma a cikin layukan ƙwayoyin huhu na WI-38.
Marasa lafiya da ke dauke da HCoV-229E sun nuna alamun sanyi na yau da kullun, gami da ciwon kai, tari, rashin jin daɗi da ciwon wuya, tare da zazzabi da tari da aka gani a cikin 10 ~ 20% na lokuta.
Daga baya a cikin 1967, an ware HCoV-OC43 daga al'adun gabobin jiki da kuma hanyar wucewa ta gaba a cikin kwakwalwar berayen da ke shayarwa.
Abubuwan asibiti na kamuwa da cutar HCoV-OC43 sun yi kama da waɗanda HCoV-229E ya haifar, waɗanda ba za a iya bambanta su da kamuwa da wasu cututtukan cututtukan numfashi kamar su ƙwayoyin cuta na mura A da rhinoviruses.
Dukansu HCoV-229E da HCoV-OC43 an rarraba su a duniya, kuma galibi ana watsa su a lokacin hunturu a yanayin zafi.
Gabaɗaya, lokacin haɓakawa na waɗannan ƙwayoyin cuta guda biyu bai kai mako ɗaya ba, sannan kusan sati 2 na rashin lafiya.
Dangane da binciken da aka yi akan masu sa kai, mutane masu lafiya da suka kamu da HCoV-229E sun sami sanyi mai sauƙi.
Wasu marasa lafiya kaɗan ne kawai da ke da rauni na rigakafi suka nuna mummunan kamuwa da cutar ta ƙananan hanyoyin numfashi.
SARS, wanda kuma aka sani da atypical pneumonia, shine farkon cutar da HCoV ta haifar a tarihin ɗan adam kuma mai haifar da cutar shine SARS-CoV, HCoV na uku da aka gano.
Ana iya gano farkon yanayin SARS a ƙarshen 2002 a lardin Guangdong na China.
Cutar SARS ta haifar da mutane 8,096 da aka ruwaito tare da mutuwar mutane 774, wanda ya bazu a ƙasashe da nahiyoyi da yawa.
Baya ga masu yaduwa, an kiyasta cewa kowane hali na iya haifar da kusan lokuta biyu na biyu, tare da lokacin ɗagawa na kwanaki 4 zuwa 7 kuma mafi girman nauyin kwayar cutar yana bayyana a ranar 10 na cutar.
Marasa lafiya da ke dauke da cutar SARS-CoV da farko suna da ciwon zuciya, ciwon kai, zazzabi, rashin jin daɗi da kuma sanyi, sannan kuma suna da dyspnea, tari da wahalar numfashi a matsayin alamun rashin lafiya.
Lymphopenia, gwajin aikin hanta da aka lalata, da kuma ƙaruwa na creatine kinase sune cututtukan da aka saba samu a cikin dakin gwaje-gwaje na SARS.
An kuma lura da lalacewar alveolar mai yaduwa, yaduwar ƙwayoyin epithelial da ƙaruwa na macrophages a cikin marasa lafiya na SARS.
Kimanin kashi 20-30% na marasa lafiya daga baya suna buƙatar kulawa mai tsanani da iska mai iska.
Baya ga ƙananan hanyoyin numfashi, gabobin da yawa ciki har da na hanji, hanta da koda suma za a iya kamuwa da su a cikin waɗannan maganganun masu tsanani, yawanci tare da guguwar cytokine, wanda zai iya zama mai kisa musamman a cikin marasa lafiya marasa ƙarfi.
An fara ware kwayar cutar daga kwayar cutar huhu ta dangi na mai cutar wanda ya yi tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai don binciken HCoV.
An ware HCoV-NL63 daga wani yaro mai wata 7 daga Netherlands a ƙarshen 2004.
Da farko an gano cewa ya fi yawa a cikin yara ƙanana, tsofaffi da marasa lafiya masu rashin ƙarfi tare da cututtukan numfashi.
Bayyana coryza, conjunctivitis, zazzabi, da bronchiolitis abu ne na yau da kullun a cikin cutar da HCoV-NL63 ke haifarwa.
Wani bincike mai zaman kansa ya bayyana ware wannan kwayar cutar daga samfurin hanci daga wani yaro mai wata 8 da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi a Netherlands, an rarraba shi a duniya.
An kiyasta cewa HCoV-NL63 yana da kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma mafi girman abin da ya faru yana faruwa a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar laryngitis mai hanawa, wanda kuma aka sani da croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 wanda aka kwantar da shi a asibiti da ciwon huhu da kuma cutar sankarar bargo a Hong Kong.
Baya ga ciwon huhu da cutar sankarar bargo da ke faruwa a cikin al'umma, an ba da rahoton cewa HCoV-HKU1 yana da alaƙa da matsanancin cutar asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an sami HCoV-HKU1 a duk duniya, yana haifar da cututtukan numfashi masu sauƙi.
Duk waɗannan HCoVs huɗu da aka samo daga al'umma sun dace da mutane sosai kuma galibi ba su da saurin canzawa don haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
Gabaɗaya, lokacin da waɗannan HCoVs suka sami damar watsawa yadda ya kamata kuma su ci gaba da kasancewa cikin mutane, suma suna zama marasa cutarwa ko masu cutarwa.
An fara ware MERS-CoV a shekarar 2012 daga huhu na wani mai shekaru 60 wanda ya kamu da cutar huhu mai tsanani da kuma rashin aikin koda a Saudi Arabia.
Yayinda yawancin magungunan da aka tabbatar da su daga dakin gwaje-gwaje suka fito ne daga Gabas ta Tsakiya, an ba da rahoton shigo da magungunan da ke da wasu lokuta na biyu zuwa kusanci da kusanci a ƙasashen Turai da Tunisia.
Wani fashewar na biyu ya faru a Koriya ta Kudu a 2015 tare da tabbatar da lamuran 186.
Bayyanar asibiti na MERS suna kama da na SARS, wanda ke nuna ci gaba da ciwon huhu mai tsanani.
Ba kamar SARS ba, marasa lafiya da yawa da ke da MERS suma sun sami gagarumar rashin aikin koda, wanda ya zuwa yanzu ya zama na musamman ga MERS tsakanin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30% na marasa lafiya suna da alamun gastrointestinal, kamar zawo da zubar da ciki.
Ya zuwa 14 ga Fabrairu, 2020, sama da mutane 2500 da aka tabbatar da su a dakin gwaje-gwaje an bayar da rahoton su tare da yawan mutuwar mutum 34.4%, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi muni da aka sani ga mutane.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano gungun marasa lafiya masu ciwon huhu da aka sani a baya cewa suna da alaƙa da kamuwa da cutar SARS-CoV-2 a Wuhan, Lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar kamuwa da cutar ta ƙananan hanyoyin numfashi da SARS-CoV-2 ya haifar da gaggawa ta lafiyar jama'a na damuwa ta duniya kuma ta kuma sanya sunan cutar COVID-19.
Ya zuwa ranar 3 ga Maris, 2020, an tabbatar da kamuwa da cutar 90,053 a duk duniya, tare da mutuwar mutum 3.4%.
Musamman ma, mutuwar cutar a Hubei, China ta kai kashi 4.2%, yayin da wacce ke wajen ta ta kai kashi 1.2%.
SARS-CoV-2 na haifar da mummunar kamuwa da cuta ta numfashi kamar SARS-CoV da MERS-CoV, wanda aka gabatar a matsayin zazzabi, tari da dyspnea.
Hakanan ana ganin zawo a wasu marasa lafiya.
Ciwon huhu yana ɗaya daga cikin mafi munin alamun kuma yana iya ci gaba cikin sauri zuwa ciwon rashin ƙarfi na numfashi.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda babban daidaiton jerin nucleotide na 82%, sun haɗu cikin rassa daban-daban a cikin itacen phylogenetic.
SARS-CoV-2 a bayyane yake ba shi da cutar amma yana da saurin yaduwa idan aka kwatanta da SARS-CoV da MERS-CoV.
An bayar da rahoton mutanen da ba su da alamun cutar SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
Kwatanta SARS-CoV-2 da sauran HCoVs shida da kuma bambance-bambance sun bayyana kamance da bambance-bambance masu ban sha'awa sosai.
Na farko, lokacin ɗorawa da tsawon lokacin cutar HCoV suna kama da juna.
Dangane da wannan, SARS-CoV-2 yana bin babban yanayin sauran HCoVs shida.
Na biyu, tsananin bayyanar cututtukan COVID-19 ya ta'allaka ne tsakanin SARS-CoV da HCoVs huɗu da aka samu a cikin al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye waɗanda galibi ana gani yayin kamuwa da cutar HCoVs da aka samu a cikin al'umma, gami da gabatar da rashin takamaiman, mai sauƙi ko ma babu alamun.
A gefe guda, ana iya ganin ƙaramin ƙaramin ƙananan maganganun COVID-19 masu tsanani kamar yadda yake a cikin cutar SARS-CoV, kodayake rabo ya ɗan ƙasa.
Na uku, watsa SARS-CoV-2 kuma yana nuna halaye masu ban sha'awa na halaye na HCoVs da SARS-CoV da aka samu a cikin al'umma.
A gefe guda, yaduwar SARS-CoV-2 aƙalla tana da girma kamar na HCoVs da aka samu a cikin al'umma.
A gefe guda, har yanzu ana tabbatar da ko yaduwar SARS-CoV-2 ta ragu bayan wucewa a cikin mutane kamar yadda yake a cikin shari'o'in SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfuran ƙwayoyin cuta.
Ko watsa SARS-CoV-2 ta hanyar kwance yana taka muhimmiyar rawa kamar yadda yake a cikin yanayin SARS-CoV aƙalla a wasu yanayi har yanzu ana bayyana shi ta hanyar nazarin gaba.
Hakanan yana da matukar sha'awa don ganin ko SARS-CoV-2 na iya nuna yanayi kamar yadda yake a cikin yanayin HCoVs da aka samu a cikin al'umma.
Duk da haka, fasalulluka na SARS-CoV-2 gami da yaduwar sa, cutar da ke haifar da cutar da kuma ci gaba da yaduwa bayan wucewa a cikin mutane zai yi tasiri a kan makomar barkewar cutar COVID-19.
Dukkanin HCoVs huɗu da aka samu a cikin al'umma waɗanda ke haifar da ƙananan alamun sun dace da mutane.
Daga wani hangen nesa, yana iya zama gaskiya cewa mutane sun dace da waɗannan HCoVs huɗu.
A wasu kalmomi, duka biyun na iya zama waɗanda suka tsira daga tsoffin annobar HCoV.
An kawar da HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma mutane waɗanda suka sami cututtukan HCoV masu tsanani.
Don wannan ya faru, HCoVs dole ne su ninka a cikin mutane har zuwa isa don ba da damar tarawa na juyin halittar da ke daidaitawa wanda ke magance abubuwan ƙuntatawa na mai masaukin baki.
A wannan ma'anar, tsawon lokacin da annobar SARS-CoV-2 ke ci gaba da yaduwa kuma mutane da yawa da ta kamu da su, mafi girman damar da za ta daidaita da mutane.
Idan ya daidaita da kyau, zai yi wuya a dakatar da yaduwarsa a cikin mutane ta hanyar keɓewa ko wasu matakan sarrafa kamuwa da cuta.
Shekaru da yawa, CoVs huɗu da aka samu a cikin al'umma suna yawo a cikin yawan mutane, suna haifar da sanyi na yau da kullun a cikin batutuwa masu rigakafi.
Wadannan ƙwayoyin cuta ba sa bukatar wani abin ajiyewa na dabba.
Akasin haka, SARS-CoV mai saurin haifar da cuta da MERS-CoV ba su dace da mutane da kyau ba kuma ba za a iya ci gaba da watsa su a cikin mutane ba.
Suna buƙatar kiyayewa da kuma yadawa a cikin wuraren da suke da cutar da kuma neman damar da za su iya kaiwa ga mutane masu saukin kamuwa, mai yiwuwa ta hanyar daya ko fiye da matsakaici da kuma masu karfafawa.
SARS-CoV-2 yana da halaye masu kama da SARS-CoV/MERS-CoV da kuma HCoVs huɗu da aka samu a cikin al'umma.
Yana da yaduwa sosai kamar HCoVs da aka samu a cikin al'umma, aƙalla a yanzu.
Koyaya, ya fi cutar HCoVs da aka samu a cikin al'umma kuma ba shi da cutar fiye da SARS-CoV ko MERS-CoV.
Har yanzu ba a san ko zai daidaita da mutane ba kuma zai zagaya cikin mutane ba tare da wani tanadi ko kuma mai masaukin dabba na tsaka-tsaki ba.
Kafin mu tattauna asalin dabbobi na HCoVs, zai yi mana kyau mu tattauna ma'anoni da halaye na juyin halitta, na halitta, na tanadi, na tsaka-tsaki da kuma masu haɓaka rundunar HCoVs.
Dabba tana aiki a matsayin mai karɓar bakuncin HCoV idan tana da kakannin da ke da alaƙa da juna waɗanda ke da babban daidaituwa a matakin jerin nucleotide.
Kwayar cutar kakannin ita ce yawanci ta dace da kyau kuma ba ta haifar da cutar a cikin wannan mai masaukin baki.
Hakanan, mai masaukin ruwa yana riƙe da HCoV a kai a kai kuma na dogon lokaci.
A duka biyun, masu masaukin suna kamuwa da cutar ta halitta kuma sune masu masaukin HCoV ko kwayar cutar iyayenta.
Akasin haka, idan an gabatar da HCoV a cikin sabon mai masaukin baki kafin ko kusa da gabatarwar sa ga mutane, ba a daidaita shi da kyau ga sabon mai masaukin baki kuma galibi mai cutarwa ne.
Wannan mai watsa shiri na tsaka-tsaki na iya zama tushen cutar ta mutum da kuma taka rawar mai watsa shiri ta hanyar ba da damar kwayar cutar ta ninka ta ɗan lokaci sannan ta watsa shi ga mutane don haɓaka sikelin kamuwa da cutar ga mutane.
HCoV na iya kamuwa da kamuwa da cuta idan ba zai iya ci gaba da watsawa a cikin mai masaukin baki ba.
Akasin haka, HCoVs na iya daidaitawa ga mai masaukin baki har ma da kafa yanayin dindindin na dogon lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na halitta.
Bayanai na cututtukan cututtuka sun bayyana a baya cewa yanayin SARS na da tarihin hulɗa da dabbobin daji.
Binciken da aka yi na saura ya nuna cewa masu cinikin dabbobi suna da yawan cutar anti-SARS-CoV IgG idan aka kwatanta da na sauran jama'a.
An fara gano civets na dabino masu rufe fuska (Paguma larvata) da kare racoon a kasuwannin dabbobi masu rai don ɗaukar ƙwayoyin cuta masu kama da SARS-CoV waɗanda kusan iri ɗaya ne da SARS-CoV.
Wannan ya kasance a kaikaice ta hanyar gaskiyar cewa ba a sake bayar da rahoton SARS ba bayan kashe duk civets a kasuwanni.
Koyaya, an ba da rahoton cewa masks na dabino daga daji ko gonaki ba tare da fallasa su ga kasuwannin dabbobi masu rai ba sun kasance masu illa ga SARS-CoV, suna ba da shawarar cewa masks na dabino na iya zama kawai a matsayin mai watsa shiri na tsaka-tsaki amma ba mai tanadin yanayi na SARS-CoV ba.
Musamman, tunda kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da anti-SARS-CoV antibodies, ba za a iya ware yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa na iya zama masu watsawa na SARS-CoV na tsaka-tsaki ba.
Duk waɗannan suna kama da masu masaukin SARS-CoV.
Binciken da aka yi na baya game da mai masaukin dabba na SARS-CoV ya bayyana wani CoV mai alaƙa da bat, wanda aka kira SARS-related Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda yake a cikin bat da ke da kama da takalmi na China.
Wadannan batutuwan suna da inganci ga anti-SARS-CoV antibodies da kuma jerin kwayoyin SARSr-Rh-BatCoV HKU3.
Wannan da sauran bat CoVs suna da daidaiton jerin nucleotide 88-92% tare da SARS-CoV.
Wadannan binciken sun kafa tushe ga sabon ra'ayi cewa batutuwan suna dauke da cututtukan mutum.
An kuma gano wasu CoVs masu kama da SARS (SL-CoVs) daga bat, amma babu wanda ya keɓe a matsayin kwayar cutar mai rai sai dai wanda aka tsara WIV1.
An san cewa enzyme mai canza angiotensin na mutum 2 (ACE2) shine mai karɓar SARS-CoV.
An nuna cewa WIV1 da aka samo daga samfurin kwandon batutuwan yana amfani da batutuwan batutuwan, civet da mutum ACE2 a matsayin mai karɓar shigar sel.
Abin sha'awa, kwayar cutar SARS mai warkewa ta iya kawar da cutar WIV1.
Ya zuwa yanzu, WIV1 yana wakiltar mafi kusanci ga kakannin SARS-CoV a cikin bat, raba kashi 95% na daidaiton jerin nucleotide.
Kodayake babban daidaituwa tsakanin waɗannan ƙwayoyin cuta biyu, gabaɗaya an yi imanin cewa WIV1 ba shine kwayar cutar mahaifa ta SARS-CoV ba kuma bat ba shine mai masaukin SARS-CoV ba.
Binciken phylogenetic ya haɗa MERS-CoV zuwa rukuni ɗaya kamar yadda bat CoV-HKU4 da bat CoV-HKU5.
Bat CoV-HKU4 da MERS-CoV suna amfani da mai karɓar mai karɓar bakuncin iri ɗaya, dipeptidyl peptidase 4 (DPP4), don shigar da kwayar cutar.
Tsarin RNA mai dogara da RNA polymerase na MERS-CoV yana da kusanci da kwatankwacinsa a cikin bat beta-CoVs da aka gano daga Turai da Afirka.
Har zuwa yanzu, ba a iya samun MERS-CoV mai rai a cikin namomin kaza na daji ba.
MERS-CoV da kuma dangin sa na kusa CoV-HKU25 suna da daidaiton jerin nucleotide kashi 87% kawai.
Saboda haka, ƙila batsa ba ta zama mai riƙe da MERS-CoV ba.
A gefe guda, bincike a Gabas ta Tsakiya ya nuna cewa raƙuman dromedary suna da kwayar cutar MERS-CoV-specific neutralizing antibodies, daidai da raƙuman asalin Gabas ta Tsakiya a ƙasashe da yawa na Afirka.
An ware MERS-CoV mai rai wanda yayi kama da kwayar cutar da aka samu a cikin mutane daga swabs na hanci na raƙuman dromedary, wanda ya kara nuna cewa raƙuman suna aiki a matsayin mai riƙe da MERS-CoV.
Hakanan ya kamata a lura cewa yawanci ana lura da alamun rashin lafiya amma ana samun yaduwar kwayar cutar a cikin rakuma da aka kamu da cutar ta MERS-CoV.
Abin lura, rakuma da ke dauke da cutar ba kawai suna watsa kwayar cutar ta hanyar numfashi ba har ma ta hanyar kwance-bakin ciki, wanda kuma shine babbar hanyar watsa kwayar cutar daga kwari.
Koyaya, tambayoyi har yanzu suna nan tunda yawancin waɗanda aka tabbatar da su na MERS ba su da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, wanda za a iya danganta shi da watsawa daga mutum zuwa mutum ko hanyoyin watsawa da ba a sani ba waɗanda suka haɗa da nau'in dabbobi da ba a san su ba waɗanda ke da MERS-CoV.
SARS-CoV-2 yana da daidaiton nucleotide na 96.2% tare da bat CoV RaTG13 wanda aka ware daga bat Rhinolophus affinis.
Kamar yadda yake a cikin shari'o'in SARS-CoV da MERS-CoV, bambancin jerin tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don sanya dangantakar iyaye.
Wato, ƙila ba za a iya samun batutuwan da ke riƙe SARS-CoV-2 ba sai dai idan an sami CoVs iri ɗaya a nan gaba.
Da alama, masu watsa kwayar cutar SARS-CoV-2 na dabbobi na tsakiya ya kamata su kasance cikin nau'ikan dabbobin daji da aka sayar da kashe su a Kasuwar Siyar da Abinci na teku ta Huanan, wanda yawancin shari'o'in farko na COVID-19 suka kasance tare da su, wanda ke nuna yiwuwar watsawa daga dabba zuwa mutum.
Karatun da yawa na kwanan nan bisa layin metagenomic sun nuna cewa wani rukuni na ƙananan dabbobi masu shayarwa da ke cikin haɗari da ake kira pangolins (Manis javanica) na iya kuma riƙe da tsoffin beta-CoVs da ke da alaƙa da SARS-CoV-2.
Wadannan sabon kwayar cutar CoV na pangolin suna da daidaiton jerin nucleotide 85-92% tare da SARS-CoV-2.
Koyaya, suna da alaƙa da RaTG13 tare da kusan 90% daidaito a matakin jerin nucleotide.
Sun haɗu cikin ƙananan ƙwayoyin cuta guda biyu na SARS-CoV-2 a cikin itacen phylogenetic, ɗayan wanda ke da yanki mai kama da mai karɓa (RBD) tare da SARS-CoV-2, tare da asalin jerin amino acid 97.4%.
Akasin haka, RBDs na SARS-CoV-2 da RaTG13 sun fi bambanta, kodayake mafi girman digiri na daidaiton jerin abubuwa a duk genom.
Wani binciken da aka yi a baya kan pangolins masu rashin lafiya ya kuma bayar da rahoton gano kwayar cutar daga samfuran huhu, wanda ya nuna cewa yana da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyin hada abubuwa daban-daban da kuma sarrafawa ta hannu don samar da jerin kwayoyin halittar bangare wanda ya kunshi kusan kashi 86.3% na cikakken kwayar halittar kwayoyin halittar.
Ba za mu iya ware yiwuwar cewa pangolin yana ɗaya daga cikin dabbobi masu watsa SARS-CoV-2 na tsaka-tsaki ba.
Koyaya, a halin yanzu babu wata hujja da ke tallafawa asalin pangolin kai tsaye na SARS-CoV-2 saboda bambancin jerin tsakanin SARS-CoV-2 da beta-CoVs masu alaƙa da pangolin SARS-CoV-2.
Bugu da kari, tazarar tsakanin SARS-CoV-2 da RaTG13 ta fi tazarar tsakanin SARS-CoV-2 da pangolin SARS-CoV-2 masu alaka da beta-CoVs.
Har yanzu ba a tabbatar da hanyar juyin halitta na SARS-CoV-2 a cikin bat, pangolins da sauran dabbobi masu shayarwa ba.
Yayin da aka sami mafi girman daidaiton jerin abubuwa a cikin RBDs tsakanin SARS-CoV-2 da pangolin, beta-CoVs masu alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi girman daidaiton jerin abubuwa a cikin kwayoyin halitta.
Yana da matukar zato cewa babban matakin kama tsakanin RBDs na pangolin SARS-CoV-2 da SARS-CoV-2 masu alaƙa da beta-CoVs ana motsa su ta hanyar juyin halitta mai daidaitawa ta hanyar zaɓi.
Wani takaddama yana goyon bayan sake haɗuwa tsakanin beta-CoV mai alaƙa da SARS-CoV-2 na pangolin da RaTG13 a cikin nau'in dabbobi na daji na uku.
A matsayin abin motsawa a juyin halitta, sake haɗuwa ya yadu tsakanin beta-CoVs.
Har yanzu alƙalai ba su yanke shawara kan asalin cutar SARS-CoV-2 ba.
Baya ga HCoVs masu cutarwa sosai, an kuma yi nazarin asalin zoonotic na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar ilimin halittu ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali daga CoVs na bat, yayin da aka sami ƙwayoyin cuta na iyaye na HCoV-OC43 da HCoV-HKU1 a cikin beraye.
An bayar da rahoton cewa wani CoV na bat da ake kira ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin bat mai launin uku na Arewacin Amurka ya nuna kusanci da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da wani bat CoV, wanda ake kira Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da kuma ana zargin cewa camelids ne ke ɗaukar nauyinsa.
Don bayyanawa, ilimin yanzu game da asalin dabbobi na HCoVs da aka sani an taƙaita su a Hoto na 1 da Table 2.
Binciken phylogenetic ya ba da shaidar abubuwan da suka faru na watsa nau'in HCoVs a cikin tarihi.
Lokacin da HCoV-OC43 ya tsallake nau'ikan don kamuwa da mutane daga dabbobin gida a kusa da 1890, an yi rikodin annobar kamuwa da cuta ta numfashi.
Tarihin watsawa tsakanin nau'ikan HCoV-229E bai bayyana sarai ba.
An gano alpha-CoVs na Bat da ke da alaƙa da HCoV-229E.
Tsakanin su akwai alpha-CoV na alpaca.
Akwai shaidu da dama da ke nuna cewa cutar ta kai tsaye daga kuraje zuwa ga mutane.
Na farko, mutane amma ba alpacas ba na iya samun hulɗa da batutuwan a cikin yanayin muhalli.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, alpha-CoVs masu alaƙa da HCoV-229E sun bambanta kuma ba su da cutar a cikin bat, yayin da alpha-CoV na alpaca ya haifar da barkewar cutar numfashi a cikin dabbobin da ke da cutar.
A ƙarshe, ba a sami alpha-CoV na alpaca a cikin dabbobin daji ba.
Saboda haka, ba za a iya ware yiwuwar cewa alpacas sun sami alpha-CoV mai alaƙa da HCoV-229E daga mutane ba.
A zahiri, bat ne tushen kai tsaye na ƙwayoyin cuta masu cutar ɗan adam ciki har da kwayar cutar rabibi, kwayar cutar Ebola, kwayar cutar Nipah da kwayar cutar Hendra.
Saboda haka ba abin mamaki bane cewa batutuwan na iya watsa HCoV-229E kai tsaye ga mutane.
A madadin haka, yayin da bat alpha-CoVs ke aiki a matsayin asalin kwayar HCoV-229E, alpacas da raƙuman raƙuman ruwa na iya zama masu watsawa na tsaka-tsaki waɗanda ke watsa ƙwayoyin cuta ga mutane, daidai kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna daga bat zuwa raƙuman dromedary da kuma daga raƙuman dromedary zuwa ga mutane.
An san asalin juyin halitta na MERS-CoV daga batsa a farkon gano shi kuma an kuma ƙarfafa shi ta hanyar binciken da aka samu daga baya.
A bayyane yake cewa batutuwan suna samar da wadataccen nau'in nau'in kwayar cuta don musayar nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan.
Tsawon rayuwa, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar
A gefe guda, an gabatar da MERS-CoV ga raƙuman dromedary shekaru da yawa.
Ya dace da waɗannan raƙuma waɗanda suka juya daga matsakaiciyar mai masaukin zuwa mai riƙe da ruwa mai ɗorewa.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙarancin canji a cikin waɗannan dabbobi.
Canza shi zuwa ga mutane ba zato ba tsammani ne kuma mutane sun kasance masu karɓar bakuncin MERS-CoV saboda ba za a iya ci gaba da watsa shi ba.
Sabanin rawar raƙuma wajen watsa MERS-CoV, rawar pangolins, idan akwai, a watsa SARS-CoV-2 ta bambanta.
Musamman, beta-CoVs na pangolin suna da cututtuka sosai a cikin pangolins.
Suna iya zama masu masaukin baki ga beta-CoVs masu alaƙa da SARS-CoV-2, kama da civets a cikin yanayin SARS-CoV.
Dole ne a yi watsi da yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa ga mutane a cikin karatu na gaba.
Da farko, batutuwan na iya zama mai masaukin wani kwayar cutar SARS-CoV-2 mai kama da SARS-CoV-2.
Mutane na iya raba yanayin muhalli tare da batutuwan ta hanyar yanka ko hakar kwal.
Na biyu, pangolins na iya zama ɗayan matsakaiciyar rundunar da ke haɓaka wanda aka gabatar da sabon kwayar cutar da ke da alaƙa da SARS-CoV-2.
Mutane suna kamuwa da kwayar cutar ta hanyar yanka da cin naman dabbobin daji.
Yana yiwuwa yawancin dabbobi masu shayarwa ciki har da dabbobin gida suna iya kamuwa da SARS-CoV-2.
Ana buƙatar bincika dabbobi na gida da na daji don gano ƙwayoyin cuta.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in nau'in na uku wanda ke da hulɗa da duka bat da pangolins.
Ana ci gaba da neman asalin dabba na SARS-CoV-2.
Baya ga nau'ikan nau'ikan dabbobi, manyan abubuwa uku a gefen kwayar cutar ma suna da mahimmanci wajen sauƙaƙe CoVs don ƙetare shingen nau'in.
Da farko, yawan canjin da suke samu a kwafin RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ana iya ɗaukar ƙimar canjin CoVs a matsayin  matsakaici zuwa high tare da matsakaicin canjin canji wanda ya kai ~ 10-4 sauye-sauye a kowace shekara a kowane wuri 2, dangane da matakin daidaitawar CoV zuwa sabbin runduna.
CoVs suna da hujja-karatun exoribonuclease, wanda share shi ke haifar da sauyawa sosai da raguwa ko ma rashin aiki.
Abin sha'awa, an san kwatankwacin nucleotide Remdesivir don hana kwafin CoV ta hanyar hana wannan exoribonuclease da RNA mai dogara da RNA polymerase.
Remdesivir yana ɗaya daga cikin magungunan anti-SARS-CoV-2 masu alƙawarin da za a gwada a gwajin asibiti.
Duk da haka, yawan canjin CoVs ya ninka na masu karɓar su sau miliyan.
Bugu da kari, yawan canjin sau da yawa yana da girma lokacin da CoVs ba su dace da mai masaukin ba.
Idan aka kwatanta da SARS-CoV tare da babban canjin canji, a bayyane yake canjin SARS-CoV-2 ya fi ƙasa, yana nuna matakin daidaitawa mafi girma ga mutane.
Wataƙila, an riga an daidaita shi zuwa wani mai masaukin da ke kusa da mutane.
Baya ga SARS-CoV-2, wannan kuma ya shafi MERS-CoV, wanda ya dace da raƙuman dromedary.
A ka'ida, ba shi yiwuwa cewa jujjuyawar kwayoyin halitta za ta sa alluran rigakafi da magungunan rigakafin cutar SARS-CoV-2 su zama marasa tasiri da sauri.
Na biyu, babban kwayar RNA a cikin CoVs yana da ƙarin filastik a cikin gyaran kwayar halitta don sauyawa da sake haɗawa, don haka yana ƙara yiwuwar juyin halitta tsakanin jinsuna, wanda ke da fa'ida don fitowar sabbin CoVs lokacin da yanayi ya dace.
Wannan yana tallafawa ta hanyar manyan takamaiman buɗe ɗakunan karatu da ayyukan furotin da aka tsara zuwa ƙarshen 3 'na kwayoyin halitta.
Na uku, CoVs suna canza samfuran bazuwar kuma sau da yawa yayin kwafin RNA ta hanyar tsari na musamman na copy-choice.
A cikin mai masaukin da ke aiki a matsayin kwandon haɗuwa, sauya zaren yana faruwa sau da yawa yayin kwafin RNA na CoV.
RNAs masu cikakken tsawon da subgenomic masu kama da juna na iya sake haɗuwa don samar da sabbin CoVs.
An sami shaidar phylogenetic na sake haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma CoVs na dabbobi kamar su bat SL-CoV da batCoV-HKU9.
Haɗin kai tsakanin kwayar cutar da mai masaukin a dangane da watsawa
Baya ga abubuwan da aka ambata a sama guda uku, hulɗar kwayar cuta da mai karɓar mai watsawa wani muhimmin abu ne wanda ke tasiri kan watsawar tsakanin jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna shaidar zaɓi mai kyau yayin abubuwan watsawa tsakanin nau'ikan.
Dangane da kwatancen bincike tsakanin keɓaɓɓun mutane da civet SARS-CoVs, ana tsammanin SARS-CoV yana fuskantar saurin daidaitawa a cikin runduna daban-daban, musamman tare da sauye-sauye a RBD na furotin S.
Gabaɗaya, RBD a cikin furotin S na CoV yana hulɗa tare da mai karɓar ƙwayoyin cuta kuma ana zaɓar shi sosai ta hanyar amsawar kwayar cutar mai masaukin baki.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 akan ɓangaren S1, wanda ke ɗaure ga ACE2 na ɗan adam da kuma masu karɓar ƙwayar cuta don shigar da kwayar cuta.
RBD na SARS-CoV yana iya gane masu karɓar ACE2 na dabbobi daban-daban, gami da bat, civet, linzamin kwamfuta da kare raccoon, wanda ke ba da damar watsa kwayar cutar tsakanin jinsuna.
A zahiri, an lura da ragowar amino acid 6 kawai sun bambanta da na mutum da na kwayar cutar kwayar cutar a cikin RBD kuma 4 daga cikinsu suna cikin yanayin da ke ɗaure mai karɓar don hulɗa tare da mai karɓar ACE2.
Civet SARS-CoV yana da sauye-sauyen K479N da S487T a cikin RBD, wanda zai iya haɓaka kusanci na hulɗar furotin mai ƙwanƙwasa tare da mai karɓar ACE2 na ɗan adam.
A wasu kalmomi, waɗannan maye gurbin amino acid guda biyu na iya zama mahimmanci ga daidaitawar kwayar cutar ga mutane.
Ya kamata a lura cewa SARS-CoV-2 yana da mai karɓar kwayar halitta iri ɗaya tare da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na furotin S yana nuna cewa alaƙar da ke haɗa furotin S tare da ACE2 na ɗan adam na iya canzawa.
Tabbas, binciken cryo-EM ya nuna kusancin wannan haɗin sau 10 zuwa 20 fiye da na tsakanin ACE2 na ɗan adam da furotin SARS-CoV S.
Hakanan zai zama mai ban sha'awa don sanin ko ana iya buƙatar kowane mai karɓar ƙwayar cuta don watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 shima yana ɗaure zuwa ACE2 amma tare da wani ɓangare na S.
Akwai sauran masu karɓar HCoV da yawa, kamar su aminopeptidase N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan suna iya ba da labarin nasarar daidaita waɗannan CoVs a cikin mutane bayan watsawa tsakanin jinsuna daga masu masaukin su na dabbobi.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon watsa nau'in HCoVs tsakanin nau'ikan kuma ana sarrafa shi ta wasu dogaro da mai masaukin baki da abubuwan ƙuntatawa.
Bambancin waɗannan sunadarai masu karɓar bakuncin tsakanin mutane da masu karɓar bakuncin HCoVs na halitta kamar su bat, raƙuman ruwa da masu tsutsa na iya zama shinge ga watsawa tsakanin jinsuna.
HCoVs dole ne su mamaye abubuwan dogaro da mai masaukin baki da kuma lalata abubuwan da ke hana mai masaukin baki don samun nasarar watsawa tsakanin jinsuna.
A wannan batun, abubuwan da ke saurin bayyana kwayoyin a wannan muhimmin yanki na hulɗar kwayar cutar-mai masaukin baki har yanzu suna buƙatar ganowa da kuma bayyana su.
Binciken da ba shi da son zuciya na tushen mai masaukin baki da abubuwan ƙuntatawa don SARS-CoV-2 ta amfani da fasahar zamani ta CRISPR na iya zama mai amfani.
Fitowar sabbin HCoVs: koma zuwa ƙasa
Bambancin bat CoVs yana ba da dama mai yawa don fitowar sabbin HCoVs.
A wannan ma'anar, bat CoVs suna aiki a matsayin tarin kwayoyin HCoVs.
Bugu da kari, saurin canji da kuma sake hada kwayoyin halitta suma suna motsa ci gaban HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Misali, saye ko rasa sabbin kwayoyin da ke yin kwayar halitta na da damar sauya fasalin kwayar cutar sosai.
Daga cikin sunadarai masu amfani da SARS-CoV, ORF8 an yi tunanin yana da mahimmanci wajen daidaitawa ga mutane, kamar yadda aka ware ƙwayoyin cutar bat da ke da alaƙa da SARS-CoV amma an gano cewa suna ɓoye sunadarai ORF8 masu banbanci.
An sami fasalin cire kwayar cutar 29-nucleotide na SARS-CoVs a cikin nau'ikan da aka ware a farkon annobar ɗan adam.
Wannan sharewa ya raba ORF8 zuwa ORF8a da ORF8b kuma ana tsammanin ya zama maye gurbin da ke inganta sauyawar mai masaukin baki.
Bayan haka, SARS-CoV yana da tarihin sake haɗuwa tare da layin alpha- da gamma-CoVs, inda aka gano adadi mai yawa na ƙananan yankuna masu haɗuwa a cikin RNA mai dogara da RNA polymerase.
An kuma gano wuraren sake haɗawa a cikin nsp9, yawancin nsp10, da sassan nsp14.
Hakazalika, an nuna cewa annobar MERS-CoV ta sami abubuwan sake haɗuwa tsakanin jinsuna daban-daban, wanda ya faru a cikin raƙuman dromedary a Saudi Arabiya.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan sake haɗuwa a cikin wasu HCoVs, wanda HCoVs ke sake haɗuwa da sauran CoVs na dabbobi a cikin ƙwayoyin halittar su.
Ya kamata kuma a yi gargadin cewa zabin wucin gadi na iya taimakawa ga canje-canje da ba a so ba a cikin kwayoyin halittar kwayar cutar, wanda wataƙila sakamakon sauƙaƙe ƙwayoyin cuta daga matsin zaɓin da aka yi, kamar ta tsarin garkuwar jiki.
Misali na waɗannan tasirin shine asarar ORF4 mai cikakken tsayi a cikin kwayar kwayar HCoV-229E, saboda cire nucleotide biyu.
Duk da yake ana iya lura da ORF4 mara lalacewa a cikin ƙwayoyin cuta na bat da raƙumi da ke da alaƙa da HCoV-229E, alpha-CoV na alpaca yana nuna shigar da nucleotide guda ɗaya, wanda ke haifar da sauya fasalin.
A ƙarshe amma ba mafi ƙaranci ba, haɓakar sabbin HCoVs kuma ana motsa ta ta matsin zaɓi a cikin masu masaukin ajiyar su.
An gano alamun rashin alamun ko kuma marasa nauyi ne kawai lokacin da batutuwan suka kamu da CoVs, wanda ke nuna daidaituwa tsakanin CoVs da batutuwan.
Ya bayyana cewa batutuwan sun dace da CoVs sosai ta hanyar jiki da kuma ilimin lissafi.
Misali, lahani a cikin kunna amsa mai haifar da kumburi a cikin batutuwan yana rage tasirin cutar da CoVs ke haifar da shi.
Bugu da ƙari, aikin kwayar kisa ta halitta a cikin wutsiyoyi an hana shi saboda haɓaka mai hana mai karɓar kwayar halitta ta halitta NKG2/ CD94 da ƙananan matakin bayyana manyan kwayoyin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin
Bugu da ƙari, babban matakin nau'ikan oxygen mai amsawa (ROS) wanda aka samar daga babban aikin maye na bat zai iya hana kwafin CoV kuma ya shafi sake karantawa ta hanyar exoribonuclease, don haka samar da matsin lamba don samar da ƙwayoyin cuta masu cutarwa sosai lokacin da aka gabatar da su cikin sabon mai masauki.
Hakanan za a iya samun ƙarin nau'ikan CoV masu cutarwa ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko fasalin sunadarai don daidaitawar mai masaukin baki.
Saboda haka, ba daidaituwa ba ce cewa sabbin HCoVs guda uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutar ko kuma suna haifar da wasu alamun rashin lafiya a cikin masu masaukin su kamar su bat da rakuma.
Suna yin kwafi sosai ba tare da haifar da amsawar garkuwar jiki mai ƙarfi ba.
A nan ne asirin dalilin da ya sa ake ganin masu dauke da cutar ba tare da bayyanar cututtuka ba da kuma abin da ke haifar da munanan cututtuka a cikin mutane.
Alamun cutar sun fi yawa saboda yawan amsawar garkuwar jiki da kuma guguwar cytokine inda mafi ƙarfin amsawar garkuwar jiki, mafi munin lalacewar huhu.
Akasin haka, a cikin masu ɗaukar asymptomatic, an cire martani na rigakafi daga kwafin CoV.
Irin wannan dabarar cire haɗin amsawar rigakafi na iya samun fa'ida a maganin anti-SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin bat.
Saboda haka, bayar da nau'in interferon na I aƙalla a farkon matakin kamuwa da cutar SARS-CoV-2 a cikin mutane ya kamata ya kasance mai amfani.
Bugu da ƙari, kunnawar NLRP3 mai kumburi a cikin bat ba shi da kyau.
Ta wannan tunanin, hana NLRP3 mai kumburi tare da MCC950 na iya zama da amfani a maganin COVID-19.
Fitowar SARS-CoV-2 ya bi babban jigon da SARS-CoV da MERS-CoV suka tashi.
Yayin da aka sami bat beta-CoV wanda ke da kashi 95% na nucleotide homology tare da SARS-CoV, akwai kuma bat-CoV wanda ke da kashi 96% na nucleotide homology tare da SARS-CoV-2.
Duk da yake an gano cewa civets da sauran dabbobi a kasuwa suna da ƙwayoyin cuta iri ɗaya da SARS-CoV, ba a gano masu watsa shiri na tsakiya na SARS-CoV-2 ba.
An gano beta-CoVs na pangolin da ke da kama da SARS-CoV-2, wanda ke nuna cewa pangolins na iya zama ɗaya daga cikin masu masaukin baki ko kuma beta-CoVs na pangolin na iya ba da gudummawar ɓangarorin kwayoyin zuwa sigar ƙarshe ta SARS-CoV-2.
Kodayake tambayoyi sun kasance, babu wata hujja da ke nuna cewa SARS-CoV-2 mutum ne ya yi shi ko da gangan ko kuma ba da gangan ba.
CoVs sun dawo cikin hasken rana saboda barkewar cutar SARS-CoV-2 kwanan nan.
Nazarin CoVs a cikin bat da sauran dabbobi ya canza ra'ayinmu sosai game da mahimmancin asalin zoonotic da wuraren ajiyar dabbobi na HCoVs a cikin watsawar ɗan adam.
Shaida mai yawa ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da asalin bat kuma ana watsa su ga mutane ta hanyar masu watsawa na tsakiya.
Ganin cewa kamuwa da cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da civets a cikin kasuwanni, rufe kasuwannin da ke da ruwa da kashe civets a ciki na iya kawo ƙarshen annobar SARS.
Ta hanyar irin wannan tunani, ya kamata a cire pangolins daga kasuwannin da ke da ruwa don hana yaduwar cutar zoonotic, saboda gano zuriya da yawa na beta-CoVs na pangolin da ke da alaƙa da SARS-CoV-2.
Koyaya, ko kuma yadda SARS-CoV-2 ke yaduwa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa har yanzu ana bayyana su a cikin bincike na gaba.
A gefe guda, MERS-CoV ya wanzu a cikin raƙuman dromedary na dogon lokaci.
Waɗannan raƙuma suna da muhimmanci wajen sufuri da kuma tushen nama, madara, fata da kuma kayan ɗamara ga mazauna yankin.
An rarraba su sosai a duk Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a yi hadaya da dukkan rakuma ba don sarrafa MERS, kamar yadda aka yi a kasuwannin dabbobin daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da sake fashewar cutar ta MERS, ya kamata a bi cikakkiyar hanya don samar da ingantattun alluran rigakafi kan MERS-CoV don raƙuma, tare da sauran matakan sarrafa kamuwa da cuta.
Tun da ba za mu iya kawar da wadannan ƙwayoyin cuta ba, za a iya samun sababbin nau'o'in kwayoyin halittar da za su iya haifar da barkewar cutar.
An samu nau'ikan nau'ikan CoVs masu cutar dabbobi a cikin daji.
Musamman, bat CoVs tare da yiwuwar zoonotic suna da bambanci sosai.
Akwai dama da yawa da waɗannan CoVs na zoonotic ke haɓaka da sake haɗuwa, wanda ke haifar da fitowar sabbin CoVs waɗanda ke da saurin watsawa da / ko masu kisa a cikin mutane a nan gaba.
Ya kamata a daina cin dabbobi a wasu wurare na kasar Sin domin rage hulda da dabbobi ba dole ba.
Tare da wahalar SARS, MERS da COVID-19, ya kamata a samar da kyakkyawan shiri da shirin amsawa.
A gaskiya ma, ƙwayoyin cuta da yawa sun wanzu a duniya na dogon lokaci.
Suna zama a cikin ɗakunan ajiyarsu na halitta har sai akwai damar watsawa.
Ko da yake wutsiyoyi suna da abubuwa da yawa da suke sa mutane su yaɗa ƙwayoyin cuta, za a iya rage haɗuwa da wutsiyoyi da sauran dabbobi idan aka koya wa mutane su guje musu.
Ana buƙatar ci gaba da sa ido a cikin dabbobi masu shayarwa don fahimtar yanayin halittu na CoVs da kuma masu masaukin su na halitta, wanda zai zama da amfani wajen hana yaduwar dabbobi zuwa mutane da kuma barkewar cutar nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar zoonosis ta kwayar cuta ita ce mutane su nisanta kansu daga wuraren da ke da alaƙa da yanayin halittu na ƙwayoyin cuta masu cutar.
Har yanzu akwai wasu abubuwa da suka ɓace a cikin jigon asalin cutar SARS-CoV-2.
Da farko, idan dabbobin daji sun watsa kwayar cutar SARS-CoV-2 ga pangolins, zai zama mai ban sha'awa a ga a wane yanayi dabbobin daji da pangolins zasu iya raba wuri guda na muhalli.
Na biyu, idan dabbobin da ke wasa suna taka rawa a kai tsaye wajen yaduwar cutar ga mutane, ya kamata a tantance yadda mutane ke hulɗa da su.
Na uku, idan dabba mai shayarwa ta uku tana aiki a matsayin mai masaukin baki na gaske, yadda take hulɗa da nau'ikan daban-daban ciki har da mutane, bat da pangolins dole ne a bayyana.
A ƙarshe, tun da yawancin dabbobi masu shayarwa ciki har da dabbobin gida na iya zama masu saukin kamuwa da SARS-CoV-2, ya kamata a gudanar da sa ido da kuma kamuwa da gwaji.
Idan ya kasance bat, pangolin ko wani dabba mai shayarwa, ana sa ran cewa SARS-CoV-2 ko kuma kwayoyin cutarsa na iyaye waɗanda suke kusan iri ɗaya za a gano su a cikin masu masaukin halitta a nan gaba.
Ci gaba da bincike a wannan fannin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da muhimman tasiri a cikin rigakafi da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ka'idodin ganewar asali na COVID-19 kasar da ake zargi da kasar da aka tabbatar
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar shawarwari mai sauri don ganewar asali da magani na kamuwa da cutar coronavirus (2019-nCoV) na 2019, kuma wannan jagorar ta ba da kwarewarmu kuma ta zama kyakkyawan tunani don yaƙi da wannan annobar a duk duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, wayewarmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da kwarewar asibiti; saboda haka, dabarun ganewar asali da magani suma ana ci gaba da sabunta su.
A cikin wannan wasika, mun amsa wata sanarwa game da jagorarmu kuma mun samar da sabbin ka'idojin gano cutar na kasar da ake zargi da kasar da aka tabbatar da ita bisa ga sabon Ka'idojin Gano cutar da kuma Kula da COVID-19 (na bakwai) wanda Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya fitar.
A watan Disamba na shekarar 2019, sabon coronavirus (2019-nCoV) ya haifar da barkewar cutar, wanda yanzu aka sanya masa suna a hukumance da cutar coronavirus 2019 (COVID-19) kuma an sanya wa kwayar cutar sunan coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don yaƙi da cutar SARS-CoV-2, ƙungiyarmu ta samar da jagorar shawara mai sauri kuma an buga ta ta yanar gizo a cikin Binciken Likita na Soja a ranar 06 ga Fabrairu 2020.
Tun da aka buga shi, ya jawo hankalin mutane.
Ka lura duk da haka cewa COVID-19 sabuwar cuta ce, wayewarmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da kuma kwarewar aikin asibiti; saboda haka, dabarun ganewar asali da magani kuma ana ci gaba da sabunta su.
Misali, Jagororin Ganowa da Kulawa don COVID-19 da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya fitar, tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, ya fitar da jimillar bugu bakwai tare da wasu mahallin da aka canza sosai.
Yanzu jagorarmu ta sami tsokaci daga Zhou et al., sun gabatar da tsari mai sauki na kimantawa bisa ga kwarewarsu ta asibiti.
Aikin su ya kara sabbin shaidu ga jagorarmu kuma ya kuma zama muhimmin tunani ga wannan annobar a duk duniya.
Muna goyon bayan muhimmin aikin da suke yi kuma muna gode musu.
Koyaya, aikin su kuma yana buƙatar sabuntawa bisa ga sabon Jagoran Ganowa da Kulawa don COVID-19 (Gwaji na bakwai) da kuma binciken kwanan nan.
A cewar fitowar ta bakwai (3 Maris 2020), don tabbatar da yanayin da ake zargi yana buƙatar haɗa kowane ɗayan abubuwan tarihin annobar tare da abubuwa biyu na bayyanar asibiti don yin cikakken bincike, ko kuma yana buƙatar haɗuwa da abubuwa uku na bayyanar asibiti idan ba tare da bayyanar cutar ba:
Tarihin cutar: (1) tarihin tafiya ko zama a birnin Wuhan da kewaye, ko kuma wasu al'ummomin da aka samu rahoton cututtukan COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin hulɗa da cututtukan SARS-CoV-2 masu kamuwa da cuta (tare da gwajin nucleic acid mai kyau); (3) tarihin hulɗa da marasa lafiya da zazzabi ko cututtukan numfashi daga birnin Wuhan da kewaye, ko kuma sauran al'ummomin da aka samu rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtukan; (4) tarihin hulɗa da tarin waɗanda aka tabbatar da su (ƙananan lokuta ≥ 2 da zazzabi da / ko cututtukan numfashi sun faru cikin makonni 2 a ƙananan yankuna, kamar gida, ofis, aji na makaranta, da sauransu).
Bayyanar asibiti: (1) zazzabi da/ ko alamun numfashi; (2) tare da siffofin hoton kamuwa da cutar COVID-19; (3) jimlar ƙididdigar ƙwayoyin jini na farin jini suna nuna al'ada, raguwa, ko rage ƙididdigar lymphocyte a farkon farkon farawa.
Gano tabbataccen yanayin ya kamata ya dogara da batun da ake zargi tare da kowane abu na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Za mu iya ganin cewa an kara gwajin PCR na ainihin lokacin don acid nucleic a cikin hanyoyin numfashi ko samfuran jini a cikin na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An kara gano kwayar cutar a cikin samfurin jini a fitowar ta huɗu (27 Janairu 2020) da ta biyar (8 Fabrairu 2020); sannan kuma an kara hujjojin ƙwayar cuta a fitowar ta bakwai.
Waɗannan gyare-gyare bisa ga masu binciken sun ci gaba da aiki don neman ingantaccen kayan aikin gano acid na nucleic don saurin ganewar asali, da kuma samfuran daga hanyoyin numfashi ciki har da ɗaukar jini, wanda ya haɓaka wadatar samfuran daban-daban, kuma ya goyi bayan kawo sakamakon tabbataccen kwayar cutar a cikin ka'idojin da aka tabbatar.
Bugu da ƙari, akwai ƙarin tabbaci da ke tunatar da mu mu yi taka tsantsan da marasa lafiya marasa alamun bayyanar cututtuka da marasa alamun cutar.
Saboda haka, ya kamata a sabunta jadawalin gudanawar Zhou et al., kamar yadda suka rarraba mutumin da ba shi da alamun asibiti a matsayin  ƙananan haɗari .
Hakanan dole ne a tabbatar da tsarin ƙimar a cikin ƙarin aikin asibiti da nazarin.
A ƙarshe, muna sa rai cewa za a samu ƙarin tabbaci kai tsaye kuma muna kira ga masu karatu su ba da ra'ayinsu.
Don ganewar cutar suspect case da confirmed case, muna ba da shawarar su bi kuma su bi sabbin ka'idojin ƙasashen su.
Ƙungiyarmu za ta kuma sabunta jagorarmu a kan lokaci don bayar da taimako.
Bangladesh ta ba da rahoton sabbin mutane biyar da suka mutu saboda COVID-19, wanda ya fi kowace rana.
A jiya, Bangladesh ta tabbatar da sabbin mutane biyar da suka mutu sakamakon COVID-19 a ranar.
Wannan shi ne mafi yawan mutuwar a rana daya saboda cutar.
Ya zuwa jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton adadin mutanen da suka kamu da cutar da aka rubuta sun hada da masu cutar 114 da kuma masu cutar 33 da suka warke da ke zama a gida.
An samu mutuwar mutane 17.
A wani taron labarai na kan layi, daraktan IEDCR, Dr Meerjady Sabrina Flora, ta ce wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr Meerjady, mutane biyu sun haura shekaru 60, biyu tsakanin 51 da 60, kuma daya yana da shekaru 41 zuwa 50.
Ta kuma ce biyu daga cikin wadanda aka kashe sun fito ne daga birnin Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, daraktan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ake kula da shi a asibitin Kuwait Maitree.
A ranar Asabar, a cikin sanarwar bidiyo ta yanar gizo, Ministan Sufuri da Bridges na Bangladesh Obaidul Quader ya ce za a rufe jigilar jama'a na tsawon lokaci fiye da yadda aka tsara tun farko, har zuwa wannan Asabar mai zuwa.
Wannan dakatarwar sufuri na jama'a da farko ya fara ne a ranar 26 ga Maris kuma an shirya zai ƙare a ranar Asabar, 4 ga Afrilu.
Har ila yau ana ba da izinin jigilar kayayyakin rayuwa - magani, man fetur da abinci.
Abubuwan farko da aka rubuta na kamuwa da cutar COVID-19 a Bangladesh sun kasance a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar ɗaya daga cikinsu.
Ya zuwa ranar 19 ga watan Maris, waɗannan uku sun riga sun warke.
SARS-CoV-2 ya zarce miliyan daya na kamuwa da cutar a duniya
A ranar Alhamis, jimillar adadin masu kamuwa da cutar SARS-CoV-2 coronavirus ya zarce miliyan daya a duniya, kamar yadda bayanan Jami'ar Johns Hopkins suka nuna.
Akalla mutane dubu 52 ne suka mutu sakamakon cutar COVID-19, cutar da coronavirus ta haifar.
Wannan muhimmin abu ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar coronavirus ta farko kuma Zambia ta samu mutuwar ta farko da ke da nasaba da cutar coronavirus.
Koriya ta Arewa ta yi ikirarin cewa, a ranar Alhamis, tana daya daga cikin ƙananan ƙasashe da suka rage daga kamuwa da cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton 1,051,635 da suka tabbatar da cutar, ciki har da 79,332 a cikin awanni ashirin da huɗu kafin karfe 10 na safe lokacin Tsakiyar Turai (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an yi rikodin sama da mutane dubu 244 da suka kamu da cutar coronavirus, wanda ya danganta su da mutuwar mutane akalla 5,900.
CBS News ta ruwaito, tana mai ambaton bayanan Jami'ar Johns Hopkins, akwai sama da mutane 1,000 da suka mutu a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A dukan duniya, ƙasashe sun sanar da tsauraran matakai don hana cutar yaɗuwa.
A ranar Alhamis, Sergei Sobyanin, magajin garin Moscow, ya tsawaita dokar kulle birnin har zuwa ranar 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya bayyana cewa za a ci gaba da biyan 'yan Rasha albashi ba tare da zuwa aiki ba har zuwa ranar 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar tsawaita dokar ta baci ta kasa har na kwanaki 15; an amince da kuri'ar ne da kuri'u 215 a kan, goma sun kaurace, kuma daya ya ki.
Saudi Arabia ta tsawaita dokar hana fita a biranen Makka da Madina don ta ci gaba har tsawon yini; a baya, dokar hana fita ta kasance tsakanin karfe 3 na yamma zuwa 6 na safe.
Thailand ta shirya aiwatar da dokar hana fita tsakanin karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar zama a gida har zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya sun rage iyakar takardar bayan gida a kowane ma'amala
A ranar Lahadi da Asabar da yamma, manyan shagunan Australiya Woolworths da Coles sun rage takunkumin sayen takardar bayan gida zuwa biyu da kunshin daya a kowane ma'amala a duk shagunan da ke matakin kasa, bi da bi.
ALDI ta kuma gabatar da iyakar fakiti guda, a ranar Litinin.
An sanya wadannan iyakoki a matsayin sakonni a kan caji, da kuma a shafukan Facebook na sarkar.
An bayar da rahoton cewa masu siye suna tara kaya saboda tsoron COVID-19 idan har mutane suna buƙatar keɓe kansu.
A ranar Laraba, Woolworths kuma ya iyakance sayen takardar bayan gida don isar da gida zuwa fakiti ɗaya a kowane oda.
Waɗannan canje-canjen sun biyo bayan ƙuntatawa na farko na fakiti huɗu a kowace ma'amala da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris, bi da bi.
" Coles, a cikin sanarwar da ta fitar a ranar 8 ga watan Maris, ta ruwaito cewa tare da takunkumin kunshin hudu, ""duka shagunan suna ci gaba da sayarwa cikin awa daya bayan isarwa"", kuma ya kira bukatar ""marasa misali"", yayin da ALDI, a cikin wani sakon Facebook a ranar Talata, ya kira shi ""ba zato ba tsammani"". "
"Tallace-tallace sun tashi cikin ""haɓaka mai ƙarfi"" makon da ya gabata, a cewar mai magana da yawun Woolworths. "
Shagon Costco a Canberra kuma ya iyakance adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ya ba da umarni mafi girma daga masu samarwa da kuma ƙara yawan isar da kaya, Woolworths ya ba da umarnin ƙarin kaya, yayin da ALDI ya sanya kayayyaki don shirin ranar Laraba na musamman.
Russell Zimmerman, babban daraktan kungiyar 'yan kasuwar Australiya, ya ce 'yan kasuwar suna kokarin tara kayayyaki, amma takunkumin da majalisar karamar hukuma ta kafa a kan lokacin da ake kawo kaya da manyan motoci na sa ya yi wuya.
Yana tsammanin hauhawar farashin samarwa, yayin da masu samarwa ke ƙoƙarin biyan buƙata, da ƙarancin kayan musamman.
A ranar Talata, ALDI ta sanar da cewa bayan fitowar kayayyaki da wuri, wasu shagunan ba za su iya gudanar da shirin na ranar Laraba ba.
A wani rahoto na News.com.au, Dr Gary Mortimer, ƙwararren mai sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, ya ce shagunan suna cika kayayyaki kowane dare.
Ya lura cewa takardar bayan gida abu ne mai girma, wanda ke haifar da karancin kaya a adadi, kuma, idan aka sayar, ya bar manyan ɗakunan ajiya a banza, yana ƙarfafa jin ƙarancin.
"Coles da Woolworths suna da ra'ayin [cewa] idan akwai abubuwa da yawa a kan shiryayye, idan za a iya [saya] kayayyaki kamar su takardar bayan gida da mai tsabtace jiki kuma suna nan a adadi, tabbas za ku rage fargaba"" in ji Russell Zimmerman a ABC News. "
Mai samar da takardar wanka mai sake amfani da ita wanda ke ba da Crap ya ce a ranar Laraba da ta gabata sun ƙare.
Kimberly-Clark, wanda ke yin Kleenex Toilet Tissue, da Solaris Paper wanda ke yin Sorbent, sun jaddada cewa suna aiki 24 / 7 don kiyaye wadatar, a cewar rahoton News.com.au.
Domain.com, wani shafin sayar da kayayyaki, ya ruwaito wasu masu sayar da kayayyaki suna ba da takardar bayan gida kyauta ga wanda ya fara yin gwanjo a wajen gwanjo a Melbourne, lokacin da aka yi karancin gwanjo saboda masu saye suna da hutu a karshen mako mai tsawo na ranar ma'aikata.
Fitowar ranar Alhamis na NT News, jaridar da ake bugawa a Darwin, ta haɗa da wani shafi na takwas da aka shirya a yanka kuma a yi amfani da shi a matsayin takardar bayan gida.
Shagunan da farko sun yi jinkirin sanya takunkumi, a cewar wani rahoto daga ABC Australia a ranar 3 ga Maris inda suka ce ba su da shirin gabatar da takunkumi kan sayayya.
Russell Zimmerman ya kara da cewa wasu kayayyaki ma suna da matukar bukatar, ciki har da masks, mai tsabtace jiki, bushe kayan, wanke hannu da gari.
Hakazalika, a wajen Ostiraliya, a ranar Lahadi da yammacin ranar, an lura da kantin sayar da kayayyaki na Ocado na Burtaniya da ke iyakance sayen takardar bayan gida ta Andres zuwa fakiti biyu masu juyawa 12.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19  cutar da coronavirus SARS-CoV-2  ke haifarwa a matsayin annoba.
" Kodayake kalmar " annobar" kawai tana nufin yadda cutar ta yadu, ba yadda hatsarin wasu lokuta yake ba, WHO ta lura da bukatar tura gwamnatoci zuwa aiki: "
" "Dukkanin kasashe na iya canza yanayin wannan annobar. "
" Idan kasashe suka gano, gwada, bi da, ware, gano da kuma tattara mutanensu a cikin martani, " in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO. "
"Muna matukar damuwa da matakin yaduwar cutar da kuma tsananin cutar da kuma matakin rashin aiki".
"A cewar Dr. Tom Frieden, tsohon daraktan Cibiyoyin Kula da Cututtuka da Rigakafin Amurka, annobar ta kasance "marasa misali".
"Ya ce, a cikin tsokaci da CNN ta wallafa a watan Fabrairu, ""ban da mura, babu wani kwayar cutar numfashi da aka gano tun daga fitowar ta zuwa ci gaba da yaduwar duniya. """
" Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa ""ba mu taɓa ganin annobar da coronavirus ta haifar ba"."
Ya ci gaba, "kuma ba mu taɓa ganin wata annoba da za a iya sarrafawa a lokaci guda ba. "
Sabon matsayin a matsayin annoba ya biyo bayan shawarar WHO a watan Janairu don ayyana barkewar cutar a matsayin gaggawa ta lafiyar jama'a na damuwa ta duniya.
"Darakta na Cibiyar Kula da Allergy da Cutar Cutar Cutar Amurka, Dr. Anthony Fauci, ya ce game da barkewar cutar, ""ainihin, zai kara muni. "" "
Ya zuwa ranar Alhamis, Kamfanin dillancin labarai na Associated Press ya ruwaito akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duk duniya, wanda ya haifar da mutuwar sama da 4,600.
Cutar cutar coronavirus ta 2019-20 annoba ce mai gudana ta cutar coronavirus ta 2019 (COVID-19), wacce cutar coronavirus 2 (SARS-CoV-2) mai tsanani ta haifar.
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, an ayyana ta a matsayin Matsalar Lafiya ta Duniya ta Damuwa ta Duniya a ranar 30 ga Janairu, 2020, kuma an gane ta a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa 10 ga Afrilu 2020, an bayar da rahoton kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210, wanda ya haifar da mutuwar mutane kusan 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta yawan mutuwar cutar ya kai kashi 4 cikin 100 a China, yayin da a duniya ya kasance daga 13.04% a Aljeriya zuwa .08% a New Zealand.
Alamun da aka saba da su sun hada da zazzabi, tari da kuma numfashi.
Abubuwan rikitarwa na iya haɗawa da ciwon huhu da kuma ciwon numfashi mai tsanani.
Lokaci daga bayyanar cutar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma na iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Babu maganin rigakafi ko takamaiman maganin rigakafin cutar.
Maganin farko shine maganin cututtuka da tallafi. Matakan rigakafi da aka ba da shawarar sun hada da wanke hannu, rufe bakin mutum lokacin da yake tari, kiyaye nesa da sauran mutane, da kuma sa ido da keɓe kai ga mutanen da suke zargin cewa suna da kamuwa da cutar.
Hukumomi a dukan duniya sun amsa ta wajen kafa takunkumin tafiye-tafiye, keɓewa, dokar hana fita, sarrafa haɗarin aiki, da kuma rufe wuraren aiki.
Cutar ta haifar da mummunar rushewar tattalin arziki da zamantakewar duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu, da kuma karancin kayayyaki da aka fadada ta hanyar sayen firgici.
Makarantu da jami'o'i sun rufe ko dai a ƙasa ko a gida a ƙasashe 193, wanda ya shafi kusan kashi 99.4 na ɗaliban duniya.
Rashin fahimta game da kwayar cutar ya bazu a yanar gizo, kuma an sami abubuwan da suka shafi kyamar baki da nuna wariya ga Sinawa, wasu mutane na Gabas da Kudu maso Gabashin Asiya da kuma bayyanar, da sauransu daga yankunan da ke da manyan shari'o'in kwayar cutar.
Saboda rage tafiye tafiye da rufe masana'antu masu nauyi, an sami raguwar gurbataccen iska da fitowar carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton tarin cututtukan ciwon huhu na sanadin da ba a sani ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin shari'o'in suna da alaƙa da Kasuwar Siyar da Kayan Kifin Huanan kuma saboda haka ana tsammanin kwayar cutar tana da asalin zoonotic.
Kwayar cutar da ta haifar da barkewar cutar ana kiranta SARS-CoV-2, sabuwar cutar da aka gano wacce ke da alaƙa da kwayar cutar bat coronaviruses, pangolin coronaviruses, da SARS-CoV. An gano daga baya cewa farkon mutumin da ke da alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma wannan mutumin ba shi da alaƙa da alamar kasuwar da ta biyo baya.
Daga farkon rukunin shari'o'in da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku an gano cewa suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya nuna cewa wani shari'ar da aka gano a ranar 17 ga Nuwamba, 2019, a cikin wani mutum mai shekaru 55 daga lardin Hubei, na iya zama na farko. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yayin da aka ba da rahoton cewa sabbin shari'o'in sun ragu a China amma ba zato ba tsammani sun karu a Italiya, Iran, da Koriya ta Kudu, adadin sabbin shari'o'in da ke wajen China ya wuce adadin sabbin shari'o'in a cikin China a karon farko.
Za a iya samun karancin rahoto na cututtuka, musamman a tsakanin waɗanda ke da alamun rashin lafiya.
A ranar 26 ga watan Fabrairu, an samu rahotanni na ƙarancin cututtuka a tsakanin matasa, waɗanda shekarunsu 19 da ƙasa da haka sun kai kashi 2.4% na cututtuka a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su buƙaci kamuwa da cutar kafin a sami tasirin garken garken.
Al'amuran suna nufin adadin mutanen da aka gwada wa COVID-19, kuma wanda aka tabbatar da gwajin sa yana da inganci bisa ga ka'idojin hukuma.
Ya zuwa ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawan jama'arta, kuma ƙasashe da yawa suna da manufofin hukuma na rashin gwada waɗanda ke da ƙananan alamun cutar, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani bincike da aka buga a ranar 16 ga watan Maris ya gano cewa a kasar Sin, har zuwa ranar 23 ga watan Janairu, kimanin kashi 86% na kamuwa da cutar COVID-19 ba a gano su ba, kuma wadannan kamuwa da cuta da ba a rubuta su ba ne tushen kamuwa da cutar a kashi 79% na wadanda aka rubuta su.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa adadin kamuwa da cutar a Italiya ya fi adadin da aka ruwaito.
Kwanan nan an kiyasta cewa yawan haifuwa (R0) na COVID-19 ya kai 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka da Rigakafin Amurka ta wallafa ya kammala cewa zai iya zama 5.7.
Yawancin mutane da ke da COVID-19 suna murmurewa.
Ga waɗanda ba su yi ba, lokacin daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, tare da mafi yawan kwanaki 14 .
Ya zuwa 10 ga Afrilu 2020, kusan mutane 97,000 ne suka mutu sakamakon COVID-19.
A China, har zuwa 5 ga Fabrairu, kusan kashi 80% na mutuwar sun kasance a cikin waɗanda suka haura shekaru 60, kuma kashi 75% suna da yanayin kiwon lafiya da suka riga sun kasance ciki har da cututtukan zuciya da ciwon sukari. Ƙididdigar hukuma na mutuwar daga cutar COVID-19 gabaɗaya tana nufin mutanen da suka mutu waɗanda suka gwada tabbatacce ga COVID bisa ga ka'idojin hukuma.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, saboda ba zai haɗa da mutanen da suka mutu ba tare da yin gwaji ba - misali a gida, a gidajen kula da tsofaffi, da sauransu.
Bayanai na ɓangare daga Italiya sun gano cewa yawan mutuwar wuce haddi yayin annobar ya wuce adadin mutuwar COVID na hukuma da kashi 4-5x.
" Wata mai magana da yawun Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka (CDC) ta yarda da cewa "Mun san cewa [yawan mutuwar da aka bayyana] rashin kimantawa ne", wata sanarwa da rahotanni na rashin kimantawa a Amurka suka tabbatar. Irin wannan rashin kimantawa yakan faru a cikin annoba, kamar cutar zazzabin H1N1 na aladu na shekarar 2009. An tabbatar da mutuwar farko a Wuhan a ranar 9 ga Janairu 2020. "
Mutuwa ta farko a wajen kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 14 ga watan Fabrairu.
Zuwa 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane fiye da goma sha biyu a kowanne a Iran, Koriya ta Kudu, da Italiya.
Zuwa 13 ga Maris, sama da kasashe da yankuna arba'in sun ba da rahoton mutuwar, a duk nahiyoyi ban da Antarctica. Ana amfani da ma'auni da yawa don ƙididdige yawan mutuwar.
Wadannan lambobi sun bambanta ta yankuna da kuma tsawon lokaci, kuma ana rinjayarsu ne da yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar, da halaye na yawan jama'a kamar su shekaru, jinsi, da kuma lafiyar gaba ɗaya. Matsayin mutuwa zuwa yanayin yana nuna adadin mutuwar da aka raba da adadin waɗanda aka gano a cikin wani lokaci.
Dangane da kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya zuwa cutar ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu 2020.
Adadin ya bambanta bisa ga yankin.
A China, kimantawa game da adadin mutuwar zuwa yanayin ya ragu daga 17.3% (ga waɗanda ke da bayyanar cututtuka 110 Janairu 2020) zuwa 0.7% (ga waɗanda ke da bayyanar cututtuka bayan 1 Fabrairu 2020). Sauran matakan sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano waɗanda suka mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan masu kamuwa da cuta (wanda aka gano da wanda ba a gano ba) waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta zuwa warwarewar shari'ar.
Masana kimiyya da yawa sun yi ƙoƙari su ƙididdige waɗannan adadi don takamaiman mutane.
Cibiyar Kula da Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar a cikin annobar gaba ɗaya yana tsakanin 0.1% da 0.39%.
Kimanin sama na wannan zangon ya yi daidai da sakamakon gwajin bazuwar farko na COVID-19 a Jamus, da kuma nazarin kididdiga da ke nazarin tasirin gwajin akan ƙididdigar CFR.
Hukumar ta WHO ta tabbatar da cewa za a iya sarrafa annobar.
Ba a san lokacin da cutar za ta kai kololuwa ba kuma tsawon lokacin da za ta yi ba kuma zai iya bambanta dangane da wurin da ake ci gaba.
" Maciej Boni na Jami'ar Jihar Penn ya bayyana, ""A bar shi ba tare da kulawa ba, yawanci annobar cutar tana kwance sannan kuma ta fara raguwa lokacin da cutar ta ƙare daga masu masaukin da ke akwai. "
"Amma kusan ba zai yiwu a yi wani tunani mai ma'ana ba a yanzu game da lokacin da hakan zai kasance".
" Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin China Zhong Nanshan ya yi jayayya cewa ""zai iya karewa a watan Yuni"" idan za a iya tattara dukkan kasashe don bin shawarar WHO kan matakan da za a dauka don dakatar da yaduwar cutar. "
"A ranar 17 ga watan Maris, Adam Kucharski na Makarantar Lafiya da Magungunan Yanayi ta London ya bayyana cewa SARS-CoV-2 ""zai ci gaba da yaduwa, mai yiwuwa na shekara daya ko biyu". "
"A cewar binciken kwalejin Imperial da Neil Ferguson ya jagoranta, za a bukaci nisantar jiki da sauran matakan "har sai an samu rigakafin (mai yiwuwa watanni 18 ko sama da haka) ".
"William Schaffner na Jami'ar Vanderbilt ya bayyana, ""Ina ganin ba zai yiwu ba cewa wannan coronavirusdomin yana da saukin yaduwazai ɓace gaba ɗaya"" kuma zai iya ""mai yiwuwa ya zama cutar yanayi, yana dawowa kowace shekara"". "
Rashin lafiyar dawowar zai dogara ne da rigakafin garken da kuma yawan canjin.
Alamun COVID-19 na iya zama marasa takamaiman kuma mutanen da ke kamuwa da cutar na iya zama marasa alamun.
Alamun biyu da suka fi kowa sune zazzabi (88%) da busassun tari (68%).
Alamun da ba sa bayyana sosai sun hada da gajiya, samar da ƙura a cikin numfashi (flegm), rashin jin ƙanshi, rashin numfashi, ciwon tsoka da na haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, hawan jini, zawo, ko cyanosis. WHO ta ce kusan mutum ɗaya cikin shida ya kamu da rashin lafiya mai tsanani kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka da Rigakafin Amurka (CDC) sun lissafa alamun gaggawa kamar wahalar numfashi, ciwon kirji ko matsin lamba, rikicewar kwatsam, wahalar farkawa, da fuska ko lebe masu shuɗi; ana ba da shawarar kulawar likita nan da nan idan waɗannan alamun sun kasance. Ƙarin ci gaban cutar na iya haifar da mummunar ciwon huhu, ciwon numfashi mai tsanani, sepsis, girgizar jini da mutuwa.
Wasu daga cikin wadanda suka kamu da cutar na iya zama marasa alamun cutar, ba tare da wata alama ta asibiti ba amma tare da sakamakon gwajin da ke tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawara cewa ya kamata a kula da waɗanda ke da kusanci da mutanen da aka tabbatar da kamuwa da cutar sosai kuma a bincika su don kawar da kamuwa da cuta.
Kimanin Sin na yawan marasa alamun cutar ya kasance daga kadan zuwa 44%.
Lokacin hawan da aka saba (lokacin tsakanin kamuwa da cuta da bayyanar cututtuka) ya kasance daga kwana daya zuwa 14, yawanci kwana biyar. A matsayin misali na rashin tabbas, kimantawa na kashi na mutanen da ke da COVID-19 waɗanda suka rasa ƙanshin su ya kasance 30% da farko kuma daga baya ya ragu zuwa 15%.
Har yanzu ana tantance wasu bayanai game da yadda cutar ke yaduwa.
An yi imanin cewa cutar tana yaduwa ne a lokacin kusanci da kuma ta ƙananan ɗigon ruwa da aka samar yayin tari, tari, ko magana; tare da kusanci na kusa da mita 1 zuwa 2 (3 zuwa 6 feet).
Nazarin ya gano cewa tari da ba a rufe ba na iya haifar da ɗigon ruwa da ke tafiya har zuwa mita 4.5 (15 feet) zuwa mita 8.2 (27 feet).
Wasu sun ba da shawarar cewa za a iya watsa kwayar ta ƙananan ɗigon ruwa waɗanda ke kasancewa na dogon lokaci a cikin iska, wanda za a iya samarwa yayin magana. Hakanan za a iya samar da ɗigon numfashi yayin numfashi, gami da lokacin magana, kodayake kwayar ba ta da iska.
Rashin ruwan zai iya sauka a bakin ko hanci na mutanen da ke kusa ko kuma a iya sha shi cikin huhu.
Wasu hanyoyin kiwon lafiya kamar su intuba da kuma sake farfadowa na zuciya da huhu (CPR) na iya haifar da ɓarkewar numfashi a cikin iska kuma don haka ya haifar da yaduwar iska.
Hakanan zai iya yaduwa idan mutum ya taɓa wani abu da ya ƙazantu, har da fata, sannan ya taɓa idanunsa, hanci, ko bakinsa.
Duk da cewa akwai damuwa cewa zai iya yaduwa ta hanyar kwance, ana ganin wannan hadarin yana da ƙaranci.
Gwamnatin China ta musanta yiwuwar watsa SARS-CoV-2 ta hanyar kwance-kwance. Kwayar cutar tana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwa na iya yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Mutane sun gwada tabbatacce ga cutar har zuwa kwanaki uku kafin bayyanar cututtuka yana nuna yiwuwar watsawa kafin ci gaba da bayyanar cututtuka masu mahimmanci.
Rahotanni kaɗan ne kawai na lab-tabbatar da marasa alamun cutar, amma wasu ƙasashe sun gano watsawar marasa alamun cutar yayin binciken gano lamba.
Cibiyar rigakafin cututtuka da kula da cuta ta Turai (ECDC) ta ce ko da yake ba a bayyana yadda cutar ke yaduwa cikin sauƙi ba, mutum ɗaya yawanci yana cutar da mutane biyu zuwa uku. Kwayar cutar tana rayuwa na tsawon sa'o'i zuwa kwanaki a kan farfajiyar jiki.
Musamman, an gano cewa cutar tana iya ganowa har tsawon kwanaki uku akan filastik (polypropylene) da bakin karfe 304, har tsawon rana daya akan kwali, da kuma har tsawon awanni huɗu akan jan karfe.
Wannan, duk da haka, ya bambanta dangane da zafi da zafin jiki. Dabbobi da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu wata shaida da ta nuna cewa dabbobi na iya yada cutar zuwa ga mutane, duk da cewa hukumomin Birtaniya sun shawarci wanke hannu bayan sun yi hulda da dabbobi, kamar bayan sun yi hulda da wasu wuraren da mutane masu kamuwa da cutar suka taɓa.
Cutar coronavirus mai tsanani na numfashi mai tsanani 2 (SARS-CoV-2) wani sabon kwayar cuta ne, wanda aka fara warewa daga mutane uku da ke da ciwon huhu da ke da alaƙa da tarin cututtukan numfashi mai tsanani a Wuhan.
Dukkanin fasalulluka na sabon kwayar SARS-CoV-2 suna faruwa ne a cikin kwayar cutar corona da ke da alaƙa da juna a yanayi. A wajen jikin mutum, ana kashe kwayar cutar ta sabulu na gida, wanda ke narkar da murfin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Ana tunanin cewa yana da asalin zoonotic.
Binciken kwayoyin halitta ya bayyana cewa kwayar cutar coronavirus ta haɗu da nau'in Betacoronavirus, a cikin ƙaramin nau'in Sarbecovirus (tsarin B) tare da nau'ikan nau'ikan bat biyu.
Ya yi daidai da kashi 96% a matakin dukkanin kwayoyin halitta da sauran samfuran coronavirus na bat (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci guda daya kawai na amino acid a wasu sassan jerin kwayoyin halittar tsakanin ƙwayoyin cuta daga pangolins da waɗanda daga mutane.
Kwatantawar dukkanin kwayoyin halitta ya zuwa yanzu ya gano a mafi yawan kashi 92% na kayan halittar da aka raba tsakanin pangolin coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da pangolins su zama mai masaukin baki ba.
Ana iya tantance kamuwa da kwayar cutar a wucin gadi bisa ga alamun, kodayake tabbatarwa a ƙarshe ta hanyar jujjuyawar juzu'in polymerase (rRT-PCR) na ɓoyayyen ɓoyayyen ƙwayar cuta ko CT.
Wani bincike da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi PCR hankali, kodayake ba shi da takamaiman bayani, tare da yawancin fasalulluka na hoton da ke rufewa da sauran cututtukan huhu da kuma hanyoyin cutar.
"A watan Maris na shekarar 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa ""kada a yi amfani da CT don tantancewa ko a matsayin gwajin farko don gano COVID-19". "
WHO ta wallafa wasu ka'idojin gwajin RNA don SARS-CoV-2, wanda aka fara fitarwa a ranar 17 ga Janairu.
Gwajin yana amfani da halayen sarkar polymerase na lokaci-lokaci (rRT-PCR).
Ana iya yin gwajin a kan hanyoyin numfashi ko kuma jinin.
Sakamakon yawanci ana samunsa cikin 'yan sa'o'i zuwa kwanaki.
A yadda aka saba ana yin wannan gwajin ne a kan wani abu da aka yi da shi a hanci ko kuma a cikin hanci, ko da yake ana iya yin amfani da wani abu da aka yi da shi a cikin hanci.
A ranar 6 ga Afrilu 2020, babu ɗayan waɗannan da aka tabbatar da cewa ya isa ya zama daidai don a amince da shi don amfani da shi a ko'ina.
A Amurka an amince da gwajin kwayar cutar da Cellex ta samar don amfani da gaggawa ta hanyar dakunan gwaje-gwaje masu lasisi kawai.
Abubuwan da ke nuna hoto a kan radiographs da kuma CT (computed tomography) na mutanen da ke da alamun sun hada da rashin daidaituwa na gilashin gilashin gilashi da kuma rashin zubar da jini.
Kamfanin Radiological na Italiya yana tattara bayanan yanar gizo na duniya na binciken hotuna don tabbatar da shari'o'in.
Saboda haɗuwa da sauran cututtuka kamar adenovirus, yin hoto ba tare da tabbatarwa ta hanyar PCR yana da iyakantaccen takamaiman bayani wajen gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa kodayake hoton ba shi da takamaiman bayani game da kamuwa da cuta, yana da sauri kuma yana da saukin fahimta, yana ba da shawarar yin la'akari da shi azaman kayan aikin bincike a yankunan da cutar ta barke.
An haɓaka hanyoyin sadarwar ƙwayoyin cuta masu ƙyalli bisa ƙwarewar kere kere don gano fasalin hoto na kwayar cutar tare da duka radiographs da CT.
Dabaru don hana yaduwar cutar sun hada da kiyaye tsabtar mutum gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci, ko baki da hannaye marasa wankewa, da yin tari ko tari a cikin takarda da sanya takarda kai tsaye a cikin kwandon shara.
Wadanda suka riga sun kamu da cutar an shawarce su da su sanya abin rufe fuska na tiyata a fili.
Ana kuma bada shawarar kiyaye nesa ta jiki don hana yaduwar cutar. Gwamnatoci da yawa sun takaita ko ba da shawara game da duk tafiye-tafiye marasa mahimmanci zuwa da daga ƙasashe da yankunan da cutar ta shafa.
Koyaya, kwayar cutar ta kai matakin yaduwar al'umma a manyan sassan duniya.
Wannan na nufin cewa kwayar tana yaduwa a cikin al'ummomi, kuma wasu membobin al'umma ba su san inda ko yadda aka kamu da su ba. Ana ba da shawarar masu ba da kiwon lafiya da ke kula da wani wanda zai iya kamuwa da cutar su yi amfani da matakan kariya na yau da kullun, matakan kariya na tuntuɓar, da kariya ga idanu. Binciken tuntuɓar hanya ce mai mahimmanci ga hukumomin kiwon lafiya don sanin tushen kamuwa da cuta da kuma hana ci gaba da yaduwa.
Amfani da bayanan wurin da aka samu daga wayoyin salula da gwamnatoci ke yi don wannan dalili ya haifar da damuwa game da sirrin mutane, inda Amnesty International da sama da wasu kungiyoyi 100 suka fitar da wata sanarwa da ke kira ga a takaita irin wannan sa ido.
An aiwatar da aikace-aikacen wayar hannu daban-daban ko aka ba da shawarar don amfani da son rai, kuma a ranar 7 ga Afrilu, 2020, sama da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar
Masu amfani sai su karɓi saƙo idan sun kasance cikin kusanci da wani wanda ya gwada tabbatacce ga COVID-19. Rashin fahimta suna yawo game da yadda za a hana kamuwa da cuta; misali, wanke hanci da gargling tare da ruwan sha na baki ba su da tasiri.
Babu allurar rigakafin COVID-19, kodayake ƙungiyoyi da yawa suna aiki don haɓaka ɗaya.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa na akalla sakan ashirin, musamman bayan sun je gidan wanka ko kuma idan hannayensu suna da datti a bayyane; kafin cin abinci; da kuma bayan sun hura hanci, sun yi tari, ko kuma sun yi tari.
Wannan saboda a waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wadda take fashewa da kumfa mai kariya.
CDC ta kuma ba da shawarar yin amfani da maganin tsabtace hannu na barasa tare da aƙalla kashi 60% na barasa idan sabulu da ruwa ba su samuwa.
Hukumar ta WHO ta shawarci mutane su guji taɓa idanunsu, hanci, ko baki da hannuwa marasa wanki.
Za'a iya tsabtace farfajiyar da wasu mafita (a cikin minti daya na fallasa ga maganin kashe cuta don farfajiyar bakin karfe), gami da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Sauran hanyoyin, kamar su benzalkonium chloride da chrohexidine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan ana zargin ko an tabbatar da cutar COVID a cikin wani wuri kamar ofishi ko wurin kula da yara, ya kamata a kashe ƙwayoyin cuta a duk wuraren kamar ofisoshi, dakunan wanka, wuraren gama gari, kayan aikin lantarki da aka raba kamar allunan, allon taɓawa, maɓallan rubutu, na'urorin sarrafawa na nesa, da na'urorin ATM da marasa lafiya ke amfani da su.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hanci da wuyan hannu ko kuma takarda sa'ad da suke tari ko sassaka, kuma su zubar da duk wani takarda nan da nan.
Ana ba da shawarar sanya abin rufe fuska ga waɗanda za su iya kamuwa da cutar, saboda sanya abin rufe fuska na iya iyakance girma da nisan tafiyar ɗigon numfashi da ke warwatsewa yayin magana, tari, da tari.
Hukumar lafiya ta duniya ta fitar da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
"A cewar Stephen Griffin, masanin ilimin cutar a Jami'ar Leeds, ""Sanya abin rufe fuska na iya rage yawan mutane su taba fuskokinsu, wanda babban tushen kamuwa da cuta ne ba tare da tsaftace hannu ba. ""An kuma bada shawarar yin amfani da abin rufe fuska ga wadanda ke kula da wanda ke da cutar. "
WHO ta ba da shawarar sanya abin rufe fuska ga mutanen da ke da lafiya kawai idan suna cikin babban haɗari, kamar waɗanda ke kula da mutumin da ke da COVID-19, kodayake sun kuma yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskokinsu.
Kasashe da dama sun fara karfafa amfani da abin rufe fuska ta hanyar jama'a.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska wanda ba na likita ba wanda aka yi da masana'anta. China ta ba da shawarar musamman amfani da abin rufe fuska na likita da za a iya zubar da shi ta hanyar mutanen da ke da lafiya, musamman lokacin da suka kusanci (1 mita 3 ko ƙasa da haka) tare da wasu mutane.
Hong Kong ta ba da shawarar sanya abin rufe fuska lokacin da take amfani da sufuri na jama'a ko kuma zama a wuraren da mutane ke yawan zama.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su yi takunkumin fuska na masana'anta a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga Maris, Vietnam ta nemi kowa ya sanya abin rufe fuska lokacin da ya je wuraren jama'a don kare kansa da wasu.
Gwamnatin Austria ta ba da umarnin cewa duk wanda ya shiga shagon kayan masarufi dole ne ya sanya abin rufe fuska.
Isra'ila ta nemi dukkan mazauna su sanya abin rufe fuska a lokacin da suke cikin jama'a.
Taiwan, wacce ke samar da abin rufe fuska miliyan goma a rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da motocin bas na tsakanin birane su sanya abin rufe fuska a ranar 1 ga Afrilu.
Panama ta sanya sanya abin rufe fuska a duk lokacin da ta fita waje, yayin da kuma ta ba da shawarar yin abin rufe fuska na gida ga waɗanda ba za su iya siyan abin rufe fuska ba.
An kuma yi amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Nisa nesa (wanda kuma aka sani da nisantar jiki) ya hada da ayyukan sarrafa kamuwa da cuta da nufin rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyi sun haɗa da keɓewa; ƙuntatawa tafiye-tafiye; da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo, ko cibiyoyin kasuwanci.
Mutane na iya amfani da hanyoyin nisantar jama'a ta hanyar zama a gida, iyakance tafiya, guje wa wuraren da mutane ke cunkoso, amfani da gaisuwa ba tare da tuntuɓar mutum ba, da nisantar kansu daga wasu.
Gwamnatoci da yawa yanzu suna ba da umarni ko ba da shawarar nisantar jama'a a yankunan da annobar ta shafa.
Matsakaicin girman taron da hukumomin gwamnati na Amurka da kungiyoyin kiwon lafiya suka ba da shawarar an rage shi cikin sauri daga mutane 250 (idan ba a san yaduwar COVID-19 a wani yanki ba) zuwa mutane 50, kuma daga baya zuwa mutane 10.
"A ranar 22 ga Maris, 2020, Jamus ta haramta taron jama'a na mutane sama da biyu. Manya tsofaffi da waɗanda ke da yanayin rashin lafiya kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da tsarin garkuwar jiki suna fuskantar haɗarin kamuwa da cuta mai tsanani da rikitarwa kuma CDC ta shawarce su da su zauna a gida gwargwadon iko a yankunan da cutar ta barke.A ƙarshen Maris 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar ""yanke nesa"" da ""yanke nesa ta jiki"", don fayyace cewa manufar ita ce rage hulɗa ta jiki yayin kiyaye alaƙar zamantakewa, ko dai a zahiri ko a nesa. "
"Amfani da kalmar ""yanke nesa da jama'a"" ya haifar da ma'anar cewa mutane su shiga cikin keɓewar jama'a, maimakon ƙarfafa su su ci gaba da hulɗa da wasu ta hanyar madadin. Wasu hukumomi sun ba da jagororin kiwon lafiya na jima'i don amfani a lokacin annobar. "
Waɗannan sun haɗa da shawarwari na yin jima'i da wanda kuke zaune tare da shi kawai, wanda ba shi da kwayar cutar ko kuma alamun cutar.
An ba da shawarar keɓe kai a gida ga waɗanda aka gano suna da COVID-19 da waɗanda suke zargin cewa sun kamu da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun umarni don keɓewa da kansu yadda ya kamata. Gwamnatoci da yawa sun ba da umarni ko sun ba da shawarar keɓewa da kansu ga dukkan mutanen da ke zaune a yankunan da cutar ta shafa.
An bayar da umarni mafi tsauri na keɓewa ga waɗanda ke cikin rukunin haɗari.
Wadanda suka iya fuskantar wani da ke dauke da COVID-19 da kuma wadanda suka yi tafiya kwanan nan zuwa wata ƙasa ko yanki da ke da yaduwar yaduwar cutar an shawarce su da su keɓe kansu na tsawon kwanaki 14 daga lokacin da suka kamu da cutar.
Dabaru a cikin sarrafa fashewar cuta sune hanawa ko hanawa, da ragewa.
Ana gudanar da rigakafi a farkon matakan barkewar cutar kuma yana nufin ganowa da kebe waɗanda suka kamu da cutar da kuma gabatar da wasu matakan sarrafa kamuwa da cuta da allurar rigakafi don dakatar da cutar daga yaduwa ga sauran jama'a.
Lokacin da ba zai yiwu a hana yaduwar cutar ba, sai a koma matakin rage cutar: ana daukar matakan rage yaduwar cutar da rage tasirin ta a kan tsarin kiwon lafiya da al'umma.
Za a iya yin haɗuwa da matakan hanawa da ragewa a lokaci guda.
Dakatar da cutar na bukatar karin matakai masu tsananin gaske domin a mayar da annobar ta hanyar rage yawan haifuwa zuwa kasa da 1. Wani bangare na sarrafa barkewar cutar mai yaduwa shine kokarin rage yawan annobar, wanda aka sani da daidaita yanayin annobar.
Wannan yana rage haɗarin ayyukan kiwon lafiya da za a shawo kansu kuma yana ba da ƙarin lokaci don samar da alluran rigakafi da magunguna.
Matakan da ba na magani ba da ke iya sarrafa barkewar cutar sun hada da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da keɓewa; matakan al'umma da aka nufa don nisantar jiki kamar rufe makarantu da soke taron taro; haɗin gwiwar al'umma don ƙarfafa karɓa da shiga cikin irin waɗannan tsoma bakin; da kuma matakan muhalli kamar tsabtace farfajiyar. An ɗauki ƙarin matakai masu mahimmanci da nufin hana barkewar cutar a China da zarar tsananin barkewar cutar ya bayyana, kamar keɓe birane gaba ɗaya da sanya takunkumin hana tafiye -tafiye.
Sauran ƙasashe kuma sun ɗauki matakai daban-daban da nufin rage yaduwar kwayar cutar.
Koriya ta Kudu ta gabatar da binciken taro da keɓewar wuri, kuma ta ba da gargadi kan motsin mutane masu kamuwa da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda suka kamu da cutar waɗanda suka keɓe kansu kuma suka sanya manyan tarar ga waɗanda suka kasa yin hakan.
Taiwan ta kara samar da abin rufe fuska kuma ta hukunta tara kayan kiwon lafiya.Kayan kwaikwayo na Burtaniya da Amurka sun nuna cewa ragewa (ragewa amma ba dakatar da yaduwar annobar) da dakile (juyawa ci gaban annobar) suna da manyan ƙalubale.
Manufofin rage yawan cutar na iya rage yawan bukatar kiwon lafiya da kashi biyu bisa uku da kuma mutuwar da rabi, amma har yanzu yana haifar da dubban dubban mutuwar da kuma tsarin kiwon lafiya da ke cike da damuwa.
Ana iya fifita hanawa amma ana buƙatar kiyaye shi muddin kwayar cutar tana yawo a cikin yawan mutane (ko har sai an sami allurar rigakafi, idan hakan ta fara), saboda in ba haka ba watsawar yana dawowa da sauri lokacin da aka sassauta matakan.
Shigar da hankula na dogon lokaci don dakile annobar na haifar da tsada ta zamantakewa da tattalin arziki.
Babu takamaiman magungunan rigakafin cutar da aka amince da su don COVID-19, amma ana ci gaba da kokarin ci gaba, gami da gwajin magungunan da ke akwai.
Shan magungunan sanyi da ake sayar da su a kantin magani, shan ruwa, da kuma hutawa na iya taimaka wajen rage alamun.
Dangane da tsananin cutar, za a iya buƙatar maganin oxygen, ruwan jini, da taimakon numfashi.
Yin amfani da steroids na iya sa sakamakon ya yi muni.
Ana binciken wasu mahaɗan da aka amince da su a baya don maganin wasu cututtukan ƙwayoyin cuta don amfani da su wajen magance COVID-19.
" WHO ta kuma bayyana cewa wasu ""magungunan gargajiya da na gida"" na iya ba da agajin bayyanar cututtukan da SARS-CoV-19 ke haifarwa".
WHO ta bayyana haɓaka iya aiki da daidaita kulawar lafiya don bukatun marasa lafiyar COVID-19 a matsayin babban matakin amsawa ga barkewar cutar.
ECDC da ofishin Yankin Turai na WHO sun fitar da jagororin asibitoci da ayyukan kiwon lafiya na farko don sauya albarkatu a matakai da yawa, gami da mai da hankali kan ayyukan dakin gwaje-gwaje zuwa gwajin COVID-19, soke hanyoyin zaɓin duk lokacin da zai yiwu, raba da ware marasa lafiya masu cutar COVID-19, da haɓaka ƙarfin kulawa ta hanyar horar da ma'aikata da haɓaka adadin masu amfani da iska da gadaje.
Akwai ra'ayoyi daban-daban game da inda farkon yanayin (wanda ake kira marasa lafiya zero) zai iya samo asali.
An gano farkon sanannen yanayin cutar coronavirus a ranar 1 ga Disamba 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
Waɗannan galibi suna da alaƙa da Kasuwar Siyar da Kayan Kifin Teku ta Huanan, wanda kuma ke sayar da dabbobi masu rai, kuma wata ka'ida ita ce cewa kwayar cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko, a wasu kalmomin, tana da asalin zoonotic. An lura da tarin ciwon huhu na sanannen sanadin a ranar 26 ga Disamba kuma likita Zhang Jixian ya kula da shi a Asibitin lardin Hubei, wanda ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
"A ranar 30 ga watan Disamba, wani rukuni na likitoci a asibitin Wuhan na tsakiya sun gargadi abokan aikinsu game da "tsarin coronavirus mai kama da SARS". "
'Yan sanda sun tsauta wa takwas daga cikin waɗannan likitoci, har da Li Wenliang, don ya yaɗa jita-jita, kuma shugabanninta sun tsauta wa wata, Ai Fen, don ta yi gargadi.
Daga baya Hukumar Kiwon Lafiya ta Wuhan ta fitar da sanarwa a ranar 31 ga Disamba kuma ta sanar da WHO.
An bayar da rahoton isassun shari'o'in cutar huhu da ba a sani ba ga hukumomin kiwon lafiya a Wuhan don ƙaddamar da bincike a farkon watan Janairu.A farkon farkon barkewar cutar, adadin masu cutar ya ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairu na 2020, kwayar cutar ta bazu zuwa wasu lardunan China, wanda aka taimaka ta hanyar ƙaurawar Sabuwar Shekarar Sin da Wuhan kasancewar cibiyar sufuri da babbar hanyar jirgin ƙasa.
A ranar 20 ga Janairu, Sin ta ba da rahoton kusan sabbin mutane 140 a rana guda, ciki har da mutane biyu a Beijing da ɗaya a Shenzhen.
Bayanai na baya sun nuna cewa mutane 6,174 sun riga sun sami alamun cutar a ranar 20 ga Janairu 2020.Zuwa 26 ga Maris, Amurka ta zarce China da Italiya tare da mafi yawan adadin waɗanda aka tabbatar da su a duniya.Zuwa 9 ga Afrilu 2020, an ba da rahoton sama da mutane miliyan 1.61 a duk duniya; sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
Kimanin kasashe da yankuna 200 sun sami akalla mutum daya da ya kamu da cutar.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun takaita motsi kyauta kuma sun kafa kulawar kan iyakoki.
Amsoshin ƙasa sun haɗa da matakan hanawa kamar keɓewa (wanda aka sani da umarnin zama a gida, umarnin mafaka a wuri, ko kulle-kulle) da dokar hana fita. Ya zuwa ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, suna ƙarƙashin wani nau'in kulle-kulle a Amurka, sama da mutane miliyan 50 suna cikin kulle-kulle a Philippines, kusan mutane miliyan 59 suna cikin kulle-kulle a Afirka ta Kudu, kuma mutane biliyan 1.3 suna cikin kulle-kulle a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna ƙarƙashin wani nau'i na kulle-kulle, wanda ya ƙaru zuwa biliyan 2.6 bayan kwana biyu kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano farkon wanda aka tabbatar da cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon wanda aka tabbatar da shi ya kasance a ranar 17 ga Nuwamba.
Dokta Zhang Jixian ta lura da tarin cututtukan ciwon huhu na sanadin da ba a sani ba a ranar 26 ga Disamba, wanda asibitin ta sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Gwajin asalin farko na samfuran marasa lafiya a ranar 27 ga Disamba 2019 ya nuna kasancewar cutar coronavirus mai kama da SARS.
Hukumar Kiwon Lafiya ta Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a ranar.
" Yayin da wadannan sanarwar suka faru, likitoci a Wuhan sun gargadi 'yan sanda saboda "" yada jita-jita "" game da barkewar cutar. "
" Hukumar Lafiya ta Kasa ta kasar Sin da farko ta yi ikirarin cewa babu wata "bayyanawa" ta hanyar mutum zuwa mutum. "
"A ƙarshen watan Janairu, gwamnatin China ta ƙaddamar da wani yunkuri mai zurfi wanda daga baya babban sakataren Jam'iyyar Kwaminis ta Sin Xi Jinping ya bayyana a matsayin "yaƙin jama'a" don hana yaduwar kwayar cutar. "
"A cikin abin da aka bayyana a matsayin" mafi girman keɓewa a tarihin ɗan adam, "an sanar da cordon sanitaire a ranar 23 ga Janairu don dakatar da tafiya a ciki da waje na Wuhan, wanda aka faɗaɗa zuwa jimillar birane 15 a Hubei, wanda ya shafi jimillar mutane kusan miliyan 57. "
An haramta amfani da motoci masu zaman kansu a cikin birni.
An soke bukukuwan Sabuwar Shekarar Sin (25 ga Janairu) a wurare da yawa.
Hukumomin sun kuma sanar da gina asibitin wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti bayan haka, asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta kuma sauya wasu wurare 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta kafa wasu matakai don hana barkewar COVID-19, gami da bayar da sanarwar lafiya ga matafiya da tsawaita hutun bikin bazara.
Jami'o'i da makarantu a duk fadin kasar ma an rufe su.
Yankunan Hong Kong da Macau sun kafa wasu matakai, musamman game da makarantu da jami'o'i.
An kafa matakan aiki daga nesa a yankuna da dama na kasar Sin.
An kafa takunkumin tafiye-tafiye a ciki da wajen Hubei.
An canja hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi a dukan ƙasar Sin na ɗan lokaci.
"An yi amfani da iko kan motsin jama'a a birane da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan takunkumi a waje. Bayan barkewar cutar ta shiga matakin ta na duniya a watan Maris, hukumomin China sun dauki tsauraran matakai don hana kwayar cutar " shigowa " daga wasu ƙasashe. "
Misali, Beijing ta sanya wa dukkan matafiya na duniya da ke shiga birnin keɓewar kai na kwanaki 14. A ranar 23 ga watan Maris, ƙasar Sin ta sami mutum ɗaya kawai da ya kamu da cutar a cikin gida a cikin kwanaki biyar da suka gabata, a wannan yanayin ta hanyar matafiyi da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan China Li Keqiang ya ba da rahoton cewa an toshe yaduwar cututtukan da aka yada a cikin gida kuma an sarrafa barkewar cutar a China.
A wannan rana an sassauta takunkumin tafiye-tafiye a Hubei, ban da Wuhan, watanni biyu bayan da aka sanya dokar kulle. Ma'aikatar Harkokin Wajen Sin ta sanar a ranar 26 ga Maris 2020 cewa za a dakatar da shigar masu da takardar izinin shiga ko izinin zama daga ranar 28 ga Maris zuwa gaba, ba tare da takamaiman bayani kan lokacin da wannan manufar za ta ƙare ba.
Wadanda suke son shiga kasar Sin za su nemi biza a ofisoshin jakadancin kasar Sin ko ofisoshin jakadancin kasar.
Gwamnatin China ta karfafa kasuwancin da masana'antu don sake buɗewa a ranar 30 ga Maris, kuma ta ba da fakitoci na kuɗi don kamfanoni. Majalisar Jiha ta ayyana ranar makoki don farawa tare da minti uku na shiru a ranar 4 ga Afrilu, daidai da bikin Qingming, kodayake gwamnatin tsakiya ta nemi iyalai su nuna girmamawarsu ta yanar gizo don kiyaye nisantar jiki don kaucewa sake barkewar COVID-19.
An tabbatar da cewa COVID-19 ya bazu zuwa Koriya ta Kudu a ranar 20 ga Janairu 2020 daga China.
Hukumar kiwon lafiya ta kasar ta ba da rahoton karuwar masu kamuwa da cutar a ranar 20 ga Fabrairu, wanda aka danganta shi da yawa ga taron a Daegu na sabon motsi na addini da aka sani da Shincheonji Church of Jesus.
An yi zargin cewa masu bin Shincheonji da ke ziyartar Daegu daga Wuhan ne suka haifar da barkewar cutar.
Ya zuwa 22 ga Fabrairu, a cikin mabiya 9,336 na cocin, 1,261 ko kusan 13% sun ba da rahoton alamun. Koriya ta Kudu ta ayyana matakin gaggawa a ranar 23 ga Fabrairu 2020.
A ranar 28 ga Fabrairu, an bayar da rahoton fiye da mutane 2,000 da aka tabbatar da su a Koriya, wanda ya tashi zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan gwajin da aka tabbatar cewa sojoji uku sun kamu da cutar.
An kuma shafi jadawalin jiragen sama kuma saboda haka an canza su. Koriya ta Kudu ta gabatar da abin da aka ɗauka shine mafi girma kuma mafi kyawun tsari a duniya don bincika yawan jama'a don cutar, da ware duk wani mutum da ya kamu da cutar da kuma ganowa da keɓe waɗanda suka tuntube su.
Hanyoyin tantancewa sun haɗa da tilastawa masu shigowa daga ƙasashen waje su ba da rahoton alamun cutar ta hanyar aikace-aikacen wayar hannu, gwajin cutar ta hanyar tuki tare da sakamakon da ake samu washegari, da kuma ƙara ƙarfin gwajin don ba da damar har zuwa mutane 20,000 a gwada kowace rana.
Ana ganin shirin Koriya ta Kudu ya yi nasara wajen shawo kan barkewar cutar duk da cewa ba a killace dukkan birane ba. Da farko al'ummar Koriya ta Kudu ta kasance mai tsaka-tsaki a kan yadda Shugaba Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman tsige Moon saboda abin da suka ce rashin kulawar gwamnati ne game da barkewar cutar, ko kuma yabon martanin da ya bayar.
A ranar 23 ga Maris, an bayar da rahoton cewa Koriya ta Kudu tana da mafi ƙarancin adadin masu kamuwa da cutar a cikin kwana ɗaya cikin makonni huɗu.
A ranar 29 ga Maris an ba da rahoton cewa daga ranar 1 ga Afrilu duk sabbin masu zuwa kasashen waje za a killace su na tsawon makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta sami buƙatun taimako don gwajin kwayar cutar daga ƙasashe daban-daban 121.
Iran ta ba da rahoton farkon tabbatar da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu suka mutu daga baya a wannan ranar.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da sauran al'amuran al'adu, wasannin motsa jiki, da sallar Juma'a, da rufe jami'o'i, cibiyoyin ilimi mafi girma, da makarantu.
Iran ta ware tiriliyan biyar na riyal don yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairu 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa, kuma mutane ne kawai za a killace su.
An sanar da tsare-tsaren iyakance tafiye-tafiye tsakanin birane a watan Maris, kodayake ana ci gaba da zirga-zirgar ababen hawa tsakanin birane kafin Sabuwar Shekarar Farisa ta Nowruz.
An bude wuraren ibada na Shia a Qom ga mahajjata har zuwa 16 ga Maris 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A tsakanin ikirarin rufewa game da yaduwar cutar a Iran, sama da kasashe goma sun gano yanayin su zuwa Iran a ranar 28 ga Fabrairu, wanda ke nuna cewa yaduwar cutar na iya zama mafi tsanani fiye da 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran, tare da 23 daga cikin mambobinta 290 da aka ruwaito sun gwada tabbatacce ga kwayar cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin gidan yari na Iran da su saki masu kare hakkin dan adam da aka tsare saboda rashin amincewarsu ta lumana, da kuma sake duk fursunonin da suka cancanci hakan.
Ya bayyana cewa akwai babban haɗarin yaduwar kwayar cutar a cikin rufe cibiyoyi kamar cibiyoyin tsare, waɗanda kuma ba su da isasshen kulawa ta likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta bayar da rahoton mutuwar mutane 100 a rana guda, wanda shine mafi yawan da aka samu a kasar tun lokacin da annobar ta fara.
Akalla 'yan siyasa 12 da tsoffin jami'an gwamnati sun mutu sakamakon cutar a ranar 17 ga watan Maris.
Zuwa 23 ga Maris, Iran tana fuskantar sabbin masu kamuwa da cutar 50 a kowace awa kuma sabon mutuwa a kowane minti goma saboda coronavirus.
A cewar wani jami'in WHO, akwai yiwuwar masu kamuwa da cutar sun ninka sau biyar na wadanda ake bayar da rahoto.
An kuma ba da shawarar cewa takunkumin Amurka kan Iran na iya shafar ikon tattalin arzikin kasar don amsa cutar ta kwayar cutar.
Babban Kwamishinan Majalisar Dinkin Duniya na 'Yancin Dan Adam ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar zuwa Italiya a ranar 31 ga Janairu, lokacin da masu yawon bude ido biyu na China suka gwada tabbatacce ga SARS-CoV-2 a Rome.
Al'amuran sun fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da dawowa daga China kuma ta ayyana dokar ta baci.
Daga baya an gano wani rukuni na marasa alaƙa da COVID-19, farawa da 16 da aka tabbatar da su a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta sanar da sabon doka don hana barkewar cutar, gami da keɓewa sama da mutane 50,000 daga garuruwa daban-daban 11 a arewacin Italiya.
" Firayim Minista Giuseppe Conte ya ce, " " A yankunan da cutar ta bulla, ba za a samar da shiga da fita ba. "
"An riga an ba da umarnin dakatar da ayyukan aiki da abubuwan wasanni a waɗancan yankunan. ""A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar yayin da Italiya ta kai mutuwar mutane 100".
Duk manyan wasannin wasanni, gami da wasannin kwallon kafa na Serie A, za a gudanar da su a rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin gaba daya na akalla wata daya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Kula da Magunguna ta Italiya (SIAARTI) ta buga shawarwarin ɗabi'a game da hanyoyin da za a iya amfani da su.
A ranar 19 ga Maris, Italiya ta zarce China a matsayin kasar da ke da yawan mutuwar da ke da nasaba da cutar coronavirus a duniya bayan ta bayar da rahoton mutuwar mutane 3,405 daga cutar.
A ranar 22 ga Maris, an ruwaito cewa Rasha ta aika da jiragen sama na soja tara tare da kayan aikin likita zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, akwai mutane 128,948 da aka tabbatar da cutar, 15,887 sun mutu, kuma 21,815 sun warke a Italiya, tare da mafi yawan waɗannan shari'o'in da ke faruwa a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da yawan tsofaffi na Italiya da rashin iya gwada duk waɗanda ke da kwayar cutar har zuwa yau na iya taimakawa ga yawan mutuwar.
Amsar Burtaniya ga cutar ta fara fitowa a matsayin ɗaya daga cikin ƙasashe masu sassaucin ra'ayi, kuma har zuwa 18 ga Maris 2020, gwamnatin Burtaniya ba ta sanya kowane nau'i na nisantar zamantakewa ko matakan keɓewa ga 'yan ƙasa ba.
Sakamakon haka, gwamnati ta fuskanci suka saboda rashin saurin da kuma tsananin amsawa ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar ba da shawara game da duk tafiye-tafiye da alaƙar zamantakewa, yana ba da shawarar mutane su yi aiki daga gida a duk lokacin da zai yiwu kuma su guji wuraren da ake shaguna, gidajen cin abinci, da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar su mashaya da wuraren motsa jiki za a rufe su da wuri-wuri, kuma ta yi alkawarin biyan har zuwa kashi 80% na albashin ma'aikata zuwa iyakar £2,500 a wata don hana rashin aikin yi a cikin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisantar zamantakewar jama'a, hana tarurrukan mutane sama da biyu da kuma takaita tafiye-tafiye da ayyukan waje zuwa abin da aka ɗauka da mahimmanci.
Ba kamar matakan da suka gabata ba, 'yan sanda sun tilasta aiwatar da waɗannan ƙuntatawa ta hanyar bayar da tarar da kuma tarwatsa tarurruka.
" An umarci yawancin kasuwancin da su rufe, sai dai ga kasuwancin da aka yi la'akari da su ""masu muhimmanci"", ciki har da manyan kantuna, kantunan magani, bankuna, shagunan kayan aiki, tashoshin mai, da kuma gidajen ajiye motoci. "
A ranar 20 ga Janairu, an tabbatar da farkon sanannen yanayin COVID-19 a jihar Arewa maso Yammacin Tekun Pacific na Washington a cikin wani mutum wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa Hukumar Kula da Cutar Korona a Fadar White House a ranar 29 ga Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana dokar ta baci ta lafiyar jama'a, kuma ta sanya takunkumi kan shigowar matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka babban cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka ta sanar da cewa sun kirkiro nasu kayan gwajin.
Duk da yin hakan, Amurka ta fara gwajin a hankali, wanda ya ɓoye ainihin yaduwar cutar a lokacin.
Gwajin ya lalace saboda kit ɗin gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwajin da ba na gwamnati ba (ta hanyar ilimi, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma takunkumin ƙa'idodi ga mutane don cancantar gwaji har zuwa farkon Maris (ana buƙatar umarnin likita daga baya).
Zuwa 27 ga Fabrairu, Jaridar Washington Post ta ruwaito cewa an gudanar da gwaje-gwaje kasa da 4,000 a Amurka.
A ranar 13 ga Maris, The Atlantic ta ruwaito cewa an gudanar da gwaje-gwaje kasa da 14,000.
"A ranar 22 ga Maris, Associated Press ta ruwaito: "Mutane da yawa da ke da alamun cutar da umarnin likita sun jira sa'o'i ko kwanaki don gwaji. ""Bayan an ba da rahoton mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, matakin da wasu jihohi suka bi nan da nan. "
Makarantu a yankin Seattle sun soke darussa a ranar 3 ga Maris, kuma a tsakiyar Maris, makarantu a duk faɗin ƙasar suna rufewa. A ranar 6 ga Maris 2020, an sanar da Amurka game da hasashen tasirin sabon coronavirus a kan ƙasar ta hanyar ƙungiyar masana cututtukan cuta a Kwalejin Imperial ta London.
A wannan ranar ne Shugaba Trump ya rattaba hannu kan Dokar Shirye-shiryen Coronavirus da Amsawa ta Ƙarin Kuɗaɗe, wanda ya samar da dala biliyan 8.3 a matsayin kuɗin gaggawa ga hukumomin tarayya don amsa cutar.
Kamfanoni sun kafa takunkumin tafiye-tafiye ga ma'aikata, sun soke taro, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
An soke abubuwan wasanni da lokutan wasanni. A ranar 11 ga Maris, Trump ya sanar da takunkumin tafiye-tafiye ga yawancin Turai, ban da Burtaniya, na kwanaki 30, wanda ya fara aiki a ranar 13 ga Maris.
Washegari, ya faɗaɗa takunkumin ya haɗa da United Kingdom da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci ta kasa, wanda ya sanya kudaden tarayya a bayyane don amsa matsalar.
Tun daga ranar 15 ga watan Maris, kamfanoni da dama sun rufe ko rage awoyi a duk fadin Amurka don kokarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da annobar a jihohi 50 da kuma a gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa Birnin New York yana da mutane 10,700 da suka kamu da cutar coronavirus, fiye da jimillar adadin masu kamuwa da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce ya yi kama da nisantar jama'a yana aiki, yayin da kimantawar ninka adadin masu kamuwa da cutar ta ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
Ya zuwa 28 ga Maris, akwai mutane 32,308 da aka tabbatar da cutar a birnin New York, kuma mutane 672 sun mutu daga cutar. A ranar 26 ga Maris, an bayar da rahoton cewa Amurka tana da ƙarin masu tabbatar da kamuwa da cutar coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya. Ya zuwa 8 ga Afrilu, an tabbatar da mutane 400,335 a Amurka, kuma mutane 12,841 sun mutu.
A cewar rahotannin kafofin watsa labarai a ranar 30 ga Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita ka'idojin nisantar jama'a har zuwa 30 ga Afrilu.
A wannan rana, jirgin USNS Comfort, wani jirgin asibiti mai gado kusan 1,000, ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta sami rikodin mutuwar 884 saboda cutar coronavirus a cikin awanni 24.
A jihar New York, adadin masu kamuwa da cutar ya wuce mutum 100,000 a ranar 3 ga Afrilu. An soki fadar White House saboda rage girman barazanar da kuma sarrafa saƙon ta hanyar ba da umarnin jami'an kiwon lafiya da masana kimiyya su daidaita maganganun jama'a da wallafe-wallafen da suka shafi kwayar cutar tare da ofishin Mataimakin Shugaban Kasa Mike Pence.
Gabaɗaya amincewa da yadda Trump ya magance rikicin ya kasance mai rarrabuwa a kan layin bangare.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayan masarufi, gami da kayan kiwon lafiya masu mahimmanci, daga China.
An yi amfani da nazarin tsarin tafiye-tafiye na iska don tsarawa da kuma hango hanyoyin yaduwa kuma an buga shi a cikin Jaridar Tafiya ta Tafiya a tsakiyar watan Janairu na 2020.
Dangane da bayanan 2018 daga Kungiyar Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei sun sami mafi yawan matafiya daga Wuhan.
An kuma bayar da rahoton cewa Dubai, Sydney, da Melbourne sune shahararrun wuraren da mutane ke tafiya daga Wuhan.
An bayar da rahoton Bali a matsayin mafi ƙarancin iyawa tsakanin shahararrun biranen 20 na shirye-shirye, yayin da biranen Ostiraliya aka yi la'akari da mafi iyawa. Ostiraliya ta fitar da Tsarin Amincewa da Gaggawa don Sabon Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya bayyana cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19, kuma cewa Ostiraliya za ta jaddada kula da kan iyakoki da sadarwa a cikin martani ga annobar.
A ranar 21 ga Maris, an ayyana dokar ta baci ta kare lafiyar dan adam a Ostiraliya.
Saboda ingantaccen keɓewar sufuri na jama'a a Wuhan da Hubei, ƙasashe da yawa sun shirya fitar da 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, galibi ta hanyar jiragen haya na ƙasar, tare da hukumomin China suna ba da izini.
Kanada, Amirka, Japan, Indiya, Sri Lanka, Ostareliya, Faransa, Argentina, Jamus, da Thailand suna cikin waɗanda suka fara shirin kwashe 'yan ƙasarsu.
Pakistan ta ce ba za ta kwashe kowane dan kasar Sin ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu ban da 'yan Poland hudu, da wani dan China, da kuma wani dan Indiya.
'Yan ƙasar Poland, China, da Indiya sun sauka a ƙasar Poland, inda jirgin saman Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan kasar Brazil da suka je Wuhan a wani sansanin soji kusa da Brasília.
A wannan ranar, an kwashe 'yan Kanada 215 (masu 176 daga jirgin farko, da 39 daga jirgin na biyu da gwamnatin Amurka ta yi haya) daga Wuhan zuwa CFB Trenton don keɓewa na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Australiya sun kwashe 'yan kasar 277 a ranar 3 da 4 ga watan Fabrairu zuwa Cibiyar Tsare-tsare ta Tsibirin Kirsimeti, wacce aka sake amfani da ita a matsayin cibiyar killacewa, inda suka zauna na kwanaki 14.
Jirgin saukar jiragen ruwa na New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojinsa (gami da wasu daga Ostiraliya da Pacific) an killace su a wani sansanin sojan ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa a jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama dauke da fasinjoji 129 na Kanada waɗanda aka kwashe daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris jirgin saman kamfanin jiragen sama na South African Airways da gwamnatin Afirka ta Kudu ta yi haya ya dawo da 'yan kasar Afrika ta Kudu 112.
An gudanar da binciken likita kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu waɗanda ke nuna alamun coronavirus don rage haɗarin.
'Yan Afirka ta Kudu ne kawai aka mayar da su gida idan gwajin su bai yi daidai ba.
Sakamakon gwajin ya tabbatar da cewa duk 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji, wadanda, a matsayin matakin kariya, duk sun kasance a karkashin lura da keɓewa na tsawon kwanaki 14 a The Ranch Resort.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako zuwa kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen aika taimako zuwa yankunan da cutar ta shafa na kasar Sin, tare da wata kungiya a yankin Chicago da aka ruwaito ta samu nasarar aika da takunkumin N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. Kungiyar agaji ta Direct Relief, tare da hadin gwiwa da FedEx, ta aika da takunkumin fuska 200,000 tare da sauran kayan kariya na mutum, ciki har da safofin hannu da riguna, ta hanyar jigilar jirgin sama na gaggawa zuwa Asibitin Wuhan Union a ranar 30 ga Janairu.
"A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da kokarin magani tare da kare "mutane masu hadarin gaske a Afirka da Kudancin Asiya". "
Interaksyon ta ruwaito cewa gwamnatin China ta ba da gudummawar abin rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 na taimako zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan ɗaya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayan aikin likita sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safofin hannu na likita miliyan 18 zuwa China, Jamus ta ba da kayan aikin likita daban-daban ciki har da rigunan Hazmat 10,000, kuma Amurka ta ba da gudummawar tan 17.8 na kayan aikin likita ga China kuma ta yi alkawarin ƙarin dala miliyan 100 a matsayin tallafin kuɗi ga ƙasashen da abin ya shafa. Bayan da lamuran a China suka yi kamar sun daidaita, ƙasar ta tura taimako ga ƙasashe daban-daban da cutar ta shafa.
A watan Maris, Sin, Cuba da Rasha sun aika da kayan kiwon lafiya da masana don taimakawa Italiya magance annobar coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da rigunan kariya 60,000 zuwa Addis Ababa, Habasha don rarraba ta Tarayyar Afirka.
Daga baya ya aika da kayan gwajin 5,000, 100,000 masks da na'urorin numfashi 5 zuwa Panama.
Ma kuma ya ba da gudummawar kayan kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia, da Jamhuriyar Czech sun nuna damuwarsu game da abin rufe fuska da kayan gwajin da aka yi a kasar Sin.
Misali, Spain ta janye kayan gwajin coronavirus da aka yi a kasar Sin 58,000 tare da daidaito na kashi 30%, yayin da Netherlands ta janye takunkumin fuska na kasar Sin 600,000 wadanda suka lalace.
Belgium ta janye masks 100,000 da ba za a iya amfani da su ba, da ake zaton daga China ne, amma a zahiri daga Colombia ne.
A gefe guda, an yi maraba sosai da taimakon da kasar Sin ta bayar a wasu sassan Latin Amurka da Afirka. A ranar 2 ga Afrilu, Bankin Duniya ya kaddamar da ayyukan gaggawa na tallafa wa kasashe masu tasowa.
Hukumar ta WHO ta yaba wa kokarin da hukumomin China suka yi wajen sarrafa da kuma dakile annobar.
" WHO ta lura da bambanci tsakanin barkewar cutar SARS ta 2002-2004, inda aka zargi hukumomin China da yin sirri wanda ya hana rigakafin da kokarin hanawa, da kuma rikicin na yanzu inda gwamnatin tsakiya ta "ba da sabuntawa akai-akai don kauce wa firgici kafin hutun Sabuwar Shekarar Lunar". "
"A ranar 23 ga Janairu, a mayar da martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da haramcin sufuri a Wuhan, wakilin WHO Gauden Galea ya lura cewa yayin da "ba shawarar da WHO ta yi ba", hakan ma "alamu ne masu mahimmanci na jajircewar da za a yi na hana annobar a wurin da ta fi yawa" kuma ya kira ta "marasa misali a tarihin lafiyar jama'a". "A ranar 30 ga Janairu, bayan tabbatar da yaduwar mutum-zuwa-mutum a wajen China da karuwar adadin masu kamuwa da cutar a wasu ƙasashe, WHO ta ayyana barkewar cutar a matsayin gaggawa ta lafiyar jama'a (PHEIC International), PHEIC na shida tun lokacin da aka fara kiran matakin a lokacin annobar cutar mura ta 2009".
" Darakta Janar na WHO Tedros Adhanom ya ce PHEIC ta faru ne saboda "hadarin yaduwar duniya, musamman ga ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi ba tare da ingantaccen tsarin kiwon lafiya ba. "
"A martanin aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa ""babu wani dalili na matakan da ba dole ba da ke tsoma baki tare da tafiye-tafiye na kasa da kasa da kasuwanci"" kuma cewa ""WHO ba ta ba da shawarar iyakance kasuwanci da motsi ba"." "
"A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 domin tallafawa shirye-shiryen dabarun a kasashe masu karancin kudin shiga, inda ta yi nuni da gaggawar tallafawa kasashen da "ba su da tsarin gano mutanen da suka kamu da cutar, koda kuwa ta bayyana". "
"Tedros ya kara yin maganganu yana mai cewa ""mu masu karfi ne kawai kamar yadda muke da rauni"" kuma ya bukaci al'ummar duniya da su ""saka hannun jari a yau ko kuma su biya ƙarin daga baya"".A ranar 11 ga Fabrairu, WHO a wani taron manema labarai ta kafa COVID-19 a matsayin sunan cutar. "
" A wannan rana, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince ya samar da ""ikon dukkan tsarin Majalisar Dinkin Duniya a cikin martani"". "
" An kunna Kungiyar Gudanar da Rikicin Majalisar Dinkin Duniya a sakamakon haka, wanda ya ba da damar daidaita dukkan martani na Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar ""mai da hankali kan martani na kiwon lafiya yayin da sauran hukumomin za su iya kawo ƙwarewarsu don ɗaukar nauyi kan tasirin zamantakewa, tattalin arziki da ci gaba na barkewar cutar". "
"A ranar 14 ga watan Fabrairu, an kunna tawagar hadin gwiwar WHO tare da China don samar da masana na kasa da kasa da na WHO a kasar Sin don taimakawa wajen kula da cikin gida da kuma kimanta ""taurin da yaduwar cutar"" ta hanyar gudanar da bita da tarurruka tare da manyan cibiyoyin matakin kasa da kuma gudanar da ziyarar filin don kimanta ""tasirin ayyukan amsawa a matakan lardi da na gunduma, gami da birane da karkara"".A ranar 25 ga Fabrairu, WHO ta bayyana cewa ""ya kamata duniya ta yi karin shiri don yiwuwar annobar coronavirus, ""yana mai cewa yayin da ya yi da wuri a kira shi annoba, duk da haka ya kamata kasashen su kasance ""a cikin wani mataki na shiri "".
"Dangane da barkewar cutar a Iran, WHO ta aika da tawagar hadin gwiwa don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ɗaga kimar barazanar coronavirus a matakin duniya daga ""high"" zuwa ""very high"", matakin sa na gaggawa da kimanta hadarin. "
" Mike Ryan, babban daraktan shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa ""Wannan shine ainihin gaskiya ga kowace gwamnati a duniya: Tashi. "
"Wannan kwayar cuta na iya kasancewa a kan hanyar ta kuma kana bukatar ka kasance a shirye, " ya bukaci cewa matakan da suka dace na iya taimakawa duniya ta guji "mafi munin sa".
" Ryan ya kara da cewa bayanan na yanzu ba su ba da izinin jami'an kiwon lafiyar jama'a su ayyana annobar duniya ba, yana mai cewa irin wannan sanarwar za ta nuna cewa "a zahiri muna yarda cewa kowane mutum a duniya zai kamu da wannan kwayar cutar. "
A ranar 11 ga Maris, WHO ta ayyana barkewar cutar coronavirus a matsayin annoba.
"Darakta Janar ya ce WHO ta "damu matuka da matakan tarwatsawa da tsananin cutar, da kuma matakan rashin daukar mataki". "WHO ta fuskanci zargi mai yawa saboda abin da ake gani a matsayin rashin kula da cutar, gami da sanar da dokar ta baci ta lafiyar jama'a da kuma rarraba cutar a matsayin annoba. "
Sakamakon ya hada da takardar neman daraktan WHO Tedros Adhanom ya mika murabus, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, ƙwararrun masanan hakkin bil'adama na Majalisar Dinkin Duniya sun jaddada girmama haƙƙin kowane mutum yayin annobar COVID-19.
Kungiyar masana ta bayyana cewa kowa na da hakkin samun taimakon da zai ceci ransa kuma gwamnati ce ke da wannan hakkin.
Ƙungiyar ta nanata cewa rashin albarkatu ko inshorar lafiya bai kamata ya zama hujja ba ga nuna bambanci ga takamaiman rukuni.
Masana sun jaddada cewa kowane mutum na da hakkin kiwon lafiya, gami da nakasassu, 'yan tsiraru, tsofaffi, mutanen da suka rasa gidajensu, marasa gida, wadanda ke rayuwa cikin matsanancin yanayi, mutane da ke tsare, da kuma 'yan gudun hijira da sauran kungiyoyi da ba a bayyana su ba da suke bukatar tallafin gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar hadin kai da ci gaban tattalin arziki ta kaddamar da wani dandamali don samar da cikakken bayani kan matakan da ake dauka a fannin siyasa a kasashe a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin kulle-kulle da ƙuntatawa kan tafiye-tafiye, cibiyar dijital ta haɗa da Mai Kula da Manufofin Kasashe, kuma tana da nufin taimakawa ƙasashe su koya daga juna da kuma sauƙaƙe daidaitaccen martani na duniya ga ƙalubalen coronavirus.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan Majalisar Dokoki na Burtaniya Michael Gove, da kuma dan Shugaban Brazil Jair Bolsonaro Eduardo Bolsonaro saboda yadda ta magance annobar, wacce ta fara a lardin Hubei na kasar Sin.
An kori wasu jami'an gwamnatin lardin na Jam'iyyar Kwaminis ta Sin (CPC) saboda yadda suka gudanar da ayyukan killacewa a tsakiyar kasar Sin, alamar rashin jin daɗi da yadda hukumomin siyasa ke amsa annobar a waɗannan yankuna.
Wasu masu sharhi sun yi imanin cewa wannan matakin an yi shi ne don kare babban sakataren jam'iyyar Kwaminis ta kasar Sin Xi Jinping daga fushin jama'a kan barkewar cutar coronavirus.
Wasu jami'an kasar Sin, misali Zhao Lijian sun yi watsi da amincewa da barkewar cutar coronavirus da ta fara a Wuhan, a madadin ka'idodin makirci game da COVID-19 wanda ya samo asali daga Amurka ko Italiya.
" Gwamnatin Amurka ta Donald Trump ta ambaci cutar coronavirus a matsayin ""kwayar cutar Sin"" ko ""kwayar Wuhan"" inda ta ce "tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace-tsabtace".
" Daily Beast ta samu wani sakon gwamnatin Amurka wanda ke bayyana dabarun sadarwa tare da bayyananniyar asali a cikin Majalisar Tsaro ta Kasa, tare da dabarar da aka nakalto a matsayin "Duk abin game da China ne. "
"An gaya mana mu yi kokarin yada wannan sakon ta kowace hanya, ciki har da taron manema labarai da kuma fitowar talabijin. " "Kasuwanci kamar Politico, Foreign Policy, da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na aika da agaji ga kasashen da cutar ta shafa na daga cikin yunkurin yada labarai ne na samun rinjaye a duniya. "
" Shugaban manufofin kasashen waje na EU Josep Borrell ya yi gargadin cewa akwai ""wani bangare na siyasa da ya hada da gwagwarmaya don samun tasiri ta hanyar juyawa da kuma 'siyasa ta karimci'" ".
"Borrell ya kuma ce ""China tana tura saƙon da karfi cewa, ba kamar Amurka ba, ita abokiyar tarayya ce mai alhakin gaske da abin dogaro. "" "
China ta kuma bukaci Amurka da ta dage takunkumin da ta kakaba kan Syria, Venezuela da Iran, yayin da ake zargin cewa ta tura taimakon ga kasashen biyu na karshe.
Jack Ma ya ba da gudummawar abin rufe fuska 100,000 ga Cuba an toshe shi ta takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da karkatar da taimakon da aka yi niyya ga wasu ƙasashe zuwa ƙasarsu.
Kuma an bayar da rahoton rikice-rikice da suka shafi abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan na'urorin numfashi da aka nufa zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai da Italiya da cutar coronavirus ta shafa.
" Maurizio Massari, jakadan Italiya a EU, ya ce " China ce kawai ta amsa ta fuskar biyu. "
"Tabbas wannan ba alama ce mai kyau ta hadin kan Turai ba".
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya shirya sojojin Rasha su aika da likitocin soja, motocin kashe ƙwayoyin cuta na musamman, da sauran kayan aikin likita zuwa Italiya.
" Jaridar La Stampa ta Italiya ta ambato wani "tushen siyasa na babban matakin" wanda ba a san sunansa ba cewa kashi 80 cikin 100 na taimakon Rasha "ba shi da amfani ko kuma ba shi da amfani ga Italiya". "
" Tushen ya zargi Rasha da fara wani "harin siyasa da diflomasiyya" na fara'a. "
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahoton da kafofin watsa labarai suka bayar kuma sun nuna godiyarsu.
Rasha ta kuma aika da jirgin jigilar kayayyaki da taimakon likita zuwa Amurka.
" Kakakin Kremlin Dmitry Peskov ya ce ""lokacin da yake ba da taimako ga abokan aikinsa na Amurka, [Putin] yana ɗauka cewa lokacin da masana'antun Amurka na kayan aikin likita da kayan aiki suka sami ƙarfi, za su iya mayar da martani idan ya cancanta. "" "
" Tsarin aikin sojin NATO ""Defender 2020"" a Jamus, Poland, da kasashen Baltic, babban aikin sojin NATO tun bayan karshen yakin sanyi, za a gudanar da shi a kan karamin sikelin. "
" Babban sakataren Kamfen na Rashin makaman nukiliya Kate Hudson ta soki aikin Defender 2020: ""A cikin rikicin lafiyar jama'a na yanzu, yana barazana ba kawai ga rayukan sojojin Amurka da na kasashen Turai da yawa da ke halarta ba amma ga mazaunan kasashen da suke aiki. ""Gwamnatin Iran ta sha wahala sosai daga kwayar cutar, tare da kusan 'yan majalisa ashirin da suka kamu da cutar da kuma wasu mutane goma sha biyar na yanzu ko na baya. "
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya yana neman taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa tana fama da cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka akan Iran. Cutar ta haifar da kira ga Amurka da ta aiwatar da manufofin zamantakewa na sauran kasashe masu arziki, gami da kiwon lafiya na duniya, kula da yara na duniya, izinin iyali da aka biya, da kuma karin kudade don kiwon lafiyar jama'a.
Masu nazarin siyasa sun yi hasashen hakan na iya shafar damar Donald Trump na sake zaɓe a zaben shugaban kasa na 2020. Dangantakar diflomasiyya tsakanin Japan da Koriya ta Kudu ta tabarbare saboda annobar.
"Koriya ta Kudu ta soki "ƙoƙarin keɓewar kai da rashin fahimta" na Japan bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a sanya shi cikin keɓewar makonni biyu a wuraren da gwamnati ta tsara. "
Da farko al'ummar Koriya ta Kudu ta kasance mai tsaka-tsaki a kan martani na Shugaba Moon Jae-in ga rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman tsige Moon saboda abin da suka ce rashin kulawar gwamnati ne game da barkewar cutar, ko kuma yabon martanin da ya bayar. Cutar ta ba kasashe damar zartar da dokar ta baci a matsayin martani.
Wasu masu sharhi sun nuna damuwa cewa zai ba gwamnatoci damar ƙarfafa ikon da suke da shi.
A Hungary, majalisar dokoki ta kada kuri'a ta ba firaminista, Viktor Orbán, damar yin mulki ta hanyar doka ba tare da wani lokaci ba, dakatar da majalisar da kuma zaben da kuma hukunta wadanda ake ganin sun yada bayanan karya game da kwayar cutar da kuma yadda gwamnati ta magance matsalar.
An zargi barkewar cutar coronavirus da yawa daga cikin karancin wadata, wanda ya samo asali ne daga karuwar amfani da kayan aiki a duniya don yaƙar barkewar cutar, sayen firgici, da katsewar masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita saboda karuwar bukatar masu amfani da kuma katsewar masu samar da kayayyaki.
An kuma ga mutane da dama suna ta sayen kaya cikin fargaba wanda hakan ya sa aka share shelves na kayan masarufi kamar abinci, takardar wanka, da ruwan kwalba, wanda hakan ya haifar da karancin kayayyaki.
Musamman masana'antar fasaha ta kasance tana gargadi game da jinkiri ga jigilar kayayyakin lantarki.
A cewar darekta janar na WHO Tedros Adhanom, bukatar kayan kariya ta mutum ya ƙaru sau 100.
Wannan bukatar ta haifar da hauhawar farashi har sau ashirin fiye da farashin al'ada kuma ta haifar da jinkiri a kan samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Hakanan ya haifar da karancin kayan kariya na mutum a duniya, tare da WHO ta yi gargadin cewa wannan zai sanya ma'aikatan kiwon lafiya cikin haɗari.
A Ostiraliya, annobar ta samar da sabuwar dama ga masu siyar da daigou don sayar da kayayyakin Ostiraliya zuwa China.
Wannan aikin ya haifar da karancin kayan abinci na jarirai a wasu manyan kantuna kuma daga baya gwamnatin Ostiraliya ta hana shi. Duk da yawan kamuwa da cutar COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma babban bukatar kayayyakin abinci, an kiyaye yankunan biyu daga matsanancin karancin abinci.
Matakan da China da Italiya suka ɗauka na hana tara kayayyaki masu muhimmanci da kuma cinikin su ba bisa ka'ida ba sun yi nasara, suna kauce wa matsanancin karancin abinci da aka yi hasashen zai faru a Turai da kuma Arewacin Amirka.
Arewacin Italiya tare da yawan amfanin gona ba ta ga raguwa mai yawa ba, amma farashin na iya ƙaruwa bisa ga wakilan masana'antu.
An samu shagon abinci mara komai na wani lokaci, har ma a birnin Wuhan, yayin da jami'an gwamnatin China suka saki kayan naman alade don tabbatar da isasshen abinci ga jama'a.
Akwai irin waɗannan dokoki a Italiya da suka bukaci masu samar da abinci su ajiye tanadi don irin wannan gaggawa.
An ji lalacewar tattalin arzikin duniya a China: a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya yi matukar wahala a cikin watanni biyu na farko na shekarar 2020 saboda matakan da gwamnati ta dauka na rage yaduwar cutar, kuma tallace-tallace na sayar da kayayyaki sun fadi da kashi 20.5%.
Tunda babban yankin kasar Sin babban tattalin arziki ne da cibiyar masana'antu, an ga cewa barkewar kwayar cutar ta haifar da babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ya yi hasashen cewa kasuwanni za su ci gaba da zama masu saurin canzawa har sai an sami cikakken hoto game da sakamakon da zai iya zuwa.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arziƙin cutar a kan ci gaban duniya na iya wuce na barkewar cutar SARS ta 2002-2004.
Wani kimantawa daga wani gwani a Jami'ar Washington da ke St. Louis ya ba da dala biliyan 300+ a kan sarkar samar da kayayyaki ta duniya wanda zai iya wucewa har zuwa shekaru biyu.
" An bayar da rahoton cewa Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta "sarrafa" bayan faduwar farashin man fetur saboda karancin bukatar da kasar Sin ke yi. "
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar adadin masu kamuwa da cutar COVID-19 a wajen babban yankin kasar Sin.
A ranar 27 ga watan Fabrairu, saboda karuwar damuwa game da barkewar cutar coronavirus, wasu alamomin hannayen jari na Amurka ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average sun nuna raguwarsu mafi girma tun shekarar 2008, tare da Dow ya fadi maki 1,191, mafi girma a rana guda tun bayan rikicin kuɗi na 200708.
Dukkanin alamomin uku sun ƙare mako sama da kashi 10%.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ta tabbatar da darajar bashi na kasar Sin, amma ta ci gaba da hangen nesa mara kyau.
Hannun jari sun sake faduwa bisa tsoron coronavirus, mafi girman faduwa a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai koma baya.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakan gaggawa na bankunan tsakiya da jihohi.
Bankunan tsakiya suna amsawa da sauri fiye da yadda suka yi ga matsalar tattalin arziki ta shekara ta 2008.
Yawon shakatawa na ɗaya daga cikin ɓangarorin da suka fi fuskantar illa saboda haramcin tafiye-tafiye, rufe wuraren jama'a ciki har da wuraren jan hankali na balaguro, da kuma shawarar gwamnatoci game da kowane tafiya a duk duniya.
Sakamakon haka, kamfanonin jiragen sama da yawa sun soke jirage saboda karancin buƙata, gami da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin sama na yankin Burtaniya Flybe ya rushe.
Tasirin da ya shafi masana'antar jiragen ruwa ya kasance a matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da dama.
Cutar ta faru ne a lokacin Chunyun, babban lokacin tafiye-tafiye da ke hade da hutun Sabuwar Shekarar Sin.
Yawancin abubuwan da suka shafi taron jama'a da yawa an soke su ta hanyar gwamnatocin ƙasa da na yanki, gami da bukukuwan Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu suma suna rufe shagunan su da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe abubuwan da suka faru na Sabuwar Shekara da wuraren yawon bude ido da yawa don hana taron jama'a, ciki har da Birnin da aka hana a Beijing da kuma bikin gargajiya na haikalin.
A larduna 24 daga cikin 31 na kasar Sin, gundumomi da yankuna, hukumomi sun tsawaita hutun Sabuwar Shekara zuwa 10 ga Fabrairu, suna ba da umarnin yawancin wuraren aiki kada su sake buɗewa har zuwa wannan kwanan wata.
Wadannan yankuna sun wakilci kashi 80% na GDP na ƙasar da 90% na fitarwa.
Hong Kong ta ɗaga matakin amsa cutar zuwa mafi girma kuma ta ayyana dokar ta-baci, ta rufe makarantu har zuwa Maris kuma ta soke bukukuwan Sabuwar Shekara. An shafi sashen sayar da kayayyaki a duniya, tare da rage lokutan kasuwanci ko rufewa na ɗan lokaci.
Ziyarar 'yan kasuwa a Turai da Latin Amurka ta ragu da kashi 40%.
Kasuwancin Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar kashi 50 zuwa 60%.
Wannan kuma ya haifar da raguwar 3343% na zirga-zirgar ƙafa zuwa cibiyoyin cin kasuwa a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin cin kasuwa a duk duniya sun sanya ƙarin matakan, kamar haɓaka tsabtace muhalli, shigar da na'urorin bincike na zafin jiki don bincika zafin jiki na masu siye, da soke abubuwan da suka faru.Dangane da kimantawar Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki da cutar ta haifar na iya barin tsakanin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka fiye da yadda za su kasance a wannan yanayin ba tare da cutar ba.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta yi zafi a Wuhan, mutane kusan miliyan 5 a China sun rasa ayyukansu.
Da yawa daga cikin kusan ma'aikatan ƙaura na karkara miliyan 300 na China sun makale a gida a lardunan ciki ko kuma sun makale a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 suka rasa ayyukansu kuma suka nemi taimakon gwamnati.
Cutar coronavirus na iya kashe ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa kashi 32%, a cewar kimantawa da Bankin Tsaro na Tarayya na St. Louis.Kullewa a Indiya ya bar miliyoyin ma'aikatan bakin haure na Indiya (waɗanda ake biyan su ta hanyar albashin yau da kullun) marasa aiki.Binciken daga Cibiyar Angus Reid ya gano cewa kashi 44% na iyalai na Kanada sun sami wani nau'in rashin aikin yi.Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka shiga kulle a tsakiyar Maris 2020.
A cikin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi a basu kudin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi a basu tsarin bashi na duniya. Kusan kamfanoni miliyan rabi a Jamus sun tura ma'aikatansu a kan tsarin aiki na gajeren lokaci da gwamnati ke tallafawa da ake kira Kurzarbeit.
Faransa da Ingila sun amince da tsarin biyan diyya na aikin takaitaccen lokaci na Jamus.
Yankin wasan kwaikwayo da al'adun al'adu sun sami mummunan tasiri daga annobar, wanda ya shafi ayyukan ƙungiyoyi da kuma mutane ma'aikata da masu zaman kansua duniya.
Kungiyoyin bangaren fasaha da al'adu sun yi kokarin kiyaye manufa (sau da yawa ana samun kudaden shiga daga gwamnati) don samar da damar zuwa al'adun al'adu ga al'umma, kiyaye lafiyar ma'aikatansu da jama'a, da kuma tallafawa masu zane-zane a duk inda zai yiwu.
Zuwa Maris 2020, a duk faɗin duniya kuma zuwa matakai daban-daban, gidajen tarihi, ɗakunan karatu, wuraren wasan kwaikwayo, da sauran cibiyoyin al'adu an rufe su har abada tare da baje kolin su, abubuwan da suka faru da wasan kwaikwayon da aka soke ko kuma aka jinkirta.
A sakamakon haka an yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Wani kwanan nan kuma mai saurin hanzarta cutar shine soke ayyukan addini, manyan abubuwan da suka faru a cikin wasanni, da sauran abubuwan zamantakewa, kamar bukukuwan kiɗa da kide kide, taron fasaha, da nunin tufafi.
Har ila yau, masana'antar fim ta fuskanci rikici. Vatican ta sanar da cewa an soke bikin Makon Mai Tsarki a Roma, wanda ke faruwa a makon ƙarshe na lokacin tuba na Kirista na Lent.
Diocese da yawa sun ba da shawarar tsofaffin Kiristoci su zauna a gida maimakon halartar Mass a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kan layi ta kan layi ko talabijin yayin da wasu ke ba da bautar mota.
Tare da Diocese na Roman Katolika na Roma rufe majami'u da kuma chapel da kuma St. Peter's Square da aka kwashe daga Kirista mahajjata, sauran kungiyoyin addini kuma soke ayyuka da kuma iyakance jama'a tarurruka a majami'u, masallatai, majami'u, temples da gurdwaras.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma daga baya aka rufe wuraren ibada, yayin da Saudi Arabiya ta hana shiga baƙi da mazaunanta zuwa wuraren ibada a Makka da Madina.
Cutar ta haifar da babbar matsala ga kalandar wasanni ta duniya tun bayan yakin duniya na biyu.
An soke ko kuma an jinkirta yawancin manyan wasannin wasanni, gami da 2019 20 UEFA Champions League, 2019 20 Premier League, UEFA Euro 2020, 2019 20 kakar NBA, da kuma 2019 20 kakar NHL.
" Cutar ta katse shirye-shiryen gasar wasannin Olympics ta bazara ta 2020, wanda aka tsara a farkon watan Yuli; Kwamitin Olympics na Duniya ya sanar a ranar 24 ga Maris cewa za a "sake tsara taron zuwa ranar da ta wuce 2020 amma ba ta wuce bazara 2021 ba". An rufe gidajen caca da sauran wuraren caca a duk duniya kuma an jinkirta ko soke wasannin karta kai tsaye. "
Wannan ya sa 'yan caca da yawa suka koma kan layi, tare da shafukan caca da yawa na kan layi suna ba da rahoton ƙaruwa mai yawa a cikin ƙimar sabbin rajista. Har ila yau, masana'antar nishaɗi ta shafa, tare da ƙungiyoyin kiɗa daban-daban suna dakatar ko soke rangadin kide-kide.
Yawancin manyan gidajen wasan kwaikwayo kamar waɗanda ke Broadway suma sun dakatar da duk wasan kwaikwayo.
"Wasu masu zane-zane sun bincika hanyoyin da za su ci gaba da samarwa da raba aiki ta hanyar intanet a matsayin madadin wasan kwaikwayon gargajiya na rayuwa, kamar wasan kwaikwayon raye-raye na raye-raye ko ƙirƙirar "bikin" na yanar gizo don masu zane-zane su yi, rarraba, da kuma tallata aikinsu. "
A kan layi, memes na Intanet da yawa na coronavirus sun bazu kamar yadda mutane da yawa suka juya zuwa ban dariya da shagala a cikin rashin tabbas.
Tun barkewar COVID-19, an lura da ƙiyayya, ƙiyayya, da wariyar launin fata ga mutanen da ke da asalin Sinawa da Asiya ta Gabas, da kuma mutanen da ke daga wuraren zafi a Turai, Amurka da sauran ƙasashe.
An lura da tsoro, rashin yarda, da kuma rashin son kai a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da yankin Asiya da Fasifik.
Rahotanni daga watan Fabrairu (lokacin da yawancin shari'o'in har yanzu suna cikin China) sun rubuta ra'ayoyin wariyar launin fata da aka bayyana a cikin kungiyoyi daban-daban a duk duniya na mutanen China da suka cancanci cutar ko kuma karɓar abin da aka yi iƙirarin cewa sakamako ne mai adalci.
Wasu kasashe a Afirka ma sun ga karuwar halin adawa da kasar Sin.
Mazauna Wuhan da Hubei da dama sun ba da rahoton nuna wariya bisa asalin yankin su.
An samu goyon baya ga Sinawa, a kan layi da wajen layi, da kuma ga waɗanda ke cikin yankunan da cutar ta shafa.
Bayan yaduwar cutar zuwa sabbin kasashe masu zafi, mutane daga Italiya, ƙasar farko a Turai da ta fara fuskantar mummunan barkewar COVID-19, na iya fuskantar tuhuma da ƙin yarda da baƙi. 'Yan ƙasa a ƙasashe ciki har da Malaysia, New Zealand, Singapore, da Koriya ta Kudu da farko sun sanya hannu kan takardun neman hana Sinawa shiga ƙasashensu a ƙoƙarin dakatar da cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama ruwan dare a Twitter.
Sinawa da sauran 'yan Asiya a Burtaniya da Amurka sun ba da rahoton karuwar cin zarafin wariyar launin fata, da kuma hare-hare.
" Shugaban Amurka Donald Trump ya fuskanci suka saboda kiran coronavirus da "Cutar Sin", wata kalma da masu sukar ke ganin wariyar launin fata ce da kuma adawa da Sin. "
Masu zanga-zanga a Ukraine sun kai hari kan motocin bas da ke dauke da 'yan Ukraine da na kasashen waje da suka fice daga Wuhan zuwa Novi Sanzhary.
Daliban da suka fito daga Arewa maso Gabashin Indiya, wanda ke da iyaka da China, kuma suna karatu a manyan biranen Indiya an bayar da rahoton cewa sun fuskanci tsangwama dangane da barkewar cutar coronavirus.
"Shugaban jam'iyyar Bharatiya Janata na jihar Bengal Dilip Ghosh ya bayyana cewa Sinawa sun lalata yanayi kuma "shi ya sa Allah ya rama musu. "
"A baya dai ofishin jakadancin kasar Sin a Kolkata ya yi tir da wannan furucin, inda ya kira shi da "kuskure"".A kasar Sin, cutar ta tayar da hankalin 'yan kasashen waje da nuna wariyar launin fata ga mazauna kasashen waje, inda aka bayyana kasashen waje a matsayin "kashin shara na kasashen waje" kuma aka yi niyya a "sake kawar da su".
Jaridu da dama da ke da bangon biyan kudi sun cire su saboda wasu ko duk labaran da suka yi game da cutar coronavirus.
Yawancin masu wallafa kimiyya sun sanya takardun kimiyya da suka shafi barkewar cutar a buɗe tare da samun dama.
Wasu masana kimiyya sun zaɓi su raba sakamakon su da sauri a kan sabobin shirye-shirye kamar bioRxiv.
Cutar kamuwa da cuta mai tasowa  Cutar kamuwa da cuta ta kwayar cuta mai tasowa, sau da yawa sabo ne a cikin yanayin fashewar ta ko hanyar watsa ta
Duniya da cuta  Bayani game da duniya da kuma yaduwar cuta
Jerin annoba da annobar  Jerin adadin mutuwar da ke faruwa saboda cututtukan da ke yaduwa
Cinikin dabbobi masu zaman kansu da kuma cutar dabbobi  Rashin lafiyar da ke tattare da cinikin dabbobi masu zaman kansu
Gwajin dakin gwaje-gwaje don cutar coronavirus na numfashi 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke da alaƙa sun haɗa da hanyoyin da ke gano kasancewar kwayar cutar da waɗanda ke gano ƙwayoyin cuta da aka samar don amsa kamuwa da cuta.
An tabbatar da kasancewar ƙwayoyin cuta a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin takamaiman abu ne kuma an tsara shi ne don gano RNA na kwayar cutar SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cututtuka na kwanan nan ko na aiki.
Za a iya amfani da gano kwayoyin cutar (serology) duka don ganewar asali da kuma kulawar al'umma.
Gwajin rigakafin yana nuna yawan mutanen da suka kamu da cutar, gami da wadanda alamun cutar basu da yawa da za a iya bayar da rahoto ko kuma wadanda basu da alamun cutar.
Ana iya sanin ainihin yawan mutuwar cutar da kuma matakin rigakafin garken a cikin al'umma daga sakamakon wannan gwajin.
Saboda iyakancewar gwaji, a watan Maris na shekarar 2020 babu wata kasa da ke da tabbatattun bayanai kan yaduwar cutar a cikin al'ummarta.
Zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma akwai bambance-bambance masu yawa a yawan gwajin da aka yi a tsakanin ƙasashe.
Wannan canji kuma yana iya shafar yawan adadin mutuwar da aka ruwaito, wanda zai iya zama mai mahimmanci a wasu ƙasashe.
Ta amfani da halayen sarkar polymerase na juyawa na lokaci-lokaci (rRT-PCR) ana iya yin gwajin akan samfuran numfashi da aka samu ta hanyoyi daban-daban, gami da swab na nasopharyngeal ko samfurin sputum.
Sakamakon yawanci ana samunsa cikin 'yan sa'o'i zuwa kwana 2.
Gwajin RT-PCR da aka yi tare da swabs na makogwaro abin dogaro ne kawai a makon farko na cutar.
Daga baya kwayar cutar na iya bacewa a cikin makogwaro yayin da take ci gaba da ninka a cikin huhu.
Ga mutanen da suka kamu da cutar da aka gwada a mako na biyu, a madadin haka za a iya ɗaukar samfurin abu daga cikin hanyoyin numfashi mai zurfi ta hanyar tsotsa ko kuma za a iya amfani da kayan tari (spatum).
An haɓaka ɗayan farkon gwajin PCR a Charité a Berlin a cikin Janairu 2020 ta amfani da ainihin lokacin jujjuyawar juzu'in polymerase (rRT-PCR), kuma ya zama tushen kayan aikin 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Har ila yau, Burtaniya ta haɓaka gwajin a ranar 23 ga Janairu 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya haɓaka ƙirar bincike na SARS-CoV-2 mai tushen PCR (PowerChek Coronavirus) a ranar 28 ga Janairu 2020.
"Yana neman kwayar ""E"" da dukkan kwayar cutar beta ke da ita, da kuma kwayar RdRp ta musamman ga SARS-CoV-2.A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami amincewar amfani da gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta China don kayan aikin gano SARS-CoV-2 na PCR.A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafin (CDC) suna rarraba Sabon Kwayar cutar Coronavirus (2019-nCoV) na Real-Time RT-PCR Diagnostic Panel ga dakunan gwaje-gwajen lafiyar jama'a ta hanyar International Reagent Resource. "
Daya daga cikin gwaje-gwaje uku na kwayoyin halitta a cikin tsofaffin sigar kayan gwajin ya haifar da sakamako mara tabbatacce saboda kuskuren reagents da kuma ƙuntatawar gwaji a CDC a Atlanta; wannan ya haifar da matsakaita na ƙasa da samfura 100 a rana da aka aiwatar cikin nasara a cikin watan Fabrairu 2020.
Ba a tabbatar da cewa gwaje-gwaje ta amfani da abubuwa biyu sun kasance masu aminci ba har zuwa 28 ga Fabrairu 2020, kuma ba sai a lokacin ba ne aka ba da izinin jihohi da dakunan gwaje-gwaje na gida don fara gwaji.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin Amfani da Gaggawa. Dakunan gwaje-gwaje na kasuwanci na Amurka sun fara gwaji a farkon Maris 2020.
Ya zuwa 5 ga Maris 2020 LabCorp ta sanar da samun gwajin COVID-19 a duk faɗin ƙasar bisa ga RT-PCR.
Quest Diagnostics kamar haka ya sanya gwajin COVID-19 a duk faɗin ƙasar a 9 ga Maris 2020.
Ba a sanar da iyakancewar yawa ba; dole ne a yi tattara da sarrafa samfurin bisa ga bukatun CDC.
A Rasha, Cibiyar Bincike ta Jiha ta Virology da Biotechnology VECTOR ce ta haɓaka kuma ta samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020 an yi rajistar gwajin ne ta Hukumar Kula da Kula da Kiwon Lafiya ta Tarayya. A ranar 12 ga Maris, 2020, Mayo Clinic ta bayar da rahoton cewa ta kirkiro gwajin da zai gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a babban girma, don haka ta ba da damar na'ura ɗaya ta yi kimanin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji akan tsarin m2000 na Abbott; FDA ta riga ta ba da izini irin wannan ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta samu EUA daga FDA don gwajin da ke ɗaukar kimanin minti 45.
Hukumar FDA ta amince da gwajin da ke amfani da fasahar kara karfin isothermal nucleic acid maimakon PCR.
Tun da wannan baya buƙatar jerin hawan zafin jiki na juyawa wannan hanyar na iya ba da sakamako mai kyau a cikin mintuna biyar da sakamako mara kyau a cikin mintuna 13.
A halin yanzu akwai kimanin 18,000 na waɗannan injunan a Amurka kuma Abbott yana sa ran haɓaka masana'antu don isar da gwaje-gwaje 50,000 a kowace rana. Ana haɓaka gwajin da ke amfani da kwayar cutar monoclonal wanda ke haɗuwa da furotin nucleocapsid (N protein) na sabon kwayar cutar coronavirus a Taiwan, tare da fatan cewa zai iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin hanzari na mura.
"Binciken wallafe-wallafen Maris 2020 ya kammala da cewa ""hotunan kirji ba su da ƙimar bincike a farkon matakan, yayin da CT [tomography na kwamfuta] binciken na iya kasancewa tun kafin bayyanar cututtuka. """
Abubuwan da aka saba da su akan CT sun haɗa da ƙarancin gilashin multilobar na biyu tare da rarraba kewayen, asymmetric da na baya.
Subpleural dominance, hauka da kuma karfafawa suna tasowa yayin da cutar ke ci gaba.
Wani bincike da ya kwatanta PCR da CT a Wuhan a wurin da cutar ta fara ya nuna cewa CT ta fi PCR hankali, ko da yake ba ta da takamaiman bayani, tare da yawancin fasalulluka na hoton da ke rufewa da sauran ciwon huhu da kuma hanyoyin cutar.
"Tun daga watan Maris na shekarar 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa ""Kada a yi amfani da CT don tantancewa ko a matsayin gwajin farko don gano COVID-19"".Tun daga watan Maris na shekarar 2020, CDC ta ba da shawarar PCR don gwajin farko. "
Wani ɓangare na amsawar garkuwar jiki ga kamuwa da cuta shine samar da ƙwayoyin cuta ciki har da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta a cikin mutane farawa kwanaki 7 ko makamancin haka bayan bayyanar cututtuka, don ƙayyade rigakafi, da kuma a cikin sa ido na yawan jama'a. Ana iya yin gwaje-gwaje a cikin manyan dakunan gwaje-gwaje (CLT) ko ta hanyar gwajin wurin kulawa (PoCT).
Tsarin sarrafa kansa mai ƙarfin aiki a yawancin dakunan gwaje-gwaje na asibiti zai iya yin waɗannan gwaje-gwajen amma wadatar su zai dogara da saurin samarwa ga kowane tsarin.
Don CLT ana amfani da samfurin jini guda ɗaya na jini na waje, kodayake ana iya amfani da samfuran jerin don bin diddigin amsawar rigakafi.
Don PoCT ana samun samfurin jini guda ɗaya ta hanyar huda fata.
Ba kamar hanyoyin PCR ba ana buƙatar matakin cirewa kafin a gwada. A ranar 26 ga Maris, 2020, FDA ta ambaci ƙungiyoyi 29 waɗanda suka ba da sanarwar ga hukumar kamar yadda ake buƙata kuma yanzu haka suna iya rarraba gwajin antibody ɗin su.
Ya zuwa ranar 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, wanda zai iya gano IgG da IgA antibodies akan kwayar cutar a cikin samfuran jini.
Ikon gwajin ya kai ɗaruruwan samfura a cikin awanni kuma saboda haka ya fi saurin gwajin PCR na RNA na kwayar cuta.
Antibodies yawanci ana iya gano su kwanaki 14 bayan fara kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta gano cewa babu ɗayan kayan gwajin antibody da ta saya da suka isa amfani.
"Hong Kong ta kafa wani tsari inda marasa lafiya da ake zargi za su iya zama a gida, ""sashen gaggawa zai ba da bututun samfurin ga mai haƙuri"", za su tofa a ciki, su mayar da shi kuma su sami sakamakon gwajin bayan ɗan lokaci. NHS ta Burtaniya ta sanar da cewa tana yin gwajin gwaji don gwada masu zargin a gida, wanda ke kawar da haɗarin mai haƙuri ya kamu da wasu idan sun zo asibiti ko kuma ya kashe ambulanci idan an yi amfani da shi.A gwajin motsa jiki don COVID-19 don masu zargin, ƙwararren likitanci yana ɗaukar samfurin ta amfani da matakan kariya masu dacewa. "
Cibiyoyin tafi-da-gidanka sun taimaka wa Koriya ta Kudu wajen yin wasu gwaje-gwaje mafi sauri, mafi girma a kowace ƙasa. A Jamus, Ƙungiyar Likitocin Kula da Kiwon Lafiya ta Kasa ta ce a ranar 2 ga Maris, tana da damar yin gwaje-gwaje kusan 12,000 a kowace rana a cikin yanayin motsa jiki kuma an gwada 10,700 a makon da ya gabata.
Kudin da inshorar lafiya ke biya idan likita ya umurci gwajin.
A cewar shugaban Cibiyar Robert Koch, Jamus tana da damar yin gwaje-gwaje 160,000 a kowane mako.
Tun daga ranar 19 ga watan Maris an yi gwajin tuki a manyan birane da dama.
Ya zuwa 26 ga Maris 2020 ba a san jimillar gwajin da aka yi a Jamus ba, saboda sakamakon da aka bayar tabbatacce ne kawai.
"Binciken farko na dakin gwaje-gwaje ya bayyana cewa a cikin mako na kalanda 12/2020 an gwada aƙalla samfura 483,295 har zuwa ciki har da mako na 12/2020 da kuma samfura 33,491 (6.9%) sun tabbatar da tabbatacce ga SARS-CoV-2.A Isra'ila, masu bincike a asibitin Technion da Rambam sun haɓaka kuma sun gwada hanyar gwada samfura daga marasa lafiya 64 a lokaci guda, ta hanyar haɗa samfurori kuma kawai suna yin ƙarin gwaji idan an sami samfurin hadewa.A Wuhan wani dakin gwaje-gwaje na gaggawa mai girman murabba'in mita 2000 mai suna ""Huo-Yan"" (Sinanci: 火眼, ko ""Fire Eye"" a Turanci) an buɗe shi a ranar 5 ga Fabrairu 2020 ta BGI, wanda zai iya aiwatar da sama da samfurori 10,000 a rana. "
Tare da aikin da mai kafa BGI Wang Jian ya kula da shi kuma ya ɗauki kwanaki 5, samfurin da aka nuna a Hubei zai kasance 47% mafi girma kuma farashin da ya dace na magance keɓewa zai ninka idan wannan ƙarfin gwajin bai zo ba.
An bi Wuhan Laboratory da sauri da Huo-Yan Labs a Shenzhen, Tianjin, Beijing, da Shanghai, a cikin birane 12 a duk fadin China.
Zuwa 4 ga Maris 2020 yawan gwajin yau da kullun ya kai gwaje-gwaje 50,000 a kowace rana. An saki buɗe tushen, ƙirar da aka haɗa da yawa da Origami Assays ya saki wanda zai iya gwada samfuran marasa lafiya 1122 don COVID19 ta amfani da gwaje-gwaje 93 kawai. Ana iya gudanar da waɗannan ƙirar daidaitaccen a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar masu sarrafa ruwa na mutummutumi ba.
Zuwa Maris, karancin da isassun adadin maganin ya zama abin toshewa ga gwajin taro a cikin EU da Burtaniya da Amurka.
Wannan ya sa wasu marubuta suka bincika hanyoyin shirya samfurin da suka haɗa da dumama samfuran a 98 °C (208 °F) na mintuna 5 don sakin kwayoyin halittar RNA don ƙarin gwaji. A ranar 31 ga Maris an sanar da cewa Hadaddiyar Daular Larabawa yanzu tana gwada yawan jama'arta don Coronavirus a kan kowane mutum fiye da kowace ƙasa, kuma tana kan hanyar haɓaka matakin gwaji don isa ga yawancin jama'a.
"Wannan ya kasance ta hanyar haɗuwa da damar tuki, da siyan dakin gwaje-gwaje mai yawan jama'a daga Group 42 da BGI (bisa ga "Huo-Yan" dakunan gwaje-gwajen gano gaggawa a China). "
An gina shi cikin kwanaki 14, dakin gwaje-gwajen yana iya gudanar da dubun dubatan gwajin RT-PCR a kowace rana kuma shine na farko a duniya na wannan sikelin da zai fara aiki a wajen kasar Sin.
An kirkiro hanyoyin gwaji daban-daban da suka shafi sassa daban-daban na bayanan kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta amince da girke-girke na Jamus don kera kayan aiki da aka aika wa ƙasashe masu ƙarancin kuɗi ba tare da albarkatun da za su samar da nasu ba.
An buga girke-girke na Jamusanci a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka haɓaka ba ta kasance ba har zuwa 28 ga Janairu, yana jinkirta gwajin da ake samu a Amurka. China da Amurka suna da matsaloli game da amincin kayan gwajin a farkon barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayan aikin don gamsar da buƙata da shawarwarin gwaji na masana kiwon lafiya ba.
Akasin haka, masana sun ce samun gwajin a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
Gwamnatin Koriya ta Kudu ta gina ƙarfin gwaji, galibi a cikin dakunan gwaje-gwaje na masu zaman kansu, tsawon shekaru da yawa.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara inganta shirye-shiryen gwaji a matsayin hanya mafi kyau ta rage ci gaban annobar COVID-19. Babban bukatar gwaji saboda yaduwar kwayar cutar ya haifar da jinkirin yin daruruwan dubban gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma wadatar swabs da kayan aikin sunadarai sun zama matsi.
A watan Maris na shekarar 2020 Sin ta ba da rahoton matsaloli game da daidaito a cikin kayan gwajin su.
" A Amurka, kayan gwajin da CDC ta samar suna da ""kuskure;"" sannan gwamnati ta cire shingen da suka hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na China, amma ta gano cewa sakamakon ba daidai bane. "
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya zama sakamakon rashin tattara samfurori ko amfani da kayan aikin daidai.
Ma'aikatar Spain ta ce za ta janye kayan aikin da suka ba da sakamakon da ba daidai ba, kuma za ta maye gurbin su da wani kayan aikin gwaji daban wanda kamfanin Shenzhen Bioeasy ya bayar. 80% na kayan aikin gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamako mara kyau. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China wanda aka gano ba daidai ba ne.
" Firayim Minista Matovič ya ba da shawarar a zubar da wadannan a cikin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "babban kuskuren kuskure" kuma ba ta "sa su cikin amfani ba. ""Majalisar Burtaniya ta sayi kayan gwajin miliyan 3.5 daga China amma a farkon watan Afrilu 2020 ta sanar da cewa wadannan ba za a iya amfani da su ba. "
Gwajin, sannan tare da keɓewar waɗanda suka gwada tabbatacce da kuma bin diddigin waɗanda mutanen da ke da SARS-CoV-2 sun yi hulɗa da su, ya haifar da sakamako mai kyau.
Masu bincike da ke aiki a garin Vò na Italiya, wurin da aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da zagaye biyu na gwaji a kan dukkan jama'a na kimanin mutane 3,400, kimanin kwanaki goma a tsakanin su.
Kimanin rabin mutanen da suka gwada ba su da wata alama, kuma duk waɗanda aka gano sun kasance a keɓe.
Tare da hana tafiya zuwa garin, wannan ya kawar da sabbin kamuwa da cuta gaba daya.
Tare da bin diddigin tuntuɓar haɗari, ƙuntatawa na tafiya mai shigowa, gwaji, da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta ci gaba da jinkiri fiye da sauran ƙasashe masu tasowa, amma ba tare da takunkumi masu tsananin gaske ba kamar rufe gidajen cin abinci da wuraren sayar da kayayyaki.
An soke abubuwa da yawa, kuma Singapore ta fara ba da shawara ga mazauna su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutun hutu a ranar 23 ga Maris.
Sauran ƙasashe da yawa sun kuma gudanar da annobar ta hanyar bin diddigin tuntuɓar haɗuwa, ƙuntatawa na tafiya mai shigowa, gwaji, da keɓewa, amma tare da ƙuntatawa mai ƙarancin ƙarfi, kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya gano cewa kasashen da suka yi gwaji da yawa, dangane da yawan mutuwar, suna da ƙananan adadin mutuwar, mai yiwuwa saboda waɗannan ƙasashe sun fi iya gano waɗanda ke da ƙananan ko babu alamun.
WHO ta ba da shawarar cewa ƙasashen da ba su da ƙarfin gwaji da kuma dakunan gwaje-gwaje na ƙasa tare da ƙarancin ƙwarewa kan COVID-19 su aika da samfuran COVID-19 na farko masu inganci biyar da na farko masu ƙarancin 10 zuwa ɗaya daga cikin dakunan gwaje-gwaje na WHO 16 don tabbatar da gwaji.
Daga cikin dakunan gwaje-gwaje 16 na tunani, 7 suna Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka da 1 a Ostiraliya.
A cikin jadawalin da ke ƙasa, shafi  Positive a matsayin % na gwaje-gwaje ya shafi manufar gwajin ƙasar.
Kasar da ke gwada mutane da aka kwantar a asibitoci ne kawai za ta sami mafi girma a matsayin kashi na gwaje-gwaje fiye da ƙasar da ke gwada dukkan 'yan ƙasa, ko suna nuna alamun ko a'a, sauran abubuwa suna daidai.
Wanke hannu, wanda kuma ake kira tsabtace hannu, aikin wanke hannu ne da nufin cire datti, kitse, ƙwayoyin cuta, ko wasu abubuwa da ba a so.
" Wanke hannu da sabulu a kai a kai a wasu "lokaci masu muhimmanci" a cikin yini yana hana yaduwar cututtuka da yawa, misali zawo da cutar kwalara, waɗanda ake yadawa ta hanyar kwance. "
Mutane kuma za su iya kamuwa da cututtukan numfashi kamar su mura ko kuma sanyi, misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko bakin su (watau mucous membranes).
Abubuwa biyar masu mahimmanci a cikin rana inda wanke hannu da sabulu yake da mahimmanci sun hada da: kafin da bayan yin najasa, bayan wanke bayan yaron ko canza kayan wanka, kafin ciyar da yaro, kafin cin abinci da kafin da bayan shirya abinci ko sarrafa naman da ba a shayar ba, kifi, ko kaji.
Idan ruwa da sabulu ba su samuwa, za a iya wanke hannu da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin a dafa abinci, sa'ad da ake dafa abinci, da kuma bayan an gama.
Kafin ka kula da marar lafiya da kuma bayan ka yi hakan.
Bayan ka canja mayafin ko kuma ka tsabtace yaron da ya je gidan wanka.
Bayan ka busa hanci, ka yi tari ko kuma ka yi tari.
Bayan ka taɓa dabba ko abincin dabbobi ko kuma ƙazamar dabba.
Tsabtace hannu na likita yana nufin ayyukan tsabtace da suka shafi hanyoyin kiwon lafiya.
Wanke hannu kafin a yi amfani da magani ko kuma a yi jinya zai iya hana ko rage yaduwar cuta.
Babban manufar wanke hannu a fannin kiwon lafiya shi ne tsabtace hannaye daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da ke iya haifar da cuta) da kuma sinadarai da ke iya haifar da lahani ko cuta.
Wannan yana da mahimmanci ga mutanen da ke sarrafa abinci ko aiki a fagen likitanci, amma kuma muhimmin aiki ne ga jama'a.
Wanke hannu yana da fa'idodi da yawa ga lafiyar mutum, ciki har da rage yaduwar mura, coronavirus, da sauran cututtukan da ke yaduwa; hana cututtukan da ke haifar da zawo; rage cututtukan numfashi;
da rage yawan mutuwar jarirai a lokacin haihuwar gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa inganta hanyoyin wanke hannu na iya haifar da ɗan ci gaba a cikin tsayin yara 'yan kasa da shekara biyar.
A ƙasashe masu tasowa, za a iya rage yawan yara da ke mutuwa sakamakon cututtukan numfashi da na zawo ta hanyar yin canje-canje a halayyarsu, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage yawan mutuwar da ke faruwa saboda waɗannan cututtuka da kusan kashi 50%.
Taimako da ke ƙarfafa wanke hannu zai iya rage yawan ciwon zawo da kashi ɗaya bisa uku, kuma wannan ya yi daidai da samar da ruwa mai tsabta a yankunan da ba su da kuɗi.
48% na raguwar cututtukan zawo za a iya danganta su da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da arha don hana zawo da cututtukan numfashi mai tsanani (ARI), kamar yadda ake aiwatar da shi kai tsaye a gidaje, makarantu, da al'ummomi a duk duniya.
Ciwon huhu, babban cutar ARI, shi ne sanadin mutuwa mafi girma a tsakanin yara 'yan ƙasa da shekara biyar, yana kashe yara kusan miliyan 1.8 a kowace shekara.
Ciwon zawo da ciwon huhu suna kashe yara kusan miliyan 3.5 a kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma bayan ka je bayan gida zai iya ceton rayuka fiye da duk wani allurar rigakafi ko kuma magani, ya rage mutuwar da ke zuwa daga zawo da kusan rabi da kuma mutuwar da ke zuwa daga cututtukan numfashi da ke faruwa a jiki da kashi ɗaya cikin huɗu.
Ana yawan haɗa wanke hannu tare da sauran ayyukan tsabtace jiki a matsayin ɓangare na shirye-shiryen ruwa, tsabtace jiki da tsabta (WASH).
Wanke hannu kuma yana karewa daga impetigo wanda ake yadawa ta hanyar hulɗa ta jiki kai tsaye.
Wani karamin illa na wanke hannu shine cewa yawan wanke hannu na iya haifar da lalacewar fata saboda bushewar fata.
Wani bincike da aka yi a shekara ta 2012 a Denmark ya nuna cewa yawan wanke hannu yana iya sa mutum ya yi ciwon fata mai saurin zufa da ake kira hand eczema ko kuma dermatitis, wanda ya fi yawa a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa ana ganin yana ɗaya daga cikin alamun rashin lafiyar da ke sa mutum ya damu da abin da bai dace ba.
Akwai lokuta masu mahimmanci guda biyar a cikin rana inda wanke hannu da sabulu yana da mahimmanci don rage watsa cututtuka ta hanyar kwance-baki: bayan amfani da gidan wanka (urination, defecation), bayan tsaftace bayan yaron (canja kayan wanka), kafin ciyar da yaro, kafin cin abinci da kafin / bayan shirya abinci ko sarrafa naman alade, kifi, ko kaji.
Sauran lokutan da ya kamata a yi amfani da hanyar wanke hannu daidai domin hana yaduwar cuta sun hada da kafin da bayan kula da wani rauni ko rauni; bayan yin tari, tari, ko hura hanci; bayan taɓawa da sharar dabbobi ko taɓawa da dabbobi; da kuma bayan taɓawa da shara.
A ƙasashe da yawa, ba a wanke hannu da sabulu sosai.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa a matsakaita, kashi 38.7% na iyalai suna wanke hannu da sabulu. Wani bincike na shekarar 2014 ya nuna cewa Saudi Arabiya ce ke da kashi 97 cikin dari; Amurka tana kusa da tsakiyar da kashi 77 cikin dari; kuma China tana da mafi ƙarancin kashi 23 cikin dari. Akwai hanyoyin canza halayya da dama yanzu don ƙara karɓar halayyar wanke hannu da sabulu a lokuta masu mahimmanci. Wanke hannu a rukuni don yaran makaranta a wasu lokutan rana shine ɗayan zaɓuɓɓuka a cikin ƙasashe masu tasowa don kafa wanke hannu a cikin halayen yara.
" Shirin Kula da Lafiya na Muhimmanci " wanda Ma'aikatar Ilimi ta aiwatar a Philippines misali ne na matakin da aka dauka don inganta lafiyar yara da ilimi. "
Cire ƙwayoyin cuta sau biyu a shekara, tare da wanke hannuwanmu kullum da sabulu, da kuma wanke haƙoranmu kullum da fluoride, shi ne ainihin wannan shirin na kasa.
An kuma yi nasarar aiwatar da shi a Indonesia.
Cire kwayoyin cuta daga fata yana ƙaruwa ta hanyar ƙara sabulu ko kayan wankewa zuwa ruwa.
Babban aikin sabulu da kayan wankewa shine rage shingen maganin, da haɓaka narkewa.
Ruwa kaɗai ba shi da amfani wajen tsabtace fata domin kitse da kuma sunadarai, waɗanda suke cikin ƙasa, ba sa narkewa cikin ruwa.
Amma, ana taimakawa wajen tsabtace ta hanyar isar da ruwa mai kyau.
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, yana iya riƙe da ƙwayoyin cuta da aka samu daga amfani da su a dā.
Ƙananan adadin nazarin da suka duba canja wurin kwayoyin daga sabulu mai ƙarfi mai gurɓatacce sun kammala cewa canja wurin ba shi yiwuwa saboda ana wanke kwayoyin tare da kumfa.
" CDC har yanzu ta ce ""safi mai ruwa tare da sarrafawa kyauta don rarraba ya fi dacewa"". "
An yi wa masu kula da lafiyarsu talla sosai game da sabulu masu hana ƙwayoyin cuta.
Ya zuwa yanzu, babu wata hujja da ke nuna cewa yin amfani da maganin kashe cututtukan da aka ba da shawarar ko kuma maganin kashe cututtukan yana zaɓar don kwayoyin da ke da juriya ga maganin rigakafi a yanayi.
Koyaya, sabulun antibacterial suna ƙunshe da magungunan antibacterial na yau da kullun kamar triclosan, wanda ke da jerin nau'ikan ƙwayoyin cuta masu tsayayya.
Saboda haka, ko da ba a zaɓi nau'in da ke da juriya ga maganin rigakafi ba ta hanyar sabulu na antibacterial, ƙila ba su da tasiri kamar yadda ake tallata su.
Baya ga mai aiki da kuma kare fata, ingantattun kayan aikin na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, antibacterially aiki benzoic acid da sauran kayan kwalliyar fata (aloe vera, bitamin, menthol, tsire-tsire na tsire-tsire). Cikakken bincike daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun suna da tasiri kamar sabulu masu hana ƙwayoyin cuta masu amfani da ke dauke da triclosan wajen hana cututtuka da cire ƙwayoyin cuta daga hannaye.
Ruwan zafi da yake da kyau don wanke hannu ba ya isa ya kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 ° C).
Amma, ruwan dumi mai sabulu ya fi ruwan sanyi mai sabulu tasiri wajen cire man da ke riƙe ƙasa da ƙwayoyin cuta.
Akasin abin da mutane da yawa suka gaskata, binciken kimiyya ya nuna cewa amfani da ruwa mai ɗumi ba ya rage yawan ƙwayoyin cuta a hannu.
Mai tsabtace hannu ko maganin kashe cututtukan hannu shine mai tsabtace hannu wanda ba shi da ruwa.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, kayan aikin tsabtace hannu na barasa marasa tushen ruwa (wanda kuma aka sani da rubs na hannu na barasa, rubs na antiseptic, ko masu tsabtace hannu) sun fara samun shahara.
Yawancin suna dogara ne akan isopropyl alcohol ko ethanol da aka tsara tare da wakili mai kauri kamar Carbomer (polymer na acrylic acid) a cikin gel, ko mai danshi kamar glycerin a cikin ruwa, ko kumfa don sauƙin amfani da rage tasirin bushewar barasa.
Haɗa hydrogen-peroxide mai narkewa yana ƙara haɓaka aikin antimicrobial. Sanitizers na hannu waɗanda ke ƙunshe da aƙalla 60 zuwa 95% na barasa suna kashe ƙwayoyin cuta masu inganci.
Maganin tsabtace shan giya yana kashe kwayoyin cuta, kwayoyin cuta masu juriya da magunguna da yawa (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, mura, da hepatitis) da fungi.
Maganin tsabtace hannu na barasa wanda ke dauke da kashi 70% na barasa yana kashe kashi 99.97% (3.5 log rage, kwatankwacin rage 35 decibel) na kwayoyin cuta a hannuwanku dakika 30 bayan aikace-aikace da kuma kashi 99.99% zuwa 99.999% (4 zuwa 5 log rage) na kwayoyin cuta a hannuwanku minti 1 bayan aikace-aikace. Maganin tsabtace hannu suna da tasiri sosai akan kwayoyin cuta kuma basu da tasiri akan wasu ƙwayoyin cuta.
Tsabtace hannu na barasa kusan ba shi da tasiri gaba ɗaya akan ƙwayoyin cuta na nau'in norovirus (ko Norwalk), sanadin mafi yawan cututtukan gastroenteritis. Dole ne a yi amfani da isasshen maganin kashe ƙwayoyin cuta ko barasa don shafa hannu sosai ko rufe hannu biyu.
Ana shafa gaba da bayan hannaye biyu da tsakanin da ƙarshen yatsun hannu kusan dakika 30 har sai ruwan, kumfa ko gel ya bushe.
Dole ne a wanke yatsun yatsun hannu sosai, a shafa su a hannun hannu biyu. Cibiyar Kula da Cututtuka da Rigakafin Amurka ta ba da shawarar wanke hannu a kan kayan tsabtace hannu, musamman idan hannaye suna da datti.
Ƙara amfani da waɗannan magungunan ya dogara ne da sauƙin amfani da saurin kashewa ga ƙwayoyin cuta; duk da haka, bai kamata su zama maye gurbin wanke hannu daidai ba sai dai idan sabulu da ruwa ba su samuwa.
Amfani da kayan tsabtace hannu na barasa na iya haifar da bushewar fata sai dai idan an kara emollients da / ko kayan shafawa na fata zuwa ga kayan.
Ana iya rage ko kawar da tasirin busar da giya ta hanyar ƙara glycerin da/ko wasu emollients zuwa ga samfurin.
A cikin gwaji na asibiti, masu tsabtace hannu na tushen barasa da ke dauke da emollients sun haifar da rashin jin daɗi da bushewar fata fiye da sabulu ko magungunan tsabtace ƙwayoyin cuta.
Allergic contact dermatitis, ciwon hauka na tuntuɓar ko kuma yawan jin daɗin giya ko abubuwan da ke cikin kayan shafawa na giya ba safai ake samu.
Ƙananan yanayin haifar da cutar fata mai haɗuwa ta zama abin jan hankali idan aka kwatanta da wanke hannu da sabulu da ruwa.
Duk da ingancin su, kayan da ba ruwa ba suna wanke hannaye daga kayan kwayoyin, amma kawai suna kashe su.
Wannan shine dalilin da ya sa masu tsabtace hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar ƙwayoyin cuta da yawa, tun da ƙwayoyin cuta har yanzu suna kan hannaye.
Ingancin tsabtace hannu mara barasa ya dogara sosai da sinadarai da tsari, kuma a tarihi yana da ƙarancin aikin barasa da barasa.
Kwanan nan, an nuna cewa samfurori da ke amfani da benzalkonium chloride suna da tsayayyen aiki na antimicrobial bayan aikace-aikace, ba kamar barasa ba, wanda aka nuna ya rage tasiri bayan maimaita amfani, mai yiwuwa saboda ci gaba da halayen fata.
Mutane da yawa a yankunan da suke da ƙarancin kuɗi ba su iya sayan sabulu ba kuma suna amfani da toka ko ƙasa maimakon haka.
Ash ko ƙasa na iya zama da tasiri fiye da ruwa kaɗai, amma na iya zama da kasawa fiye da sabulu.
Wani abin damuwa shi ne idan ƙasa ko toka ta gurɓata da ƙwayoyin cuta, hakan zai iya ƙara yaɗuwar cuta maimakon rage ta.
Kamar sabulu, toka ma tana kashe ƙwayoyin cuta domin idan ta haɗu da ruwa, tana samar da maganin alkaline.
Hukumar WHO ta ba da shawarar ash ko yashi a matsayin madadin sabulu idan babu sabulu.
Tsarin wanke hannu daidai wanda Cibiyoyin Kula da Cututtuka na Amurka suka ba da shawarar don hana watsa cutar ya haɗa da matakai masu zuwa:
Ka yi wanka da ruwan dumi ko ruwan sanyi.
Ana ba da shawarar a yi amfani da ruwan da ke gudana domin ana iya gurɓata ɗakunan ruwa da ke tsaye, yayin da zafin ruwan ba ya nuna bambanci.
Ka wanke hannayenka ta wurin shafa musu sabulu mai yawa, har da bayan hannunka, tsakanin yatsunka, da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannuwansu sosai sa'ad da suke amfani da sabulu maimakon ruwa kawai.
Ka yi wanka na akalla dakika 20.
Gogewa yana haifar da tirka, wanda ke taimakawa wajen cire ƙwayoyin cuta daga fata, kuma gogewa na tsawon lokaci yana cire ƙwayoyin cuta da yawa.
Ka wanke da kyau a ƙarƙashin ruwa mai gudu.
Wanke hannu a cikin kwano zai iya sake gurɓata hannaye.
Ka bushe da tawul mai tsabta ko ka bar iska ta bushe.
Hannun da ke da danshi da kuma danshi suna da saukin sake kamuwa da cutar. Wuraren da aka fi mantawa da su sune babban yatsan hannu, wuyan hannu, tsakanin yatsun hannu, da kuma ƙarƙashin ƙusa.
Ƙuƙwalwa da ƙusa na ƙusa na iya samun ƙwayoyin cuta.
Ana ba da shawarar sau da yawa don kiyaye hannayen daga bushewa; bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin watsa kamuwa da cuta.
" Za a iya yin zaɓuɓɓuka masu tsada daban-daban don sauƙaƙe wanke hannu inda ba a samun ruwan famfo da / ko sabulu misali zuba ruwa daga kwanon rufi ko gourd tare da ramuka masu dacewa da / ko amfani da toka idan an buƙata a ƙasashe masu tasowa. A cikin yanayi tare da iyakancewar samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin adana ruwa, kamar ""tippy-taps"" da sauran zaɓuɓɓukan ƙarancin kuɗi. "
Tattalin tap wani fasaha ne mai sauki ta amfani da kwalba da aka rataye ta igiya, da kuma wani abin motsa jiki da ke aiki da ƙafa don zuba karamin ruwa a kan hannaye da sabulu.
Yin bushe hannu da kyau wani muhimmin bangare ne na tsaftace hannu, amma akwai wasu muhawara game da mafi kyawun hanyar bushewa a cikin ɗakunan wanka na jama'a.
Ƙarin bincike ya nuna cewa tawul ɗin takarda sun fi na'urar bushe hannu da ake amfani da ita a ɗakunan wanka da yawa tsabta.
A shekarar 2008, Jami'ar Westminster ta London, da kuma masana'antar takarda ta turawa, sun gudanar da wani bincike, wanda ya kwatanta matakan tsafta da takarda, masu bushe-bushe da iska mai zafi da kuma na zamani masu bushe-bushe.
Bayan wanke hannu da bushewa da na'urar bushewa da iska mai dumi, an gano cewa adadin kwayoyin cuta sun karu a matsakaici a kan yatsun hannu da kashi 194% kuma a kan hannayen hannu da kashi 254%.
Gogewa da na'urar bushewa ta iska ta haifar da karuwar matsakaicin adadin kwayoyin cuta a kan yatsun hannu da kashi 42% da kuma a kan hannu da kashi 15%.
Bayan wankewa da bushewa hannu da tawul ɗin takarda, jimillar adadin ƙwayoyin cuta ya ragu a matsakaita har zuwa kashi 76% a kan yatsun hannu da kuma a kan dabino har zuwa kashi 77%. Masana kimiyya sun kuma gudanar da gwaje-gwaje don gano ko akwai yiwuwar gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka sakamakon kowane nau'in hanyar bushewa.
Mai bushewar iska, wanda ke hura iska daga cikin na'urar a saurin da aka ce na 180 m / s (650 km / h; 400 mph), yana iya hura kwayoyin cuta daga hannaye da na'urar kuma yana iya gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka har zuwa mita 2.
Amfani da na'urar bushe hannu mai iska mai dumi ya yada kwayoyin halittar har zuwa mita 0.25 daga na'urar bushewa.
Takardar tawul ɗin ba ta nuna wani yaduwar ƙwayoyin cuta ba.A cikin 2005, a cikin binciken da TÜV Produkt und Umwelt ta gudanar, an kimanta hanyoyi daban-daban na bushe hannu.
An lura da canje -canje masu zuwa a cikin adadin ƙwayoyin cuta bayan bushe hannaye:
Akwai masana'antun bushe-bushe na hannu daban-daban, kuma an kwatanta bushe-bushe na hannu da bushewa tare da tawul ɗin takarda.
Wanke hannu ta amfani da wankin wanke hannu wani madadin ne yayin tafiya idan babu sabulu da ruwa.
Tsabtace hannu na barasa ya kamata ya ƙunshi aƙalla kashi 60% na barasa.
An soma yin wanke hannu tun da likitan ƙasar Hungary mai suna Ignaz Semmelweis ya gano cewa wanke hannu yana da amfani sosai a asibiti (a shekara ta 1846).
Akwai na'urorin lantarki da ke ba da amsa don tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya gano cewa yawan kamuwa da cuta ya ragu da amfani da su.
Wanke hannu na likita na akalla dakika 15, ta amfani da sabulu da ruwa ko gel mai yawa don yin tururi da shafa kowane ɓangare na hannaye.
Ya kamata a shafa hannaye tare da yatsunsu suna haɗuwa.
Idan akwai tarkace a ƙarƙashin kusoshi, ana iya amfani da buroshi don cire shi.
Tun da yake ƙwayoyin cuta suna iya kasancewa a cikin ruwa a hannu, yana da muhimmanci a wanke hannu sosai kuma a goge su da tawul mai tsabta.
Bayan bushewa, ya kamata a yi amfani da tawul ɗin takarda don kashe ruwa (kuma buɗe duk ƙofar fita idan ya cancanta).
Wannan yana hana sake gurɓata hannaye daga waɗancan saman.
" Manufar wanke hannu a cikin kulawar lafiya ita ce kawar da ƙwayoyin cuta masu cutarwa ("" ƙwayoyin cuta ") da kuma guje wa watsa su. "
Jaridar New England Journal of Medicine ta ba da rahoto cewa rashin wanke hannu ya ci gaba da zama abin da ba a yarda da shi ba a yawancin wuraren kiwon lafiya, da yawa daga cikin likitoci da ma'aikatan jinya suna mantawa da wanke hannayensu a kai a kai kafin su taɓa marasa lafiya, da haka suna watsa ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu ayyuka masu sauƙi za su iya rage yawan kamuwa da cuta ta hanyar katet. Ƙungiyar Lafiya ta Duniya ta wallafa wani takarda da ta nuna yadda ake wanke hannu da kuma shafa hannu a wuraren kiwon lafiya.
Ana iya samun tsarin jagorar tsaftace hannu ta ƙungiyar a shafin yanar gizon ta don ra'ayoyin jama'a.
Whitby et al. sun yi wani bincike da ya dace.
Na'urorin kasuwanci na iya auna da tabbatar da tsabtace hannu, idan ana buƙatar nuna bin ƙa'idodi.
" Hukumar Lafiya ta Duniya tana da "Lokaci Biyar" don wanke hannu: "
bayan an yi amfani da jini/ruwa na jiki
kafin aikin rashin amfani da kwayoyin halitta, da
" bayan kulawar mai haƙuri. Ƙara sinadarai masu lalata ƙwayar cuta zuwa sabulu ("sabbin ""magani"" ko ""antimicrobial"" sabulu) yana ba da aikin kashewa ga wakili mai wanke hannu. "
Ana iya son irin wannan kashewa kafin yin tiyata ko kuma a wuraren da kwayoyin da ke da juriya ga maganin rigakafi suka fi yawa. Don 'sarrafa' hannayen mutum don tiyata, ya zama dole a sami famfo da za a iya kunnawa da kashewa ba tare da taɓa shi da hannaye ba, wasu chlorhexidine ko iodine wanka, tawul mai tsabta don bushe hannayen bayan wanka, da kuma goga mai tsabta don gogewa da kuma wani kayan aiki mai tsabta don tsabtace ƙarƙashin kusoshi.
Ya kamata a cire dukan kayan ado.
Wannan aikin yana buƙatar wanke hannaye da gaban hannu har zuwa gwiwoyi, yawanci 26 minti.
Ba a bukatar tsawan lokaci na wankewa (minti 10).
Lokacin wankewa, dole ne a hana ruwa a kan hannayen baya daga gudu zuwa hannayen.
Bayan an gama wanke hannu, ana bushe hannayen da takalmi mai tsabta kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, ya fi kyau a wanke hannu ko kuma a yi amfani da maganin kashe ƙwayoyin cuta kafin a kula da mutum da kuma bayan an kula da shi.
Don sarrafa cututtukan staphylococcal a asibitoci, an gano cewa mafi girman fa'ida daga tsaftace hannu ya zo daga farkon 20% na wankewa kuma an sami ƙarin fa'ida kaɗan lokacin da aka ƙara yawan tsaftace hannu sama da 35%.
Wankewa da sabulu na yau da kullun yana haifar da fiye da sau uku na cutar cututtukan ƙwayoyin cuta da ke yaduwa a cikin abinci idan aka kwatanta da wankewa da sabulu mai hana ƙwayoyin cuta. Kwatanta goge hannu tare da maganin da ke da tushen barasa tare da wanke hannu tare da sabulu mai hana ƙwayoyin cuta na matsakaicin lokaci na sakan 30 kowane ya nuna cewa goge hannu da barasa ya rage gurɓatar ƙwayoyin cuta 26% fiye da sabulu mai hana ƙwayoyin cuta.
Amma sabulu da ruwa sun fi maganin shafawa na hannu mai amfani da barasa tasiri wajen rage kwayar cutar H1N1 A da kuma kwayar cutar Clostridium difficile daga hannaye. Matakan inganta tsaftace hannu a wuraren kiwon lafiya na iya haɗawa da ilimantar da ma'aikata kan wanke hannu, ƙara wadatar maganin shafawa na hannu mai amfani da barasa, da kuma rubutaccen tunatarwa da magana ga ma'aikata.
Akwai buƙatar ƙarin bincike kan wanne daga cikin waɗannan hanyoyin ya fi tasiri a cikin saitunan kiwon lafiya daban-daban.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu hanya ce mai sauƙi da kuma muhimmiyar hanya don samun ƙoshin lafiya, har ma da cin abinci mai kyau.
Koyaya, rashin amintaccen samar da ruwa, sabulu ko wuraren wanke hannu a gidajen mutane, a makarantu da wuraren aiki ya sanya ƙalubale don cimma halayen wanke hannu na duniya.
Alal misali, a yawancin yankunan karkara na Afirka, famfunan wanke hannu a kusa da kowane gidan wanka na jama'a ko na masu zaman kansu ba su da yawa, ko da yake akwai zaɓuɓɓuka masu arha don gina tashoshin wanke hannu.
Koyaya, ƙananan yawan wanke hannu na iya zama sakamakon halaye masu tushe maimakon saboda rashin sabulu ko ruwa.
Tallafawa da kuma tallata wanke hannu da sabulu na iya tasiri kan yanke shawara na siyasa, fadakarwa game da fa'idodin wanke hannu da kuma haifar da sauyin halayyar jama'a na dogon lokaci.
Don wannan ya yi aiki da kyau, ana bukatar sa ido da kimantawa.
" Binciken da aka yi na nazari 70 ya gano cewa hanyoyin da al'umma ke bi suna da tasiri wajen kara wanke hannu a cikin kananan hukumomin da ke da karamin karfi, yayin da kamfen na tallace-tallace na zamantakewa ba su da tasiri sosai. Misali daya na inganta wanke hannu a makarantu shine "Hanyar Taurari Uku" ta UNICEF wanda ke karfafa makarantun su dauki matakai masu sauki, masu arha don tabbatar da cewa dalibai suna wanke hannayensu da sabulu, tsakanin sauran bukatun tsabta. "
Lokacin da aka cimma mafi ƙarancin ƙa'idodi, makarantu na iya motsawa daga tauraro ɗaya zuwa ƙarshe tauraro uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen na inganta wanke hannu da ake gudanarwa don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a wanda ke kokarin cimma canjin hali. Sakamakon annobar cutar coronavirus ta 2019-20, UNICEF ta inganta amfani da emoji na wanke hannu.
Karamin bincike ya yi la'akari da tasirin farashin wanke hannu a cikin ƙasashe masu tasowa dangane da DALYs da aka kauce masa.
Duk da haka, wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin ruwa da tsaftacewa tsada.
" Muhimmancin wanke hannu don lafiyar dan adam  musamman ga mutanen da ke cikin mawuyacin hali kamar uwaye da suka haihu ko sojoji da suka ji rauni a asibitoci  an fara ganewa a tsakiyar karni na 19 ta hanyar masu aikin tsabtace hannu biyu: likitan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, Ingilishi ""wanda ya kafa aikin jinya na zamani"". "
A lokacin yawancin mutane suna gaskata cewa ƙamshi da ake kira miasmas ne ke sa kamuwa da cuta.
A cikin shekarun 1980, barkewar cututtukan da ke haifar da abinci da cututtukan da ke tattare da kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Rigakafin Amurka su inganta tsaftace hannu sosai a matsayin hanya mai mahimmanci don hana yaduwar kamuwa da cuta.
Barkewar cutar mura ta aladu a shekara ta 2009 da kuma annobar COVID-19 a shekarar 2020 sun sa a kasashe da dama aka kara fahimtar muhimmancin wanke hannu da sabulu don kare kai daga irin wadannan cututtuka masu yaduwa.
" Misali, an rataye hotunan da ke nuna ""daidaitaccen hanyoyin wanke hannu"" kusa da wanke hannu a cikin gidajen wanka na jama'a da kuma cikin gidajen wanka na gine-ginen ofis da filayen jiragen sama a Jamus. "
" Maganar "wanke hannayen mutum daga" wani abu, yana nufin bayyana rashin son ɗaukar alhakin abu ko raba hadin kai a ciki. "
Ya samo asali ne daga nassi na Littafi Mai-Tsarki a cikin Matta inda Bilatus Pontius ya wanke hannunsa daga yanke shawarar gicciye Yesu Kristi, amma ya zama magana tare da amfani mai yawa a wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari na tsabtace tabo da aka yi tunaninsa, yana wakiltar lamirinta game da laifukan da ta aikata kuma ta rinjayi mijinta ya aikata.
An kuma gano cewa mutane, bayan sun tuna ko kuma sun yi tunanin aikata ayyukan da ba na dabi'a ba, sukan wanke hannayensu sau da yawa fiye da wasu, kuma sukan fi daraja kayan wanke hannu.
"Bugu da kari, wadanda aka basu damar wanke hannayensu bayan irin wannan tunanin ba su da damar shiga wasu ayyukan "tsabtacewa" na biyan diyya, kamar aikin sa kai. "
Addinai suna ba da umarnin wanke hannu don dalilai na tsabta da na alama. Wanke hannu na alama, ta amfani da ruwa amma ba sabulu don wanke hannu ba, wani ɓangare ne na wanke hannu na al'ada da aka nuna a addinai da yawa, gami da Bangaskiyar Bahá'í, Hindu, tevilah da netilat yadayim a addinin Yahudanci, Lavabo a Kiristanci, da Wudhu a Islama. Addinai kuma suna ba da umarnin wanke hannu na tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun bukaci wanke hannu bayan amfani da bayan gida.
Kuma, addinin Hindu, addinin Buddha, Sikh, addinin Yahudanci da Musulunci sun ba da umarnin wanke hannu kafin da kuma bayan kowane abinci.
Kula da haɗarin aiki don COVID-19
Kula da haɗarin aiki don COVID-19 shine aikace-aikacen hanyoyin lafiya da lafiya na aiki don kula da haɗari don rigakafin cutar coronavirus 2019 (COVID-19).
Kulawar haɗari da ta dace a wurin aiki ya dogara da wurin aiki da aikin aiki, bisa la'akari da tushen haɗarin, tsananin cutar a cikin al'umma da kuma abubuwan haɗarin ma'aikata na mutum waɗanda ke iya kamuwa da cutar COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Aikin Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari suna da ƙarancin hulɗa da jama'a da sauran abokan aiki, wanda ake ba da shawarar matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna da rashin lafiya, ladabi na numfashi, da kiyaye tsabtace yau da kullun da kuma kashe ƙwayoyin cuta na yanayin aiki.
Ayyukan da ke da haɗarin haɗari sun haɗa da waɗanda ke buƙatar haɗuwa da mutane sau da yawa ko kusa da mutanen da ba a san su ba ko ake zargin suna da COVID-19, amma suna iya kamuwa da cutar saboda ci gaba da watsawa a cikin al'umma ko tafiye-tafiye na duniya.
Wannan ya hada da ma'aikata da ke da hulɗa da jama'a kamar a makarantu, yanayin aiki mai yawan jama'a, da wasu saitunan sayar da kaya masu yawa.
Kulawar haɗari ga wannan rukuni, ban da matakan rigakafin kamuwa da cuta na asali, sun haɗa da iska ta amfani da matattarar iska mai inganci, masu kariya da hancin, da samun kayan kariya na mutum idan mutum yana da COVID-19.
OSHA tana la'akari da ma'aikatan kiwon lafiya da na gawawwakin da aka fallasa ga sanannun ko wanda ake zargin yana da COVID-19 suna cikin haɗarin fallasawa, wanda ke ƙaruwa zuwa haɗarin fallasawa sosai idan ma'aikata suka aiwatar da hanyoyin samar da aerosol akan, ko tattara ko sarrafa samfuran daga, sanannun ko wanda ake zargin yana da COVID-19.
Kula da haɗari da suka dace da waɗannan ma'aikata sun haɗa da kulawar injiniya kamar ɗakunan iska mai matsin lamba, da kayan kariya na mutum wanda ya dace da aikin aiki.
Cutar COVID-19 na iya samun sakamako da yawa a cikin wurin aiki.
Ma'aikata na iya kasancewa daga aiki saboda rashin lafiya, bukatar kula da wasu, ko kuma tsoron yiwuwar fallasa.
Hanyoyin kasuwanci na iya canzawa, duka dangane da waɗanne kayayyaki ake buƙata, da kuma hanyoyin samun waɗannan kayayyaki (kamar sayayya a cikin lokutan da ba a cika aiki ba ko ta hanyar isarwa ko sabis na tuki).
A ƙarshe, jigilar kayayyaki daga yankunan da COVID-19 ya shafa sosai na iya katsewa. Za a iya amfani da shiri na cututtukan cututtuka da kuma shirin amsawa don jagorantar ayyukan kariya.
Shirye-shiryen suna magance matakan haɗari da ke tattare da wuraren aiki da ayyuka daban-daban, gami da tushen haɗari, abubuwan haɗarin da ke tasowa daga gida da kuma yanayin al'umma, da abubuwan haɗarin ma'aikata na mutum kamar tsufa ko yanayin rashin lafiya na kullum.
Sun kuma bayyana hanyoyin da ake bukata don magance waɗannan hadarin, da kuma tsare-tsaren gaggawa don yanayin da zai iya tasowa sakamakon barkewar cutar.
Shirye-shiryen cututtukan cututtuka da shirye-shiryen amsawa na iya zama batun shawarwari na ƙasa ko na ƙasa.
Manufofin amsawa ga fashewar sun haɗa da rage watsawa tsakanin ma'aikata, kare mutanen da ke da babban haɗarin rikitarwa na rashin lafiyar lafiya, kiyaye ayyukan kasuwanci, da rage tasirin illa ga sauran ƙungiyoyi a cikin sarkar samar da su.
Matsayin cutar a cikin al'ummar da kasuwancin ke ciki yana shafar martani da ake ɗauka.
Tsarin tsarin kula da haɗari tsari ne da ake amfani dashi a cikin aminci da lafiyar aiki don rarraba kula da haɗari ta hanyar tasiri.
Inda ba za a iya kawar da haɗarin COVID-19 ba, ingantattun hanyoyin sarrafawa sune sarrafa injiniya, sannan sarrafa gudanarwa, kuma a ƙarshe kayan kariya na mutum.
Gudanar da injiniya ya haɗa da ware ma'aikata daga haɗarin da ke da alaƙa da aiki ba tare da dogaro da halayen ma'aikaci ba, kuma yana iya zama mafi kyawun mafita don aiwatarwa.
Kulawar gudanarwa canje-canje ne a cikin manufofin aiki ko hanyoyin da ke buƙatar aiki daga ma'aikaci ko mai aiki.
Kayan kariya na mutum (PPE) ana ɗaukarsa ƙasa da inganci fiye da injiniya da kulawar gudanarwa, amma na iya taimakawa hana wasu fallasa.
Dole ne a zaɓi kowane irin PPE bisa ga haɗarin da ke ga ma'aikaci, a saka shi yadda ya kamata kamar yadda ya dace (misali, na'urorin numfashi), a saka shi daidai kuma yadda ya kamata, a duba shi a kai a kai, a kula da shi, a maye gurbinsa, kamar yadda ya cancanta, kuma a cire shi yadda ya kamata, a tsabtace shi, a adana shi ko a zubar da shi don kauce wa gurɓata.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Aikin Amurka (OSHA), ƙananan ayyukan haɗarin haɗari suna da ƙananan hulɗa na aiki tare da jama'a da sauran abokan aiki.
Matakan rigakafin kamuwa da cuta da aka ba da shawarar ga dukkan wuraren aiki sun haɗa da wanke hannu sau da yawa da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ladabi na numfashi ciki har da rufe tari da tari, samar da kayan aiki da kwandon shara, shirya don yin aiki daga nesa ko sauyawa idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aiki na wasu, da kiyaye tsabtace yau da kullun da kuma kashe ƙwayoyin cuta na yanayin aiki.
Ganowa da kuma ware mutane masu cutar da wuri yana da muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi, da wasu a wurin aiki.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikata waɗanda ke da alamun cututtukan numfashi na gaggawa su zauna a gida har sai sun sami lafiya daga zazzabi, alamun zazzabi, da duk wasu alamun aƙalla awanni 24 ba tare da amfani da maganin rage zazzabi ko wasu magungunan da ke canza alamun ba, kuma cewa manufofin rashin lafiya suna da sassauci, sun ba ma'aikata damar zama a gida don kula da dangin da ke rashin lafiya, kuma cewa ma'aikata sun san waɗannan manufofin.
Dangane da OSHA, ayyukan haɗarin haɗari sun haɗa da waɗanda ke buƙatar haɗuwa akai-akai ko kusa da ƙafa shida (1.8 m) na mutanen da ba a san su ba ko waɗanda ake zargi da COVID-19, amma suna iya kamuwa da SARS-CoV-2 saboda ci gaba da watsawa a cikin al'umma a kusa da wurin kasuwanci, ko kuma saboda mutumin ya yi balaguron ƙasa da ƙasa kwanan nan zuwa wurin da yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikata waɗanda ke hulɗa da jama'a kamar a makarantu, yanayin aiki mai yawan jama'a, da wasu saitunan sayar da kaya masu yawa. Ingantaccen sarrafawa don wannan da rukunin haɗarin haɗari sun haɗa da shigar da matattarar iska mai inganci, haɓaka ƙimar iska, shigar da shinge na zahiri kamar masu kare filastik mai tsabta, da shigar da taga ta hanyar sabis na abokin ciniki. Kulawar gudanarwa don wannan da rukunin haɗarin haɗari sun haɗa da ƙarfafa ma'aikatan da ke da rashin lafiya su zauna a gida, maye gurbin tarurruka na ido da ido tare da sadarwa ta kama-da-wane, kafa sauye-sauye, dakatar da tafiye-tafiye marasa mahimmanci zuwa wuraren da ke ci gaba da barkewar COVID-19, haɓaka tsare-tsaren sadarwa ciki har da dandalin tattaunawa don amsawa ga ma'aikata, samar da ilimi na yau da kullun da horo kan abubuwan haɗarin COVID-19, ƙarancin haɗarin haɗari, waɗanda ƙila suna buƙatar yin amfani da tufafi masu kariya da kayan aiki, samar da haɗin haɗin kayan aikin tsabtace-rubuce, wanke takalma na hannu ko wasu matakan kariya na yau da kullun, da suka haɗa da sanya takunkumin rufe fuska da takunkumin rufe fuska, wanke abokan aiki a wuraren aiki, wanke takunkumin rufe fuska ko sanya takunkumin rufe fuska ko sanya takunkumin karewa.
Ma'aikata a cikin wannan rukunin haɗarin ba sa bukatar amfani da na'urar numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da raba mai cutar da wasu ta nisan ƙafa 6, sanya memba ɗaya na ma'aikatan don kula da mai cutar, da kuma ba da abin rufe fuska ga mai cutar ko kuma tambayar mai cutar ya rufe bakinsu da hanci da kayan shafa yayin tari ko tari.
Ma'aikatan jirgin sama su sanya safofin hannu na likita mai yuwuwa lokacin kula da matafiyi mara lafiya ko taɓa ruwan jiki ko saman da ke iya gurɓata, kuma wataƙila ƙarin kayan kariya na mutum idan matafiyin mara lafiya yana da zazzabi, tari mai ɗorewa, ko wahalar numfashi.
Ya kamata a zubar da safofin hannu da sauran abubuwan da za a iya zubar da su a cikin jaka mai haɗarin halittu, kuma ya kamata a tsabtace da kuma kashe ƙwayoyin cuta bayan haka. Don jigilar kasuwanci, gami da jiragen ruwa na tafiya da sauran jiragen fasinja, sarrafa haɗarin ya haɗa da jinkirta tafiya lokacin da yake rashin lafiya, da keɓe kansa da sanar da cibiyar kiwon lafiya ta jirgin nan da nan idan mutum ya sami zazzabi ko wasu alamun yayin da yake cikin jirgin.
A mafi kyau, ya kamata a yi bin diddigin likita a cikin ɗakin mutumin da aka ware. Don makarantu da wuraren kula da yara, CDC ta ba da shawarar rufe gajeren lokaci don tsabtace ko kashe ƙwayoyin cuta idan mutumin da ke da cutar ya kasance a cikin ginin makaranta ba tare da la'akari da yaduwar al'umma ba.
Lokacin da akwai ƙarancin yaduwar cutar a cikin al'umma, ana iya aiwatar da dabarun nisantar zamantakewa kamar soke tafiye-tafiye na filin, tarurruka, da sauran manyan tarurruka kamar ilimin motsa jiki ko azuzuwan mawaƙa ko abinci a cikin cafeteria, ƙara sarari tsakanin tebur, jinkirta lokutan isowa da sallama, iyakance baƙi marasa mahimmanci, da amfani da keɓaɓɓiyar wurin ofishin kiwon lafiya don yara masu alamun kama da mura.
Lokacin da akwai yaduwar yaduwar cutar a cikin al'ummar yankin, ban da dabarun nisantar zamantakewa, ana iya yin la'akari da tsawaita sallamar makaranta. Ga ma'aikatan tilasta bin doka da ke gudanar da ayyukan yau da kullun, CDC ta ɗauki haɗarin lafiyar nan take a matsayin ƙasa.
Ana ba da shawarar jami'an tilasta bin doka waɗanda dole ne su yi hulɗa da mutanen da aka tabbatar ko ake zargin suna da COVID-19 su bi ƙa'idodin da aka ba da umarnin likitocin gaggawa, gami da kayan kariya na sirri.
Idan kusanci ya faru yayin kamawa, ma'aikata su tsabtace da kuma kashe ƙwayoyin aiki da kayan aiki kafin sake amfani da su ta amfani da fesa ko goge tsabtace gida, kuma su bi ƙa'idodin aiki na yau da kullun don riƙewa da zubar da PPE da aka yi amfani da shi da kuma don riƙe da wanke tufafi.
OSHA ta yi la'akari da wasu ma'aikatan kiwon lafiya da na gawawwakin da ke da manyan ko manyan nau'ikan haɗarin haɗari.
Ayyukan haɗarin haɗari sun haɗa da bayar da kiwon lafiya, tallafi, dakin gwaje-gwaje, da ma'aikatan jigilar likita waɗanda aka fallasa su ga waɗanda aka sani ko ake zargi da COVID-19.
Waɗannan suna zama haɗarin haɗari sosai idan ma'aikata suka yi hanyoyin samar da aerosol a kan, ko tattara ko sarrafa samfuran daga, sanannun ko waɗanda ake zargi da COVID-19.
Hanyoyin samar da iska sun hada da intubation, hanyoyin haifar da tari, bronchoscopes, wasu hanyoyin hakori da bincike, ko kuma tarin samfurin.
Ayyukan jana'izar da ke da haɗarin haɗari sun haɗa da ma'aikatan da ke cikin shirya gawarwakin mutanen da suka san ko ake zargin sun kamu da COVID-19 a lokacin mutuwarsu; waɗannan suna zama masu haɗarin haɗari sosai idan sun yi autopsy. Ƙarin sarrafa injiniya don waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don marasa lafiya da aka sani ko ake zargin suna da COVID-19, gami da lokacin da ake aiwatar da hanyoyin samar da iska.
Musamman iska mai matsin lamba na iya zama mai dacewa a wasu wuraren kiwon lafiya da kuma wuraren jana'iza.
Ya kamata a sarrafa samfurori tare da matakan tsaro na matakin 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware marasa lafiya masu shigowa zuwa yankuna daban-daban na jira dangane da ko suna da zargin cewa suna da cutar COVID-19. Baya ga sauran PPE, OSHA ta ba da shawarar masu numfashi ga waɗanda ke aiki a cikin ƙafa 6 na marasa lafiya da aka sani, ko ake zargin suna da cutar SARS-CoV-2, da waɗanda ke aiwatar da hanyoyin samar da iska.
A Amurka, dole ne a yi amfani da masu numfashi na N95 masu tace fuska ko mafi kyau na NIOSH a cikin mahallin cikakken, rubutaccen shirin kare numfashi wanda ya haɗa da gwajin dacewa, horo, da kuma binciken likita.
Sauran nau'ikan na'urorin numfashi na iya samar da ƙarin kariya da inganta kwanciyar hankali ga ma'aikata. WHO ba ta ba da shawarar suturar rufewa ba, kamar yadda COVID-19 cuta ce ta numfashi maimakon a watsa ta ta ruwa na jiki.
WHO ta ba da shawarar sanya abin rufe fuska na tiyata kawai ga ma'aikatan binciken a wurin shiga.
Ga waɗanda ke tattara samfuran numfashi daga, kulawa, ko jigilar marasa lafiyar COVID-19 ba tare da kowane hanyoyin samar da iska ba, WHO ta ba da shawarar sanya abin rufe fuska, tabarau, ko garkuwa, rigar, da safofin hannu.
Idan an yi aikin samar da iska, ana maye gurbin abin rufe fuska na tiyata da na numfashi na N95 ko FFP2.
Ganin cewa samar da PPE a duniya bai isa ba, WHO ta ba da shawarar rage buƙatar PPE ta hanyar telemedicine, shingen jiki kamar su windows masu tsabta, ba da damar waɗanda ke cikin kulawa kai tsaye su shiga cikin ɗaki tare da mai haƙuri na COVID-19, ta amfani da PPE kawai da ake buƙata don takamaiman aiki, ci gaba da amfani da na'urar numfashi ɗaya ba tare da cire shi ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya, saka idanu da daidaita sarkar samar da PPE, da hana amfani da abin rufe fuska ga mutanen da ba su da alamun cutar.
DAGA: Katherine Maher, Shugaba na Gidauniyar Wikimedia
TO: Duk ma'aikatan Gidauniyar Wikimedia
TAMBAYA: [Covid-19] Yin sauƙin kaya da kuma shirya don nan gaba
Kwanan wata/Lokaci: 14 ga watan Maris, 2020, 00:24 UTC
CC0: Babu haƙƙoƙi
Mun tsinci kanmu cikin yanayi na ban mamaki wannan watan.
Cutar COVID-19 wani abu ne da ya bayyana alakarmu ta duniya da kuma nauyin da muke da shi ga juna.
Ba mu da misali game da ƙalubalen da take fuskanta, amma mun san cewa amsarmu mafi kyau ta dogara ne da irin tausayawa, hadin kai, da kuma gina al'umma da ke cikin zuciyar wannan kungiya.
Abokan hulɗa da kulawa da muka gani tsakanin dukkan abokan aikinmu ta hanyar imel, kira, da hira tabbaci ne na ban mamaki na mutane masu ban mamaki da muke da sa'ar yin aiki tare.
Ba zan iya zama mai godiya da alfahari ba na kirga ku duka a matsayin abokan aiki.
A makon da ya gabata, wani ya nuna mini yadda yake godiya don aikinmu.
Sun tunatar da ni yadda yake da muhimmanci ga duniya ta iya juya zuwa Wikipedia a yanzu, da kuma yadda alama ce mai karfi don wannan muhimmin albarkatun ya kasance a kan layi kuma yana samuwa ga kowa.
Aikinku ne ya sa hakan ya yiwu, ko kun kiyaye shafukan yanar gizo ko kuma abokan aikinmu suna biya ko kuma al'ummominmu suna lafiya.
Duniya na bukatar bayanin da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Wannan lokaci ne da ba wai kawai abin da muke yi ba, amma yadda muke yi, zai yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aikin da kuma rawar da kuke takawa a ciki, za mu yi wasu gyare-gyare masu muhimmanci ga yadda muke aiki tare, daga wannan makon mai zuwa.
Gyara aikinmu da kuma tsarinmu
Kamar yadda Robyn ta ambata a baya, ƙungiyar C ta haɗu a daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi la'akari da abin da muka yi tunanin zai zama amsa mai dacewa ga abin da muke fuskanta da kuma hanya mafi kyau don kiyaye ƙungiyar mai dorewa a wannan lokacin.
Mafi yawanmu muna son kawar da damuwa da tallafawa aikinmu na dogon lokaci.
Idan kana bukatar sake kira, to babu matsala.
Ga dukan ma'aikata, 'yan kwangila, da ma'aikatan kwangila:
Za mu yi aiki na awa 4 a rana, ko kuma awa 20 a mako har sai an sake sanar da mu.
Ba mu ke ayyana hutu ba - idan za ka iya yin aiki a karin lokutan al'ada, ofishin zai iya amfani da kai.
Duk da haka, duniya ba ta da tabbas a yanzu, kuma ko kana bukatar ka kula da ƙaunatattunka, ka sayi kayan masarufi, ko kuma ka je wurin likita, lafiyarka ce fifiko a gare mu.
Ba ma bin sawun lokacinku.
Idan kana rashin lafiya, kada ka yi aiki.
Ya kamata a ce ba a ce ba, amma muna cewa.
Babu ranakun rashin lafiya ko PTO da ake buƙata - kawai gaya wa manajan ku kuma taimaka wa ƙungiyar ku sake duba kalandarku da jadawalin don tabbatar da cewa an rufe mahimman wuraren aiki.
(Idan an gano cewa kana da cutar COVID-19, don Allah ka sanar da Bryan a cikin T&amp;C Ops don T&amp;C ta iya taimakawa tare da tallafi kuma ka tabbata cewa halin da kake ciki ya sami kulawa mai dacewa daga gudanarwa).
Za a biya ma'aikatan sa'a cikakken albashi.
Mun riga mun ce, kuma muna sake yin alƙawarin mu cika alkawuranmu ga masu kwangila da abokan aikinmu na sa'a.
Kowa za a biya shi bisa ga yawan sa'o'in da ya yi aiki a lokacin al'ada.
Wannan ya haɗa da idan ba ka da lafiya kuma ba za ka iya yin aiki ba.
Idan kana son aiki, za mu tallafa maka.
Mutane da yawa suna amfani da aiki a matsayin hanyar da za su iya kawar da damuwarsu da duniya da ke kewaye da mu.
Abin da muke yi zai iya zama da amfani sosai, musamman a irin wannan lokacin.
Har ila yau, wannan game da kulawarka ce.
Abin da muke nema shi ne ku yi magana da manajanku, don mu san abin da za mu yi tsammani kuma mu daidaita daidai da hakan.
Ana ɗaukan wasu ayyuka da muhimmanci.
Akwai wasu abubuwa da dole ne mu ci gaba da yi.
SRE, HR Ops, Trust &amp; Safety, da kuma ƙungiyoyin tara kuɗi (a tsakanin wasu) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin tallafi.
Za mu fara wani tsari tare da dukkan sassan don tantance manufofin yanzu da kuma sauya hankalinmu ga tallafawa abin da ke da mahimmanci ga aikinmu.
Akwai abubuwa da yawa da za a yi wa dukanmu, za mu mai da hankali ne kawai ga ayyukan da suka fi muhimmanci.
Sakin jiki yanzu ba zai cutar da ku ba daga baya.
Ba mu da niyyar yin "sau biyu" don kamawa da zarar annobar ta wuce.
Ba za a sa ran cewa za ka yi aiki na sa'o'i da yawa don ka cika kwanakin da ba za ka iya cikawa ba.
Mun yarda cewa yanayi ya canza, kuma za mu yi aiki don kafa sabbin manufofi da jadawalin lokaci idan ya dace.
Menene ya faru da APP (Tsarin Shekara)?
Don daidaitawa da sabon gaskiyarmu da tsammanin sa'o'in aiki na yau da kullun, muna da niyyar daidaita jadawalin isar da shirinmu na shekara-shekara na 2020-2021.
Manufarmu ita ce ta ba da shawarar tsawaita shirinmu na 2019-2020 wanda ke ba da ƙarin lokaci don kasafin kuɗi don ba da damar ma'aikata su ba da fifiko ga aiki mai mahimmanci, kulawa da kai, da kula da ƙaunatattun su yayin da suke biyan waɗanda ke buƙatar ko son yin aiki a cikin ɗan lokaci a cikin makonni masu zuwa.
Wannan tsawaita lokaci yana rage yawan aikin tsarawa da matsin lamba a cikin dukan ƙungiyar.
Za mu gabatar da shawararmu ga Hukumar mako mai zuwa kuma za mu sanar da wakilai da ƙungiyoyi game da matakai na gaba da zarar mun sami tabbaci.
Na gode wa tawagar APP don jagorancinku a cikin wannan.
Matsayi na ofishi, fallasa, da tsaftacewa
A makon da ya gabata, mun samu labarin cewa ɗaya daga cikin abokan aikinmu da ke SF na iya kasancewa cikin kamuwa da cutar COVID-19.
Amma, saboda mu mai da hankali, mun yi amfani da masu tsabtace abubuwa da ke hana ƙwayoyin cuta su yi amfani da su wajen kashe ƙwayoyin cuta a ofishinmu da ke San Francisco.
Sun yi amfani da maganin rigakafin cutar da ake amfani da shi a asibiti don kashe cutar a kowane farfajiya, da kuma cikin harabar da kuma wurin hawa mai hawa da ke shiga bene.
Ginin yana amfani da nasa tsarin kula da kayan aiki wanda ke tallafawa amincin masu haya.
Muna jin daɗin cewa za a shirya ofishin sosai sa'ad da muka yanke shawarar komawa.
Ofishinmu na DC yana cikin WeWork, wanda ya raba yarjejeniyar COVID-19 tare da mu da duk ma'aikatan DC.
Tun makon da ya gabata, ofishinmu na DC ya koma wani wuri mai nisa daidai da jagorar da aka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu na birnin New York suka sani, mun kuma tattauna batun hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawar amma za a iya jinkirta.
Wasu daga cikin abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu na dogon lokaci sun san cewa zai iya zama daidaitawa, kuma suna so su ba ku wasu shawarwari:
Ka rage tsawon taron zuwa awa ɗaya ko biyu.
Idan ana bukatar ƙarin lokaci, ka yi la'akari da yadda za a iya raba su a cikin kwanaki da yawa.
Ka bayyana tarurruka sarai, ka tsara tsarin ayyuka, kuma ka aika da littattafan karatu tun da wuri.
Ka sanya bidiyo a matsayin abin da aka saba amfani da shi, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Ka sami wanda zai jagoranci kowane taro, wani ya lura da hira don tambayoyi da kuma bin jerin masu magana, da kuma wani don taimakawa wajen yin bayanin kula (ko yin haɗin kai).
Aika imel zuwa goyon bayan fasaha idan kana bukatar mai dadi headset.
Ka yi amfani da kuɗin da aka biya maka don abinci.
Shiga tashar #remoties a cikin Slack don tattaunawa da abokan aikinka game da rarraba aiki
Ƙungiyar Ayyukan HR tana neman jagorar ergonomics na yanar gizo don tallafawa karuwar aikin rarraba a duk faɗin Gidauniyar.
A makon da ya gabata mun nemi duk masu karɓar tallafin al'umma su soke abubuwan da Wikimedia ke tallafawa, kamar su edithons, har sai WHO ta ayyana annobar ta ƙare.
Mun sanar da su cewa mun fahimci cewa bukatarmu ta sokewa da sauran takunkumi na iya sa ba zai yiwu a kammala ayyukan tallafin da aka amince da su ba kuma ba za a hukunta kowa ba saboda jinkirta ko gyara waɗannan manufofin.
A wannan makon za mu ci gaba da ba da ƙarin jagora game da Wikimania da sauran taron yanki da na al'umma.
Jin daɗin da ke kewaye da al'ummar duniya ya zama kamar duka baƙin ciki ne saboda rushewar amma kuma jin daɗin kasancewa da haske da kuma iyawar mayar da hankali kan al'ummomin su, Wikimedia da sauransu.
A gaba, CRT tana aiki don kafa shafi a kan Meta-Wiki don samar da sarari ga al'umma don lura da tasirin da kuma bin hanyoyin sadarwa tare da su.
Kasancewa cikin hulɗa game da batutuwan da suka shafi COVID-19
Za mu tura muku gayyata zuwa kalandarku na ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokaci don raba ƙarin sabuntawa, amsa tambayoyinku kuma ku ciyar da ɗan lokaci tare da juna.
Muna cikin wannan tare kuma muna nan don taimakawa duk yadda za mu iya.
A halin yanzu, za ka iya ci gaba da samun bayanai daga wannan imel ɗin, da duk wasu muhimman bayanai da suka shafi COVID-19, a kan Office Wiki.
CRT za ta ci gaba da sabunta waɗannan shafuka da kuma duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa na yau da kullun tare da ma'aikatan da ke zaune a ƙasashen da abin ya shafa a halin yanzu.
Idan kana da wasu tambayoyi game da tafiye-tafiye, abubuwan da suka faru, babban aiki, ko ƙalubalen ɗaukar hoto, ko wani abu da za ka iya buƙatar taimako, don Allah kada ka yi jinkirin sanar da kuma aiki tare da CRT.
Muna nan don taimakawa wajen samar da tallafi da kuma sadarwa kamar yadda ake bukata.
Idan kana da wani abu na sirri ko mai mahimmanci, don Allah aika imel zuwa Bryan Judan - Daraktan HR International Global Operations.
Bai kamata a ɗauki waɗannan canje-canjen a matsayin watsi da aikinmu da kuma hakkokinmu ba.
Maimakon haka, sun nuna cewa a yanzu, aikinmu da kuma hakkokinmu suna bukatar su daidaita a hanyar da ba mu taɓa yi ba a dā.
Waɗannan su ne matakan da muke ganin wajibi ne don tallafa wa juna domin mu ci gaba da aiki, samar wa motsinmu goyon bayan da suke bukata, da kuma duniya da sabis ɗin da suke dogara da shi.
Aikin da muka shirya zai kasance a wurin yana jiranmu sa'ad da lokaci ya yi.
A yanzu, lokaci ya yi da za mu tallafa wa juna kuma mu samar da sarari don muhimmin aiki da zai zo cikin makonni da watakila watanni masu zuwa.
Muna bukatar ku duka don yin hakan, kuma don haka muna bukatar ku duka ku kula da kanku da iyalanku don ku kasance cikin mafi kyawunku lokacin da buƙata ta taso.
Yanzu, don Allah... ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
b' Angiotensin-converting enzyme 2 (ACE2) wani enzyme ne da ke haɗe da waje (cell membranes) na ƙwayoyin cikin huhu, jijiyoyi, zuciya, koda, da hanji.
ACE2 yana magance aikin enzyme mai canza angiotensin (ACE) ta hanyar rage adadin angiotensin-II da haɓaka Ang (((1-7) yana mai da shi kyakkyawan maƙasudin magani don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin hanyar shiga cikin ƙwayoyin wasu ƙwayoyin cuta.
Siffar ɗan adam na enzyme galibi ana kiranta da hACE2.
Angiotensin-converting enzyme 2 wani zinc ne mai dauke da metalloenzyme da ke kan farfajiyar endothelial da sauran kwayoyin.
Kwayar ACE2 tana dauke da yankin N-terminal peptidase M2 da kuma yankin C-terminal collectrin na jigilar amino acid na koda.
ACE2 shine furotin mai wucewa guda ɗaya na nau'in I, tare da yankin da ke aiki da enzymatically wanda aka fallasa a farfajiyar ƙwayoyin a cikin huhu da sauran ƙwayoyin.
Ana raba yankin waje da kwayar halitta na ACE2 daga yankin transmembrane ta wani enzyme da aka sani da sheddase, kuma ana sakin furotin mai narkewa a cikin jini kuma a ƙarshe a fitar da shi cikin fitsari.
ACE2 yana nan a yawancin gabobin jiki: ACE2 yana haɗe da membrane na tantanin halitta na ƙwayoyin alveolar na nau'in huhu na II, enterocytes na ƙananan hanji, ƙwayoyin endothelial na jijiya da na jijiya da ƙwayoyin tsoka mai santsi na jijiya a yawancin gabobin jiki.
Hakanan ana samun bayyanar ACE2 mRNA a cikin kwakwalwar kwakwalwa, striatum, hypothalamus, da ƙwaƙwalwar kwakwalwa.
Babban aikin ACE2 shine yin aiki azaman ma'auni ga ACE.
ACE yana rarraba hormone na angiotensin I zuwa angiotensin II mai saurin saurin.
ACE2 a bayansa yana raba carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolyses shi cikin angiotensin mai fadada jijiya (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma na iya rarraba wasu peptides da yawa ciki har da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana daidaita safarar membrane na mai jigilar amino acid mai tsaka tsaki SLC6A19 kuma an haɗa shi da cutar Hartnup.
A matsayin furotin mai wucewa, ACE2 yana aiki a matsayin babban hanyar shiga cikin ƙwayoyin cuta don wasu ƙwayoyin cuta, gami da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, haɗuwa da furotin S1 na SARS-CoV da SARS-CoV2 zuwa yankin enzymatic na ACE2 a saman ƙwayoyin yana haifar da endocytosis da sauyawar cutar da enzyme a cikin endosomes da ke cikin ƙwayoyin.
Wannan tsarin shigarwa kuma yana buƙatar ƙaddamar da furotin S ta mai masaukin baki serine protease TMPRSS2, wanda hanawa a halin yanzu yana ƙarƙashin bincike azaman mai yuwuwar magani. Wannan ya haifar da wasu suyi tunanin cewa rage matakan ACE2, a cikin ƙwayoyin, na iya taimakawa wajen yaƙar kamuwa da cuta.
Koyaya, ƙungiyoyi da yawa na ƙwararru da hukumomin kulawa sun ba da shawarar ci gaba da maganin ACE mai hanawa da ARB.
"Binciken da aka yi a hankali da kuma nazarin meta da aka buga a ranar 11 ga Yuli, 2012, ya gano cewa ""amfani da masu hana ACE yana da alaƙa da raguwar 34% na haɗarin ciwon huhu idan aka kwatanta da masu kula. """
"Bugu da ƙari, ""haɗarin ciwon huhu ya ragu a cikin marasa lafiya da aka bi da su tare da masu hana ACE waɗanda ke da haɗarin ciwon huhu, musamman waɗanda ke da bugun jini da rashin ƙarfi na zuciya. "
"Amfani da masu hana ACE kuma an haɗa shi da raguwar mutuwar da ke da alaƙa da ciwon huhu, kodayake sakamakon bai da ƙarfi kamar na haɗarin ciwon huhu gaba ɗaya. """
Ana tsammanin ACE2 na mutum mai haɗuwa (rhACE2) shine sabon magani don raunin huhu mai tsanani, kuma ya bayyana don inganta hawan jini na huhu da ƙoshin oxygen a cikin aladu tare da lipopolysaccharide-induced acute respiratory distress syndrome.
Rabin rayuwar rhACE2 a cikin mutane kusan awanni 10 ne kuma farkon aiki mintuna 30 ne ban da tsawon lokacin aiki (tsawon) awanni 24.
Abubuwa da yawa sun nuna cewa rhACE2 na iya zama magani mai kyau ga waɗanda ke da rashin haƙuri ga masu hana tsarin renin-angiotensin na gargajiya (RAS inhibitors) ko kuma a cikin cututtuka inda ake yawan zagayawar angiotensin II. An kimanta rhACE2 da aka saka a cikin gwaji na asibiti don maganin cututtukan cututtukan numfashi.
"b'COVID-19 apps aikace-aikacen software ne na wayar hannu da aka tsara don taimakawa bin diddigin tuntuɓar amsawa ga annobar cutar coronavirus ta 2019-20, watau tsarin gano mutane (""saduwa"") waɗanda wataƙila sun kasance tare da mutum mai kamuwa da cutar. "
An samar da aikace-aikace da yawa ko kuma an gabatar da su, tare da goyon bayan gwamnati a wasu yankuna da kuma hukunce-hukuncen.
An kirkiro tsarin da dama don gina aikace-aikacen bin diddigin lamba.
An yi ta damuwa da tsare sirri, musamman game da tsarin da ke kan bin diddigin wurin da masu amfani da manhajar suke.
Sauran hanyoyin da ba su da matsala sun hada da amfani da siginar Bluetooth don yin rikodin kusanci da mai amfani da wasu wayoyin salula.
A ranar 10 ga Afrilu 2020, Google da Apple sun sanar tare cewa za su haɗa aikin don tallafawa irin waɗannan aikace-aikacen da ke kan Bluetooth kai tsaye a cikin tsarin aikin su na Android da iOS.
A China, gwamnatin kasar Sin, tare da Alipay, ta tura wani manhajar da ke baiwa 'yan ƙasa damar duba ko sun yi hulɗa da mutanen da ke da COVID-19.
Ana amfani da shi a cikin birane fiye da 200 na kasar Sin. A Singapore, ana amfani da wani app da ake kira TraceTogether.
"Kungiyar IT ta yankin ce ta samar da manhajar, an sake ta a matsayin mai budewa kuma za a mika ta ga gwamnati. Arewacin Macedonia ta kaddamar da ""StopKorona!"", wani manhajar da ke kan Bluetooth don bin diddigin kamuwa da mutane da ke da cutar da kuma samar da saurin amsawa ga hukumomin kiwon lafiya".
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka haɓaka app ɗin.
Ya zuwa ranar 14 ga Afrilu 2020, aikace-aikacen yana jiran amincewa daga Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen bin diddigin tuntuɓar yana cikin wani ci gaba na ci gaba, kuma zai kasance a shirye don turawa cikin makonni. Ana shirin yin irin wannan aikace-aikacen a Ireland, da Faransa ("StopCovid"")".
Dukansu Ostiraliya da New Zealand suna la'akari da aikace-aikacen da suka dogara da aikace-aikacen TraceTogether na Singapore da kuma yarjejeniyar BlueTrace. Rasha na da niyyar gabatar da aikace-aikacen geofencing ga marasa lafiya da aka gano suna da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba sa barin gida.
Ross Anderson, farfesa na injiniyan tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli masu yuwuwa na tsarin da ke kan aikace-aikace, gami da faɗar ƙarya da kuma yiwuwar rashin tasiri idan amfani da aikace-aikacen ya iyakance ga ƙananan ɓangaren jama'a.
"Don magance damuwa game da yaduwar aikace-aikacen "coronavirus" masu yaudara ko cutarwa, Apple ya sanya iyakoki kan irin kungiyoyin da zasu iya ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store, yana iyakance su kawai ga " hukuma " ko kuma kungiyoyi masu daraja. "
Google da Amazon sun aiwatar da irin wannan takunkumi.
Masu fafutukar kare sirrin sun bayyana damuwarsu game da tasirin sa ido da yawa ta amfani da aikace-aikacen coronavirus, musamman game da ko za a rushe kayan aikin sa ido da aka kirkira don magance annobar coronavirus da zarar barazanar ta wuce.
Kungiyar Amnesty International da kuma wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira ga a takaita irin wannan sa ido.
Kungiyoyin sun bayyana sharudda takwas kan ayyukan gwamnati:
"dubawa dole ne ya zama ""doka, dole da kuma daidaita"";
tsawaita sa ido da sa ido dole ne su sami sharuddan ƙarshen rana;
amfani da bayanai dole ne a iyakance ga dalilai na COVID-19;
Tsaron bayanai da rashin saninsu dole ne a kiyaye su kuma a nuna cewa an kiyaye su bisa hujjoji;
sa ido na dijital dole ne ya guji kara nuna bambanci da kuma warewa;
duk wani musayar bayanai da wasu kamfanoni dole ne a ayyana shi a cikin doka;
dole ne a sami kariya daga cin zarafi da kuma hakkin 'yan ƙasa su amsa ga cin zarafi;
"za a buƙaci sa hannu mai ma'ana daga dukkan "'yan takara masu dacewa", ciki har da na masana kiwon lafiyar jama'a da kungiyoyin da aka yi watsi da su. Ƙungiyar Kwamfuta ta Jamus ta Chaos (CCC) da kuma 'Yan Jarida Ba tare da Iyakoki (Reporter ohne Grenzen) (RSF) sun kuma fitar da jerin abubuwan dubawa. "
Shirin da aka gabatar na Google/Apple yana da niyyar magance matsalar sa ido ta dindindin ta hanyar cire tsarin bin diddigin daga tsarin aiki na na'urorin su da zarar ba a sake buƙatarsa ba.
Wasu ƙasashe sun yi amfani da bin diddigin wurin da ke kan hanyar sadarwa maimakon aikace-aikace, suna kawar da buƙatar saukar da aikace-aikace da kuma ikon guje wa bin diddigin.
A Isra'ila, an amince da bin hanyar sadarwa.
Maganin tushen hanyar sadarwa wanda ke da damar zuwa bayanan wurin da ba a gano ba yana da mahimman matsalolin tsare sirri.
Koyaya, ba duk tsarin da ke da sabobin tsakiya ke buƙatar samun damar bayanan wurin mutum ba; an ƙirƙiri wasu tsarin kiyaye sirrin da ke amfani da sabobin tsakiya kawai don sadarwa (duba sashe a ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba na aikace-aikace ba don yin bin diddigin lambobin sadarwa.
Maimakon amfani da aikace-aikacen da aka keɓe, tsarin ya tattara bayanan bin diddigin daga tushe daban-daban ciki har da bayanan bin diddigin na'urar hannu da bayanan ma'amalar katin, kuma ya haɗa waɗannan don samar da sanarwa ta hanyar saƙonnin rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da abokan hulɗa, gwamnati ta kuma ba da bayanin wurin da ke cikin jama'a, wani abu da aka yarda saboda canje-canje masu yawa ga dokokin tsare sirri na bayanai bayan barkewar cutar MERS a wannan ƙasar.
Wannan bayanin yana samuwa ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo da yawa. Kasashe ciki har da Jamus sun yi la'akari da amfani da tsarin tsakiya da kuma tsare sirri.
A ranar 6 ga Afrilu 2020, ba a riga an fitar da cikakkun bayanai ba.
Kulawa da bayanan sirri shine ingantaccen ra'ayi, tare da babban kundin wallafe-wallafen bincike wanda ya koma aƙalla 2013.Zuwa 7 ga Afrilu 2020, sama da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun
Duk da haka, PEPP-PT wani aiki ne na daidaitawa wanda ya ƙunshi hanyoyin da aka maida hankali da kuma rarraba, kuma ba yarjejeniya ɗaya ba ce. Yarjejeniyar rarraba sun haɗa da Rarraba Tsaro na Tsaro na Tsaro (DP-PPT/DP-3T), Lambobin Saduwa na Wucin gadi (TCN, lambobin taron tuntuɓar tuntuɓar, CEN), Yarjejeniyar Tsaro na Tsaro da Tsarin Kula da Saduwa ta Wucin Gizo (PACT) da sauransu.
A cikin waɗannan ladabi, bayanan sirri na mutum ba sa barin na'urar, kuma duk daidaituwa yana faruwa a kan na'urar.
Kungiyar Sirri a MIT Media Lab tana haɓaka SafePaths, dandamali don amfani da fasahohin kiyaye sirri yayin tattarawa da amfani da bayanan wuri ko hanyar haɗuwa don bin hanyar yaduwar COVID-19.
"Ya dogara ne da bincike daga farar takarda ""Aikace-aikacen da suka tafi Rogue: Kula da Sirrin Mutum a cikin annoba"" da aka fitar a watan Maris na 2020. Wani irin wannan yunƙurin shine dandalin SafeTrace na Enigma MPC, wani kamfani da ke haɓaka fasahohin tsare sirri wanda kuma aka kafa shi a MIT Media Lab. "
SafeTrace yana amfani da fasahohin kayan aiki masu aminci don ba masu amfani damar raba bayanan wuri mai mahimmanci da bayanan lafiya tare da sauran masu amfani da jami'ai, ba tare da yin sulhu da sirrin waɗannan bayanan ba.
A ranar 5 ga Afrilu 2020, an kafa TCN Coalition na duniya ta ƙungiyoyi waɗanda suka haɗu a kusa da abin da yake ainihin hanya ɗaya da kuma manyan ladabi masu haɗuwa, tare da burin rage rarrabuwa, da ba da damar aiki tare na duniya na bin diddigin da faɗakarwa, babban mahimmin al'amari na cimma karɓar yaduwar.
A ranar 9 ga Afrilu 2020, gwamnatin Singapore ta sanar da cewa ta bude tushen yarjejeniyar BlueTrace da aka yi amfani da ita ta aikace-aikacen gwamnatin ta.
A ranar 10 ga Afrilu 2020, Google da Apple, kamfanonin da ke kula da dandamali na wayar hannu na Android da iOS, sun ba da sanarwar wani shiri don bin diddigin lamba, wanda suka yi iƙirarin zai kiyaye sirrin, bisa haɗin fasahar Bluetooth Low Energy da kuma ɓoye sirrin sirri.
Sun kuma buga takamaiman fasahohin da ake amfani da su a cikin tsarin.
A cewar Apple da Google, an yi niyyar a fitar da tsarin ne a matakai uku:
ƙaddamar da kayan aiki don bawa gwamnatoci damar ƙirƙirar aikace-aikacen bin diddigin cutar coronavirus na sirri
hade wannan aikin kai tsaye a cikin iOS da AndroidGoogle da Apple suna shirin magance matsalar karbuwa da matsalolin sa ido na dindindin ta hanyar rarraba tsarin da farko ta hanyar sabunta tsarin aiki, kuma daga baya cire shi ta wannan hanyar da zarar barazanar ta wuce.
b' Sake sanya magani (wanda kuma ake kira sake amfani da magani, sake fasalin, sake aiki ko sauyawar magani) shine sake amfani da magani da aka amince dashi don maganin wata cuta ko yanayin kiwon lafiya daban da wanda aka fara kirkirar sa.
Wannan wani layi ne na bincike na kimiyya wanda a halin yanzu ake bi don haɓaka ingantaccen magani na COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka allurar rigakafin COVID-19 da kuma canja jini na plasma. SARS-CoV-2 yana da kimanin sunadarai 66 da za a iya shan magani, kowannensu yana da wurare masu ɗaure ligand da yawa.
Yin nazarin waɗancan wuraren da ke ɗaurewa suna ba da kyakkyawan tsari na haɓaka ingantaccen maganin rigakafin kwayar cutar COVID-19.
Daga cikin mahimman sunadarai na SARS-CoV-2 sune papain-like protease, RNA mai dogara da RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein A, et al sun yi nazarin wasu mahaɗan da suka yi takara wanda daga baya suka inganta da kuma bincika kamaninsu na kasusuwa tare da magungunan da aka amince da su mafi girma don hanzarta haɓaka magungunan anti-SARS-CoV-2 mai ƙarfi a cikin binciken sa na farko don a ba da shawarar a cikin ƙirar binciken asibiti.
Chloroquine magani ne na cutar zazzabin cizon sauro wanda kuma ake amfani da shi wajen magance wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine da ke da alaƙa za su kasance cikin magungunan guda huɗu da aka yi nazari a matsayin wani ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York na chloroquine da hydroxychloroquine zai fara ne a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a karkashin Izini na Amfani da Gaggawa (EUA).
Ba a amince da maganin ba ta hanyar gwajin asibiti na FDA kuma an ba da izini a ƙarƙashin EUA kawai azaman gwaji na gaggawa don amfani a cikin marasa lafiya waɗanda aka kwantar amma ba za su iya karɓar magani a gwajin asibiti ba.
"CDC ta ce "ba a tabbatar da amfani, kashi, ko tsawon lokacin hydroxychloroquine don rigakafi ko maganin kamuwa da cutar SARS-CoV-2 ba".
"Likitoci sun ce suna amfani da miyagun ƙwayoyi lokacin da "babu wani zaɓi".
Wata ƙungiyar bincike ta Turkiya a Istanbul tana gudanar da karamin bincike kan amfani da chloroquine a hade tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da manyan bincike a Jami'ar Duke da Jami'ar Oxford.
Makarantar Likita ta NYU Langone tana gudanar da gwaji kan aminci da ingancin amfani da hydroxychloroquine.
"Gwajin asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin nuna favipiravir ya kasance ""a bayyane yake tasiri".
35 marasa lafiya a Shenzhen sun gwada mummunan sakamako a matsakaici na kwanaki 4, yayin da tsawon cutar ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba su karɓi shi ba.
A cikin wani bincike da aka gudanar a Wuhan akan marasa lafiya 240 da ke fama da ciwon huhu, rabi sun sami favipiravir kuma rabi sun sami umifenovir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa hujjojin da ke akwai na goyon bayan maganin ba su da yawa kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don ajiyar ta, kuma ta yi amfani da sojoji don isar da maganin zuwa asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiyar COVID-19.
A cewar South China Morning Post, Shinzo Abe ya yi wa gwamnatin Trump shawarwari game da siyan maganin. Magungunan na iya zama mai rauni a cikin mawuyacin yanayin rashin lafiya inda cutar ta riga ta ninka.
Mata masu juna biyu ko waɗanda suke ƙoƙarin yin ciki ba za su iya amfani da shi ba.
"Daya daga cikin binciken lopinavir/ritonavir (Kaletra), hadewar maganin rigakafin cutar lopinavir da ritonavir, ya kammala cewa ""ba a ga wata fa'ida ba".
An tsara magungunan ne domin hana kwayar cutar HIV yin kwayar halittar ta hanyar ɗaure ta da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara magungunan don nemo mahaɗin da zai ɗaure da protease na SARS-CoV-2. Akwai sukar a cikin ƙungiyar kimiyya game da tura albarkatu don sake amfani da magungunan da aka haɓaka musamman don cutar HIV / AIDS.
WHO ta haɗa lopinavir/ ritonavir cikin gwajin Solidarity na duniya.
Gilead Sciences ce ta kirkiro Remdesivir kuma ta bunkasa shi a matsayin magani ga cutar Ebola da kuma kamuwa da cutar Marburg . Gilead Sciences daga baya ta gano cewa Remdesivir yana da aikin rigakafin kwayar cuta a cikin vitro akan filao , pneumono , paramyxo , da corona-viruses da yawa .
Wata matsala da maganin rigakafin cutar ita ce ci gaban juriya ta hanyar sauye - sauye da ke iya haifar da mummunar cuta da watsawa.
Wasu binciken farko na gwaji sun nuna cewa remdesivir na iya samun babban shingen kwayoyin halitta ga juriya. Akwai gwaji da yawa na asibiti da ke gudana, gami da biyu da Asibitocin Jami'ar Cleveland suka gudanar; daya ga mutanen da ke da matsakaiciyar cuta da kuma wani ga waɗanda ke da cuta mai tsanani.
Akwai gwaji uku na asibiti na bitamin C na jijiya ga mutanen da ke asibiti kuma suna da mummunan rashin lafiya tare da COVID-19; biyu da ke sarrafa placebo (China, Kanada) da ɗaya ba tare da sarrafawa ba (Italiya).
Jihar New York ta fara gwaji don maganin rigakafi azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM) tana shirin yin gwaji na asibiti don Teijin's Alvesco (ciclesonide), corticosteroid na numfashi don asma, don maganin marasa lafiya masu alamun cutar da suka kamu da cutar coronavirus.
Wani nau'i na enzyme mai canza angiotensin 2, gwajin Phase II yana gudana tare da marasa lafiya 200 da za a karba daga mawuyacin hali, waɗanda aka kwantar a asibiti a Denmark, Jamus, da Austria don sanin tasirin maganin.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar da colchicine ke takawa wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
Binciken, wanda ake kira COLCORONA, yana daukar manya 6000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 kuma suna fuskantar ƙananan alamun da ba sa buƙatar asibiti.
Mata masu juna biyu ko masu shayarwa ko kuma waɗanda ba su da ingantacciyar hanyar hana haihuwa ba su cancanci.
Ana gwada magungunan hana kumburi da yawa a Italiya.
Ana amfani da heparin mai ƙananan ƙwayar cuta sosai wajen kula da marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta wallafa jagororin amfani da shi.
An sanar da binciken cibiyoyi da yawa akan marasa lafiya 300 da ke binciken amfani da enoxaparin sodium a cikin rigakafi da magungunan magani a Italiya a ranar 14 ga Afrilu.
Tunda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai kan ilimin kimiyya kan sake amfani da magungunan rigakafin kwayar cuta da aka amince da su waɗanda aka haɓaka don ɓarkewar da ta gabata kamar su MERS, SARS, da kwayar West Nile.
Ribavirin: an bada shawarar ribavirin don maganin COVID-19 bisa ga jagororin fitowar 7 na kasar Sin
Umifenovir: an bada shawarar umifenovir don maganin COVID-19 bisa ga jagororin fitowar 7 na kasar Sin
Wasu maganin rigakafi da aka gano cewa za a iya sake amfani da su a matsayin maganin COVID-19:
Tocilizumab (mai karɓar anti-IL-6): An amince da shi daga China.
Har ila yau gwaje-gwaje a Italiya da China. kuma duba Tocilizumab#COVID-19.
b'A COVID-19 allurar rigakafi ne na zato kan cutar coronavirus 2019 (COVID-19).
Kodayake babu wani allurar rigakafin da ya kammala gwajin asibiti, akwai ƙoƙari da yawa a ci gaba don haɓaka irin wannan allurar.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin allurar rigakafin cutar SARS-CoV-2, kwayar cutar da ke haifar da cutar, za ta kasance cikin ƙasa da watanni 18.
An yi gwajin lafiya na Phase I kan alluran rigakafi biyar a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Wani babban fashewa ya bazu a duniya a shekarar 2020, wanda ya haifar da saka hannun jari da ayyukan bincike masu yawa don haɓaka allurar rigakafi.
Kungiyoyi da yawa suna amfani da kwayoyin halitta da aka buga don haɓaka yiwuwar allurar rigakafin SARS-CoV-2.
An bayyana a watan Afrilu, abubuwan da ake buƙata na shirin CEPI don haɓaka allurar rigakafi sune saurin, ƙarfin masana'antu, turawa a sikelin, da samun damar duniya.
A watan Afrilu, masana kimiyyar CEPI sun ruwaito cewa ana gudanar da bincike da ci gaban dandamali daban-daban guda 10 a farkon shekarar 2020 don ƙirƙirar ingantaccen allurar rigakafin COVID-19.
Manyan manufofin dandamali da aka ci gaba a cikin nazarin aminci na Phase I sun haɗa da:
nucleic acid (DNA da RNA) (Mai haɓaka Phase I da mai neman allurar rigakafi: Moderna, mRNA-1273)
mai ɗaukar hoto (mai haɓaka Phase I da mai neman allurar rigakafi: CanSino Biologics, mai ɗaukar hoto na adenovirus nau'in 5)
Kamar yadda masana kimiyyar CEPI suka ruwaito a watan Afrilu, jimillar masu neman allurar rigakafi 115 suna cikin farkon matakan ci gaba, tare da 78 da aka tabbatar a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), kuma an sanar da wasu 37, amma tare da karancin bayanan jama'a (wanda ake zaton ana shirinsa ko kuma ana tsara shi).
Gwajin Mataki na I-II yana gudanar da gwajin farko na aminci da rigakafi, yawanci ana yin sa ne, ana sarrafa placebo, kuma a wurare da yawa, yayin ƙayyade mafi daidaito, ingantattun allurai.
Gwaje-gwajen Phase III yawanci suna haɗuwa da mahalarta da yawa, gami da rukunin kulawa, da kuma gwada tasirin allurar rigakafin don hana cutar, yayin lura da tasirin cutar a mafi kyawun kashi.
"Daga cikin masu neman allurar rigakafi 79 da ke cikin ci gaba (wanda aka tabbatar a farkon watan Afrilu 2020), 74 ba su kasance cikin kimantawa a cikin mutane ba (har yanzu suna cikin binciken "" preclinical "). "
A ranar 24 ga Janairu 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafin ƙwayar cuta da za ta iya canza sunadarai na kwayar cuta ta hanyar kwayoyin halitta don motsa amsawar rigakafi.
A ranar 24 ga Janairu 2020 a Kanada, Cibiyar Alurar rigakafin kasa da kasa (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin yin allurar rigakafi, da nufin fara gwajin mutum a 2021.
An sanar da ayyukan haɓaka allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin a ranar 26 ga Janairu, 2020, da Jami'ar Hong Kong a ranar 28 ga Janairu.
A kusan 29 ga Janairu 2020, Kamfanonin Magunguna na Janssen, karkashin jagorancin Hanneke Schuitemaker, sun sanar da cewa sun fara aiki kan samar da allurar rigakafi.
Janssen tana hada kai wajen samar da maganin rigakafi na baka tare da abokin aikinta na fasahar kere kere, Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar rigakafin.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya buga wata takarda kan ƙirar allurar rigakafi tare da fasaha mai kama da wacce ake amfani da ita don maganin rigakafin cutar kansa.
A ranar 25 ga watan Maris shugaban cibiyar bincike ya sanar da cewa sun kammala hada allurar rigakafin kuma suna fara gwajin.
A ranar 27 ga Fabrairu 2020, wani kamfanin da ke da alaƙa da Generex, NuGenerex Immuno-Oncology, ya sanar da cewa suna fara aikin allurar rigakafi don ƙirƙirar allurar peptide mai mahimmanci na Ii-Key akan COVID-19.
"Suna son samar da wani allurar rigakafin da za a iya gwadawa a kan mutane ""a cikin kwanaki 90"."
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da shirye-shiryenta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Hukumar Bincike da Kayan Aikin Sojojin Amurka a Fort Detrick da Cibiyar Bincike ta Sojojin Walter Reed a Silver Spring, duka a yammacin Maryland, sun sanar da cewa suna aiki kan allurar rigakafi.
A kusan 10 ga Maris 2020, Emergent Biosolutions ya sanar da cewa ya haɗu da Novavax Inc.
a cikin ci gaba da kuma samar da allurar rigakafi.
Abokan haɗin gwiwar sun kuma sanar da tsare-tsaren gwajin rigakafin asibiti da gwajin asibiti na Mataki na I zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da keɓewa 11, kuma cewa koda a kan hanya mai sauri zai ɗauki aƙalla kusan shekara ɗaya da rabi zuwa shekara biyu don haɓaka allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere kere a birnin Quebec, Quebec, ya ba da rahoton ci gaban kwayar cutar coronavirus a karkashin wani bangare na kudade daga Cibiyoyin Nazarin Lafiya na Kanada.
Ana gudanar da binciken rigakafin a cikin dakin gwaje-gwaje, tare da gwajin ɗan adam da aka shirya don Yuli ko Agusta 2020.
"A farkon wannan makon, The Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba CureVac ""'babban kuɗi' don samun damar yin rigakafin COVID-19", wanda gwamnatin Jamus ta nuna rashin amincewa da shi".
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka tare allurar rigakafin mRNA.
BNT162 wanda ke neman allurar rigakafin mRNA, a halin yanzu yana cikin gwajin rigakafin tare da gwajin asibiti da ake tsammanin zai fara a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin fasahar kere-kere na Italiya ya sanar da cewa za su sami sakamakon gwajin rigakafin a watan Afrilu na 2020 kuma za su iya fara gwajin rigakafin su na ƙarshe a kan mutane a kaka.
A Faransa a ranar 19 ga Maris 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike kan allurar rigakafin COVID-19 wanda ya haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya kawo jimillar saka hannun jari na CEPI a cikin haɓaka allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan saka hannun jari na CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na masu neman allurar rigakafi guda shida.
Masu binciken Kwalejin Imperial College London sun sanar a ranar 20 ga Maris 2020 cewa suna haɓaka allurar rigakafin RNA mai haɓaka kanta don COVID-19.
An samar da maganin rigakafin cikin kwanaki 14 bayan an karɓi jerin daga China.
A ƙarshen Maris, gwamnatin Kanada ta sanar da dala miliyan 275 na C don ba da tallafi ga ayyukan bincike 96 kan matakan magani na COVID-19, gami da masu neman allurar rigakafi da yawa a kamfanoni da jami'o'in Kanada, kamar Medicago da yunƙurin Jami'ar Saskatchewan.
"A daidai wannan lokacin, gwamnatin Kanada ta sanar da dala miliyan 192 na musamman don haɓaka allurar COVID-19, tare da shirye-shiryen kafa "bankin allurar rigakafi" na ƙasa na sabbin alluran rigakafi da yawa waɗanda za a iya amfani da su idan wani ɓarkewar cutar coronavirus ya faru".
"A ranar 2 ga Afrilu 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar COVID-19 a cikin beraye, suna bayyana cewa ""MNA ta ba da allurar SARS-CoV-2 S1 ta haifar da amsawar antigen-takamaiman antibody [a cikin beraye] wanda ya bayyana farawa makonni 2 bayan rigakafi. """
A Kanada a ranar 16 ga Afrilu 2020, Makarantar Magunguna ta Jami'ar Waterloo ta sanar da ƙirar takardar rigakafin da ke bisa DNA a matsayin mai yuwuwar fesa hanci.
Ta amfani da kwayoyin cuta, za a tsara DNA don yin kwafi a cikin kwayoyin ɗan adam don samar da ƙwayoyin cuta marasa lahani, wanda zai iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta a kan cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun hada albarkatu don samun damar manyan kwamfutoci daga IBM, tare da albarkatun sarrafa girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako na daban, wanda ake kira sakamako mara takamaiman.
Wannan yana nufin cewa za su iya samun amfanin da ya wuce cutar da suke hanawa.
Wani gwaji na bazuwar a Ostiraliya yana neman shiga ma'aikatan kiwon lafiya 4,170.
Yana yiwuwa alluran rigakafin da ake ci gaba ba su da aminci ko tasiri.
Bincike na farko don kimanta ingancin allurar rigakafi ta amfani da ƙirar dabbobi na musamman na COVID-19, kamar su ACE2-transgenic mice, sauran dabbobi na gwaji, da kuma manyan dabbobi waɗanda ba mutane ba, sun nuna buƙatar matakan kiyaye lafiyar 3 don sarrafa ƙwayoyin cuta masu rai, da haɗin kai na duniya don tabbatar da daidaitattun hanyoyin aminci.
An gwada alluran rigakafin SARS da MERS a kan dabbobi da ba mutane ba.
Ya zuwa 2020, babu magani ko rigakafin kariya ga SARS wanda aka nuna cewa yana da aminci da tasiri a cikin mutane.
Dangane da takardun bincike da aka buga a cikin 2005 da 2006, ganowa da haɓaka sabbin alluran rigakafi da magunguna don magance SARS shine fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duk duniya. Hakanan babu ingantaccen allurar rigakafi akan MERS.
Lokacin da cutar MERS ta zama ruwan dare, an yi imanin cewa binciken SARS na iya samar da samfuri mai amfani don haɓaka alluran rigakafi da magunguna a kan kamuwa da cutar MERS-CoV.
Ya zuwa Maris 2020, akwai rigakafin MERS guda ɗaya (wanda ya dogara da DNA) wanda ya kammala gwajin asibiti na farko a cikin mutane, da wasu uku da ke gudana, dukansu alluran rigakafin ƙwayoyin cuta ne, biyu adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), da ɗaya MVA-vectored (MVA-MERS-S).
Bayanan kafofin watsa labarun sun inganta ka'idar makirci da ke da'awar cewa an san kwayar cutar da ke bayan COVID-19 kuma an riga an sami allurar rigakafi.
Takardun mallakar da aka ambata ta hanyar kafofin watsa labarun daban-daban suna nuni da takardun mallakar da ke akwai don jerin kwayoyin halitta da alluran rigakafi don wasu nau'ikan coronavirus kamar SARS coronavirus.
b'Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa da cutar coronavirus 2 mai tsanani mai saurin numfashi (SARS-CoV-2) ke haifarwa.
Alamun da aka saba da su sun hada da zazzabi, tari, da kuma rashin numfashi.
Wasu alamu za su iya haɗa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin ƙanshi, da ciwon ciki.
Lokaci daga bayyanar cutar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar ne amma na iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Duk da yake yawancin lokuta suna haifar da alamun rashin ƙarfi, wasu suna ci gaba zuwa cutar huhu ta kwayar cuta da gazawar gabobin jiki.
Ya zuwa 17 ga Afrilu 2020, an bayar da rahoton fiye da mutane miliyan 2.24 a cikin kasashe da yankuna 210, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Kwayar cutar tana yaduwa tsakanin mutane yayin hulɗa ta kusa, sau da yawa ta hanyar ƙananan ɗigon ruwa da aka samar ta hanyar tari, tari, ko magana.
Ko da yake ana fitar da waɗannan ɗigon ruwa sa'ad da aka numfasa, yawanci suna faɗuwa ƙasa ko kuma a kan wasu wurare maimakon su yaɗa cutar a nesa.
Mutane kuma suna iya kamuwa da cutar ta wajen taɓa wani abu da ke da cutar, sa'an nan su taɓa idanunsu, hanci, ko kuma bakinsu.
Kwayar cutar na iya rayuwa a kan saman har zuwa awanni 72.
Yana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwa na iya yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan baya na cutar.Hanyar ganewar asali ta hanyar jujjuyawar juzu'i na polymerase a cikin lokaci na ainihi (rRT-PCR) daga swab na nasopharyngeal.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda suke zargin suna da kwayar cutar da masu kula da su.
Shawarwari game da amfani da abin rufe fuska ta hanyar jama'a sun bambanta, tare da wasu hukumomi suna ba da shawarar yin amfani da su, wasu suna ba da shawarar yin amfani da su, wasu kuma suna buƙatar amfani da su.
A halin yanzu, babu allurar rigakafi ko takamaiman maganin rigakafin cutar COVID-19.
An yi rikodin yaduwar cutar a cikin gida a yawancin ƙasashe a duk yankuna shida na WHO.
Wadanda suka kamu da kwayar cutar na iya zama marasa alamun cutar ko kuma su samu alamun cutar mura kamar zazzabi, tari, gajiya, da kuma numfashi.
Alamun gaggawa sun hada da wahalar numfashi, ciwon kirji ko matsin lamba, rikicewa, wahalar farkawa, da fuska ko lebe masu shuɗi; ana ba da shawarar neman magani nan da nan idan waɗannan alamun sun kasance.
A lokuta da ba haka ba, ana iya ganin alamun cututtukan numfashi na sama kamar yin tari, hanci mai gudana ko ciwon makogwaro.
An lura da alamun gastrointestinal kamar su tashin zuciya, amai da zawo a cikin kashi daban-daban.
Wasu mutane a China da farko sun nuna kawai da ƙuntatawa a kirji da bugun zuciya.
A wasu, cutar tana iya ci gaba zuwa ciwon huhu, rashin aiki da gabobin jiki da yawa, da mutuwa.
Ana kiran wannan lokacin lokacin da ake yin ciki.
Lokacin haɓakawa don COVID-19 yawanci kwanaki biyar zuwa shida ne amma na iya kasancewa daga kwana biyu zuwa 14.
Kashi 97.5% na mutanen da suka samu alamun cutar za su yi hakan cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda suka kamu da cutar ba ne ke samun alamun cutar.
Har yanzu ba a san matsayin wadannan masu dauke da cutar ba a hanyar watsa cutar; duk da haka, shaidar farko ta nuna cewa suna iya taimakawa wajen yaduwar cutar.
Ba a san yawan mutanen da suka kamu da cutar ba kuma ana nazarin su, tare da Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Koriya (KCDC) sun ba da rahoton cewa kashi 20% na dukkan waɗanda aka tabbatar da su sun kasance marasa alamun cutar yayin zaman su a asibiti.
Hukumar Lafiya ta Kasa ta Sin ta fara haɗa da marasa alamun cutar a cikin al'amuranta na yau da kullun a ranar 1 ga Afrilu; daga cikin kamuwa da cutar 166 a wannan ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Dukansu sputum da saliva na iya ɗaukar manyan ƙwayoyin cuta.
Magana da ƙarfi tana fitar da ɗigo fiye da magana ta al'ada.
Wani bincike a Singapore ya gano cewa tari da ba a rufe ba zai iya haifar da ɗigon ruwa mai nisa har zuwa mita 4.5.
Kodayake cutar ba ta yawan tashi ta iska, Cibiyar Kimiyya ta Kasa ta ba da shawarar cewa ana iya samun yaduwar bioaerosol kuma masu tattara iska da aka sanya a cikin hallway a waje da ɗakunan mutane sun ba da samfuran da suka nuna tabbataccen RNA na kwayar cutar.
Wasu hanyoyin kiwon lafiya kamar su intubation da cardiopulmonary resuscitation (CPR) na iya haifar da ɓarkewar numfashi a cikin iska kuma don haka ya haifar da yaduwar iska.
Duk da cewa akwai damuwa cewa zai iya yaduwa ta hanyar kwance, ana ganin wannan hadarin yana da ƙanƙanci. Kwayar cutar tana da saurin yaduwa lokacin da mutane ke da alamun; yayin da yaduwa na iya yiwuwa kafin bayyanar cututtuka, haɗarin yana da ƙanƙanci.
Cibiyar rigakafin cututtuka da kula da cuta ta Turai (ECDC) ta ce duk da cewa ba a bayyana yadda cutar ke yaduwa cikin sauki ba, mutum daya yakan kamu da mutane biyu zuwa uku. Kwayar cutar na rayuwa na tsawon sa'o'i zuwa kwanaki a kan wasu abubuwa.
Musamman, an gano cewa za a iya gano kwayar cutar har tsawon kwana daya a kan kwali, har tsawon kwanaki uku a kan filastik (polypropylene) da bakin karfe (AISI 304), da kuma har tsawon awanni huɗu a kan 99% na jan ƙarfe.
Amma, wannan ya bambanta dangane da zafi da kuma zafin jiki.
Sabulu da kayan wanki ma suna da tasiri idan aka yi amfani da su daidai; kayayyakin sabulu suna lalata fatar da ke kare kwayar cutar, suna kashe ta, da kuma kawar da ita daga fata da sauran wurare.
Sauran magungunan, kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe ƙwayoyin cuta na tiyata), ba su da tasiri sosai. A cikin binciken Hong Kong, an ɗauki samfuran hanci a matsakaici kwana biyu bayan fara asibiti.
A cikin biyar daga cikin marasa lafiya shida, samfurin farko ya nuna mafi girman nauyin kwayar cutar, kuma mai haƙuri na shida ya nuna mafi girman nauyin kwayar cutar a rana ta biyu da aka gwada.
Cutar coronavirus na numfashi mai tsanani 2 (SARS-CoV-2) wani sabon nau'in cutar coronavirus ce ta numfashi mai tsanani, wanda aka fara warewa daga mutane uku da ke da ciwon huhu da ke da alaƙa da tarin cututtukan numfashi mai tsanani a Wuhan.
Dukkanin fasalulluka na sabon kwayar SARS-CoV-2 suna faruwa a cikin coronaviruses masu alaƙa a yanayi.
A wajen jikin mutum, ana kashe kwayar cutar ta sabulu na gida, wanda ke fashewar kumfa mai kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Cutar COVID-19 ta fi shafar huhu saboda kwayar cutar tana samun damar zuwa kwayoyin da ke karbar bakuncin ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda ya fi yawa a cikin kwayoyin alveolar na nau'in II na huhu.
"Kwayar cutar tana amfani da glycoprotein na musamman da ake kira ""spike"" (peplomer) don haɗawa da ACE2 kuma shiga cikin kwayar mai masaukin baki".
An gano raunin zuciya mai tsanani a kashi 12% na mutanen da suka kamu da cutar da aka kwantar a asibiti a Wuhan, China, kuma ya fi yawa a cikin mummunar cuta.
Yawan cututtukan zuciya da jijiyoyin jini yana da yawa, saboda amsawar kumburi na tsarin da cututtukan tsarin rigakafi yayin ci gaban cutar, amma raunin zuciya mai tsanani na iya kasancewa da alaƙa da masu karɓar ACE2 a cikin zuciya.
Masu karɓar ACE2 suna da babban bayyana a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An sami yawan kamuwa da cutar thrombosis (31%) da kuma ciwon jini mai saurin narkewa (25%) a cikin marasa lafiya na ICU tare da kamuwa da COVID-19 kuma yana iya kasancewa da alaƙa da mummunan hangen nesa. Autopsies na mutanen da suka mutu daga COVID-19 sun sami lalacewar alveolar (DAD), da kuma ƙwayoyin lymphocyte masu ƙwayoyin cuta masu shiga cikin huhu.
Kodayake SARS-COV-2 yana da tropism don ƙwayoyin epithelial na hanyar numfashi na ACE2, marasa lafiya tare da COVID-19 mai tsanani suna da alamun cutar kumburi mai yawa.
Musamman, an nuna cewa kwayoyin T masu ɓoye-CSF na GM masu cutar suna da alaƙa da ɗaukar ƙwayoyin cuta masu ɓoye IL-6 da kuma cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
An kuma samu wasu kwayoyin lymphocytic a lokacin binciken gawar.
Hukumar WHO ta wallafa wasu hanyoyin gwajin cutar.
Hanyar gwaji ta yau da kullun ita ce jujjuyawar juzu'in polymerase a cikin ainihin lokacin (rRT-PCR).
Ana yin gwajin ne a kan samfurori na numfashi da aka samu ta hanyar nasopharyngeal swab; duk da haka, ana iya amfani da swab na hanci ko samfurin sputum.
Sakamakon yawanci ana samunsa cikin 'yan sa'o'i zuwa kwana biyu.
Ana iya yin gwajin jini, amma waɗannan suna bukatar a ɗauki misalai biyu na jini da aka ɗauka a tsakanin makonni biyu kuma sakamakon ba shi da amfani nan take.
Masana kimiyya na kasar Sin sun sami damar ware wani nau'in kwayar cutar coronavirus da kuma buga jerin kwayoyin domin dakunan gwaje-gwaje a duk duniya su iya samar da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar.
Ya zuwa 4 ga Afrilu 2020, ana ci gaba da gwajin antibody (wanda zai iya gano kamuwa da cuta mai aiki da kuma ko mutum ya kamu da cutar a baya) amma har yanzu ba a yi amfani da shi sosai ba.
Kwarewar Sin tare da gwaji ta nuna daidaito ne kawai 60 zuwa 70%.
Hukumar FDA a Amurka ta amince da gwajin farko na kulawa a ranar 21 ga Maris 2020 don amfani a ƙarshen wannan watan. Jagororin bincike da Asibitin Zhongnan na Jami'ar Wuhan ya fitar sun ba da shawarar hanyoyin gano kamuwa da cuta bisa ga alamun asibiti da haɗarin annoba.
Abubuwan da ke cikin gilashin multilobar na biyu tare da rarraba kewayen, asymmetric da na baya suna da yawa a farkon kamuwa da cuta.
Rashin rinjaye na subpleural, mahaukaciyar hanyar shimfidawa (ƙarfafawa na lobular septal tare da cika alveolar mai canzawa), da ƙarfafawa na iya bayyana yayin da cutar ke ci gaba.
Akwai bayanai kaɗan game da lalacewar microscopic da kuma ilimin cututtukan jiki na COVID-19.
Babban binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
Macroscopy: ciwon zuciya, ciwon zuciya, ƙarfafa huhu da kumburin huhu
Za a iya lura da nau'ikan nau'ikan cutar huhu ta kwayar cuta guda huɗu:
ciwon huhu mai sauƙi: kumburin huhu, hawan jini na pneumocyte, manyan pneumocytes atypical, kumburin interstitial tare da infiltration lymphocytic da kuma samar da kwayoyin giant mai yawa
ciwon huhu mai tsanani: lalacewar alveolar (DAD) tare da ɓarkewar alveolar mai rarraba.
DAD shine dalilin cututtukan numfashi mai tsanani (ARDS) da kuma matsanancin hypoxemia.
warkar da ciwon huhu: ƙungiyar exudates a cikin alveolar cavities da pulmonary interstitial fibrosis
Jini: yaduwar jini cikin jijiyoyin jini (DIC); halayen leukoerythroblastic
Matakan rigakafi don rage yiwuwar kamuwa da cutar sun hada da zama a gida, guje wa wuraren da mutane ke cunkoso, wanke hannu da sabulu da ruwa sau da yawa kuma aƙalla na sakan 20, yin tsaftace numfashi mai kyau da kuma guje wa taɓa idanu, hanci ko baki da hannaye marasa wanke.
CDC ta ba da shawarar rufe baki da hanci da zane lokacin tari ko tari kuma ta ba da shawarar amfani da cikin gwiwar idan babu zane.
Ana ƙarfafa tsaftace hannu da kyau bayan duk wani tari ko sanyin gwiwa.
CDC ta ba da shawarar yin amfani da murfin fuska na masana'anta a wuraren jama'a, a wani ɓangare don iyakance watsawa ta mutanen da ba su da alamun cutar. Dabarun nisantar da jama'a suna da nufin rage hulɗa da mutanen da ke da cutar tare da manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, hana tafiye-tafiye da soke manyan tarurrukan jama'a.
Ka'idodin nesa sun haɗa da cewa mutane su kasance nesa da juna na aƙalla ƙafa 6 (mita 1.8).
"Babu wani magani da aka sani da zai iya hana COVID-19. Kamar yadda ba a tsammanin allurar rigakafi har zuwa 2021 da wuri, babban ɓangare na gudanar da COVID-19 shine ƙoƙarin rage ƙaruwar annoba, wanda aka sani da ""yarfafa layin". "
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa na aƙalla sakan 20, musamman bayan sun je gidan wanka ko kuma idan hannayensu suna da datti, kafin cin abinci da kuma bayan sun hura hanci, sun yi tari ko kuma sun yi tari.
Har ila yau, tana ba da shawarar yin amfani da maganin tsabtace hannu na barasa tare da aƙalla kashi 60% na barasa, amma kawai lokacin da sabulu da ruwa ba su da sauƙi. Don yankunan da ba a samun sauƙin samun kayan tsabtace hannu na kasuwanci, WHO ta ba da tsari biyu don samarwa na gida.
A cikin waɗannan maganganun, aikin antimicrobial ya samo asali ne daga ethanol ko isopropanol.
"Ana amfani da hydrogen peroxide don taimakawa kawar da ƙwayoyin cuta a cikin barasa; ba ""abin aiki ba ne don antisepsis na hannu""."
Ana ƙara glycerol a matsayin mai ɗumi.
Ana kula da mutane tare da kulawa mai tallafawa, wanda zai iya haɗawa da maganin ruwa, tallafin oxygen, da tallafawa sauran gabobin da suka kamu.
CDC ta ba da shawarar cewa waɗanda suke zargin suna da kwayar cutar su sa abin rufe fuska mai sauƙi.
An yi amfani da oxygenation membrane na waje da jiki (ECMO) don magance matsalar rashin numfashi, amma har yanzu ana la'akari da fa'idodin sa.
An ba da shawarar tsaftace jiki da salon rayuwa mai kyau da abinci don inganta rigakafi.
Magungunan tallafi na iya zama da amfani ga waɗanda ke da ƙananan alamun cutar a farkon matakin kamuwa da cutar. WHO da Hukumar Lafiya ta Kasa ta China sun buga shawarwari don kula da mutanen da ke asibiti da COVID-19.
Masana ilimin motsa jiki da masu ilimin cututtukan huhu a Amurka sun tattara shawarwarin magani daga hukumomi daban-daban a cikin kayan aiki kyauta, IBCC.
Ya zuwa Afrilu 2020, babu takamaiman magani don COVID-19.
Don bayyanar cututtuka, wasu ƙwararrun likitoci suna ba da shawarar paracetamol (acetaminophen) maimakon ibuprofen don amfani da farko.
Dole ne a dauki matakan kariya don rage haɗarin watsa kwayar cutar, musamman a wuraren kiwon lafiya lokacin aiwatar da hanyoyin da zasu iya samar da aerosols, kamar su intubation ko iska ta hannu.
Ga masu kula da lafiya da ke kula da mutanen da ke da COVID-19, CDC ta ba da shawarar sanya mutumin a cikin dakin keɓewar kamuwa da cuta ta iska (AIIR) ban da yin amfani da ƙa'idodin kiyayewa, hanyoyin tuntuɓar mutane da hanyoyin kiyayewa ta iska. CDC ta bayyana jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar.
Kayan da aka ba da shawarar su ne: rigar PPE, na'urar numfashi ko abin rufe fuska, kariya ga idanu, da safofin hannu na likita. Idan akwai, ana son na'urar numfashi (maimakon abin rufe fuska).
An amince da na'urorin numfashi na N95 don saitunan masana'antu amma FDA ta ba da izinin amfani da abin rufe fuska a ƙarƙashin izinin Amfani da Gaggawa (EUA).
An tsara su ne don kare daga ƙwayoyin iska kamar ƙura amma ba a tabbatar da inganci a kan takamaiman mai amfani da kwayoyin halitta ba don amfani da keɓaɓɓen.
Lokacin da ba a samun abin rufe fuska, CDC ta ba da shawarar yin amfani da garkuwar fuska ko, a matsayin mafita ta ƙarshe, abin rufe fuska na gida.
Yawancin shari'o'in COVID-19 ba su da tsanani da za su buƙaci iska mai iska ko madadin, amma kashi ɗaya cikin ɗari na shari'o'in suna da tsanani.
Ana nazarin nau'in tallafin numfashi ga mutane tare da gazawar numfashi da ke da alaƙa da COVID-19 a cikin asibiti, tare da wasu shaidu cewa ana iya guje wa intubation tare da babban kwararar cannula na hanci ko matsin lamba mai kyau na iska.
Ko ko dai daga cikin wadannan biyu yana haifar da fa'ida iri ɗaya ga mutanen da ke da mummunan cuta ba a sani ba.
Wasu likitoci sun fi son kasancewa tare da iska mai guba lokacin da akwai saboda wannan fasaha tana iyakance yaduwar ƙwayoyin aerosol idan aka kwatanta da babban kwararar hanci.Matsanancin lokuta sun fi yawa a cikin tsofaffi (waɗanda suka wuce shekaru 60, kuma musamman waɗanda suka wuce shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti a kan kowacce, wanda ke iyakance ikon tsarin kiwon lafiya don magance ƙaruwar kwatsam na adadin COVID-19 masu tsanani da ke buƙatar asibiti.
Wani bincike a China ya gano cewa kashi 5% an shigar da su sashen kulawa mai tsanani, kashi 2.3% sun bukaci taimakon na'ura na iska, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na mutanen da ke asibiti tare da COVID-19 daga ƙarshe ana shigar da su ICU.
Yanayin iska na zama mai rikitarwa yayin da cutar ta COVID-19 ke haifar da ciwon numfashi mai tsanani (ARDS) kuma oxygen yana ƙara zama da wahala.
Ana buƙatar masu iska masu iya sarrafa matsin lamba da kuma PEEP mai yawa don haɓaka isar da iskar oxygen yayin rage haɗarin raunin huhu da pneumothorax da ke hade da na'urar.
Mai yiwuwa PEEP mai yawa ba zai iya samuwa a kan tsofaffin na'urorin numfashi ba.
Bincike kan yiwuwar magunguna ya fara a watan Janairun 2020, kuma magungunan rigakafin ƙwayoyin cuta da yawa suna cikin gwajin asibiti.
Remdesivir ya bayyana a matsayin wanda ya fi yin alkawari.
Kodayake sabbin magunguna na iya ɗaukar har zuwa 2021 don haɓaka, da yawa daga cikin magungunan da ake gwadawa an riga an amince da su don wasu amfani ko kuma suna cikin gwajin ci gaba.
Ana iya gwada maganin rigakafin cutar a cikin mutane da ke da mummunar cuta.
Hukumar ta WHO ta ba da shawarar masu sa kai su shiga gwajin inganci da amincin hanyoyin magani. FDA ta ba da izinin wucin gadi ga plasma mai warkewa a matsayin magani na gwaji a lokuta inda rayuwar mutumin ke cikin haɗari ko kuma nan take.
Ba a yi nazarin asibiti da ake buƙata don nuna cewa yana da aminci da tasiri ga cutar ba.
A watan Fabrairun 2020, kasar Sin ta kaddamar da manhajar wayar salula don magance barkewar cutar.
Ana tambayar masu amfani su shigar da sunansu da lambar ID.
Aikace-aikacen na iya gano 'haɗuwa ta kusa' ta amfani da bayanan sa ido kuma saboda haka yiwuwar haɗarin kamuwa da cuta.
Kowane mai amfani zai iya bincika matsayin wasu masu amfani uku.
Idan aka gano wata barazana, app ɗin ba wai kawai yana ba da shawarar keɓe kai ba, har ma yana faɗakar da jami'an kiwon lafiya na gida. Ana amfani da manyan bayanan bincike kan bayanan wayar salula, fasahar gane fuska, bin diddigin wayar salula da kuma ilimin kere kere don bin diddigin mutanen da ke kamuwa da cutar da mutanen da suka tuntube su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta baiwa hukumomin tsaro damar bin diddigin bayanan wayar salula na mutanen da ake zaton suna da cutar coronavirus.
An dauki wannan matakin ne domin tabbatar da keɓewa da kuma kare waɗanda za su iya saduwa da 'yan ƙasa da ke dauke da cutar.
Har ila yau a watan Maris na 2020, Deutsche Telekom ta raba bayanan wurin wayar tarho tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don bincike da hana yaduwar cutar.
Rasha ta tura fasahar gane fuska don gano masu keta dokar keɓewa.
"Kwamishinan kiwon lafiya na yankin Italiya Giulio Gallera ya ce masu gudanar da wayar salula sun sanar da shi cewa ""40% na mutane suna ci gaba da motsawa a ko ta yaya".
Gwamnatin Jamus ta gudanar da wani hackathon na karshen mako na tsawon sa'o'i 48 tare da sama da mutane dubu 42.
Har ila yau, shugaban Estonia, Kersti Kaljulaid, ya yi kira ga duniya don samar da hanyoyin magance yaduwar cutar coronavirus.
Mutane na iya fuskantar wahala daga keɓewa, ƙuntatawa na tafiya, tasirin sakamako na magani ko tsoron kamuwa da cutar kanta.
"BBC ta nakalto Rory O'Connor tana cewa, ""Ƙara yawan keɓewa, kadaici, damuwar lafiya, damuwa da koma bayan tattalin arziki sune hadari ne mai kyau don cutar da lafiyar mutane da lafiyarsu. """
Cutar na iya ɗaukar yanayin laushi tare da alamun bayyanar ko babu alamun, yana kama da sauran cututtukan numfashi na sama kamar sanyi na yau da kullun.
Masu saurin cutar sukan warke cikin makonni biyu, yayin da masu ciwo mai tsanani ko kuma masu tsanani na iya daukar makonni uku zuwa shida kafin su warke.
Mata masu juna biyu na iya zama cikin haɗarin kamuwa da cutar COVID-19 bisa ga bayanai daga wasu ƙwayoyin cuta masu kama da su, kamar SARS da MERS, amma bayanai game da COVID-19 sun ƙuntata. A wasu mutane, COVID-19 na iya shafar huhu yana haifar da ciwon huhu.
A cikin waɗanda suka fi fama da cutar, COVID-19 na iya ci gaba cikin sauri zuwa ciwon numfashi mai tsanani (ARDS) wanda ke haifar da gazawar numfashi, girgizar ƙasa ko gazawar gabobin jiki da yawa.
Rikicin da ke hade da COVID-19 sun hada da sepsis, rashin daidaiton daskarewar jini da lalacewar zuciya, koda da hanta.
An bayyana rashin daidaito na clotting, musamman ƙaruwa a cikin lokacin prothrombin, a cikin 6% na waɗanda aka shigar da su asibiti tare da COVID-19, yayin da aka lura da rashin daidaiton aikin koda a cikin 4% na wannan rukunin.
Kimanin kashi 20-30% na mutanen da ke da COVID-19 suna nuna ƙaruwar enzymes na hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin tsakanin bayyanar cututtuka da mutuwa kwanaki goma ne, tare da shan kwanaki biyar a asibiti.
Koyaya, marasa lafiya da aka tura zuwa ICU suna da matsakaicin lokaci na kwanaki bakwai tsakanin asibiti da mutuwa.
A cikin binciken da aka yi na farkon cututtuka, matsakaicin lokacin daga nuna alamun farko zuwa mutuwa ya kasance kwanaki 14, tare da cikakken zangon kwanaki shida zuwa 41.
A wani bincike da Hukumar Lafiya ta Kasa (NHC) ta kasar Sin ta yi, maza suna da kashi 2.8% na mace-mace kuma mata suna da kashi 1.7%.
Binciken ilimin lissafi na gwaje-gwajen huhu bayan mutuwa ya nuna lalacewar alveolar tare da fitowar fibromyxoid na tantanin halitta a cikin huhu biyu.
An lura da canje-canje na kwayar cutar kwayar cuta a cikin pneumocytes.
Hoton huhu ya yi kama da ciwon numfashi mai tsanani (ARDS).
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta China ta ruwaito, an lura da lalacewar zuciya ta hanyar ƙaruwar troponin ko bugun zuciya.
Dangane da bayanan Maris daga Amurka, kashi 89% na waɗanda aka kwantar a asibiti suna da yanayin da suka riga sun wanzu. Samun albarkatun kiwon lafiya da yanayin tattalin arziki na yanki na iya shafar yawan mutuwa.
Kimanin mutuwar daga yanayin ya bambanta saboda waɗannan bambance-bambance na yanki, amma kuma saboda wahalar da ke tattare da hanyoyin.
Rashin kidaya na ƙananan lokuta na iya haifar da ƙimar mutuwar da aka ƙididdige.
Koyaya, gaskiyar cewa mutuwar sakamakon lamuran da aka yi a baya na iya nufin cewa ba a kimanta yawan mutuwar yanzu ba.
Masu shan sigari sun fi sau 1.4 samun mummunan alamun COVID-19 kuma kusan sau 2.4 suna iya buƙatar kulawa mai mahimmanci ko mutuwa idan aka kwatanta da waɗanda ba masu shan sigari. An nuna damuwa game da sakamakon cutar na dogon lokaci.
Hukumar Asibitocin Hong Kong ta gano raguwar kashi 20% zuwa 30% a cikin ƙarfin huhu a cikin wasu mutanen da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar gabobin jiki.
Wannan kuma na iya haifar da ciwon ciwon bayan kulawa mai tsanani bayan warkewa.
Ya zuwa Maris 2020, ba a san ko kamuwa da cuta ta baya tana ba da rigakafi mai tasiri da na dogon lokaci a cikin mutanen da suka warke daga cutar ba.
Ana ganin rigakafi mai yiwuwa, bisa halayyar sauran ƙwayoyin cuta na corona, amma an ba da rahoton shari'o'in da aka warke daga COVID-19 kuma an bi su da gwajin tabbatacce don coronavirus a wani lokaci na gaba.
Ana ganin cewa waɗannan lamuran sun fi muni na kamuwa da cuta da ke ci gaba maimakon sake kamuwa da cuta.
Ana tunanin cewa kwayar cutar ta kasance ta halitta kuma tana da asalin dabba, ta hanyar kamuwa da cuta.
Ba a san ainihin asalin ba, amma zuwa Disamba 2019 yaduwar kamuwa da cuta kusan gaba ɗaya ta hanyar yaduwa daga mutum zuwa mutum.
Wani bincike na farkon mutane 41 da aka tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya bayyana farkon ranar bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Bayanai na hukuma daga WHO sun ba da rahoton farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da ma'auni da yawa don ƙididdige yawan mutuwa.
Wadannan lambobin sun bambanta ta yankuna da kuma tsawon lokaci kuma ana rinjayar su ne ta yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar da halaye na yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambobin cutar gaggawa na ICD-10 U07.1 don mutuwar cutar ta SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje da U07.2 don mutuwar COVID-19 da aka gano a asibiti ko ta hanyar annoba ba tare da tabbatar da cutar ta SARS-CoV-2 ba. Matsakaicin mutuwar-zuwa-lamari yana nuna adadin mutuwar da aka raba da adadin waɗanda aka gano a cikin wani lokaci.
Dangane da kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya zuwa cutar ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu 2020.
Adadin ya bambanta da yanki. Sauran matakan sun hada da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano cewa sun mutu daga wata cuta, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (waɗanda aka gano da waɗanda ba a gano su ba) waɗanda suka mutu daga wata cuta.
Waɗannan ƙididdigar ba su da lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta zuwa warwarewar shari'ar.
Ko da yake ba duka mutane da suka kamu da cutar ba ne suke samar da kwayoyin cutar, kasancewar kwayoyin cutar na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, wani karamin ƙauye na mutane 4,600, 80 (1.7%) sun riga sun mutu.
A Gangelt, an yada cutar ta hanyar bukukuwan Carnival, kuma ta bazu ga matasa, wanda ya haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 ba ne aka rarraba su a matsayin irin wannan.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai sha wahala ba.
A Netherlands, kusan kashi 3% na iya samun ƙwayoyin cuta, kamar yadda aka kimanta daga masu ba da jini.
An tabbatar da cewa 69 (0.004% na yawan jama'a) sun mutu daga COVID-19.
Tasirin annobar da kuma yawan mace-macen da take haifarwa sun bambanta ga maza da mata.
Mutuwa ta fi girma a cikin maza a cikin nazarin da aka yi a China da Italiya.
Mafi yawan haɗarin maza yana cikin shekaru 50, tare da bambanci tsakanin maza da mata yana raguwa a 90.
A ƙasar Sin, adadin mutanen da suke mutuwa ya kai kashi 2.8 cikin ɗari na maza da kuma kashi 1.7 cikin ɗari na mata.
Ba a san ainihin dalilan da suka sa aka samu wannan bambanci tsakanin mata da maza ba, amma za a iya cewa dalilai na halitta da na hali ne suka sa.
Bambance-bambance na rigakafi bisa jinsi, ƙananan yawan shan sigari a cikin mata da maza masu haɓaka yanayin co-morbid kamar hawan jini a cikin ƙuruciya fiye da mata na iya taimakawa ga ƙaruwar mutuwa a cikin maza.
A Turai, kashi 57% na mutanen da suka kamu da cutar maza ne kuma kashi 72% na waɗanda suka mutu da COVID-19 maza ne.
Ya zuwa Afrilu 2020, gwamnatin Amurka ba ta bin diddigin bayanan da suka shafi jima'i na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan ƙwayoyin cuta kamar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, kuma suna da damar da za su iya kamuwa da cutar.
"Kungiyar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu 2020 cewa sunan hukuma na cutar zai zama ""COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana nufin corona, VI don kwayar cutar, D don cuta da 19 don lokacin da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi sunan ne don kaucewa ambaton takamaiman wuri na ƙasa (misali China), nau'in dabbobi ko rukunin mutane, daidai da shawarwarin ƙasa da ƙasa don suna da nufin hana ƙyama. An kira kwayar cutar da ke haifar da COVID-19 da suna mai tsanani mai saurin numfashi coronavirus 2 (SARS-CoV-2).
"WHO ta kuma yi amfani da ""kwayar COVID-19"" da kuma ""kwayar da ke da alhakin COVID-19"" a cikin sadarwa ta jama'a".
"Dukkanin cutar da kwayar cutar ana kiranta da sunan ""coronavirus""."
"A lokacin barkewar cutar a Wuhan, China, an fi kiran kwayar cutar da cutar da sunan ""coronavirus"" da kuma ""Wuhan coronavirus"".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV cututtukan numfashi na gaggawa a matsayin sunayen wucin gadi na kwayar cutar da cutar daidai da jagorar 2015 game da amfani da wurare a cikin sunayen cuta da kwayar cutar.
An ba da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iya aiki a cikin daidaitaccen sarkar samarwa, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su swabs na hanci da sassan na'urar numfashi.
A wani misali, lokacin da asibiti na Italiya ke bukatar bawul din na numfashi, kuma mai samarwa bai iya kawowa cikin lokacin da ake bukata ba, wani sabon kamfanin da ke wurin ya sake tsarawa kuma ya buga bawul din 100 da ake bukata cikin dare.
Bayan barkewar COVID-19, ka'idodin maƙarƙashiya, ɓatar da bayanai da kuma ɓatar da bayanai sun bayyana game da asalin, sikelin, rigakafi, magani da sauran fannoni na cutar kuma sun bazu cikin sauri ta yanar gizo.
Mutane suna iya yada cutar zuwa wasu dabbobi.
Binciken bai sami tabbacin kwayar cutar a aladu, ducks, da kaji ba.
Babu magunguna ko allurar rigakafi da aka amince da su don magance cutar.
Ana gudanar da bincike na kasa da kasa kan alluran rigakafi da magunguna a cikin COVID-19 ta hanyar kungiyoyin gwamnati, kungiyoyin ilimi da masu bincike na masana'antu.
"A watan Maris, Hukumar Lafiya ta Duniya ta fara gwajin "SOLIDARITY Trial" don kimanta tasirin maganin ƙwayoyin cuta huɗu da ke akwai tare da mafi yawan alkawuran tasiri".
Babu rigakafin da ake da shi, amma hukumomi daban-daban suna aiki tukuru kan masu neman rigakafin.
Ana amfani da aikin da aka yi a baya akan SARS-CoV saboda SARS-CoV da SARS-CoV-2 duk suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Akwai dabarun allurar rigakafi guda uku da ake bincike.
Da farko, masu bincike suna son su gina cikakken allurar rigakafin cutar.
Amfani da irin wannan kwayar cutar, ko ta mutu ko ta mutu, na da nufin haifar da amsawar garkuwar jiki na gaggawa ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafin subunit, tana da nufin ƙirƙirar allurar rigakafin da ke sa tsarin garkuwar jiki ya zama mai hankali ga wasu ƙananan ƙwayoyin cuta.
A cikin yanayin SARS-CoV-2, irin wannan binciken ya mai da hankali ne kan furotin S-spike wanda ke taimakawa kwayar cutar shiga cikin mai karɓar enzyme na ACE2.
Dabara ta uku ita ce na allurar rigakafin nucleic acid (tallafin DNA ko RNA, sabuwar dabara ce ta samar da allurar rigakafi).
Dole ne a gwada alluran rigakafin gwaji daga kowane ɗayan waɗannan dabarun don aminci da tasiri.A ranar 16 ga Maris, 2020, gwajin asibiti na farko na allurar rigakafi ya fara tare da masu sa kai huɗu a Seattle.
Allurar rigakafin ta ƙunshi lambar kwayar halitta mara lahani da aka kwafa daga kwayar cutar da ke haifar da cutar. An ba da shawarar haɓaka mai dogara da rigakafi a matsayin ƙalubale mai yuwuwa don haɓaka allurar rigakafin SARS-COV-2, amma wannan yana da rikici.
Akwai gwaji na asibiti sama da 300 da ke gudana har zuwa Afrilu 2020.
Gwaje - gwaje bakwai sun kimanta hanyoyin maganin zazzabin cizon sauro da aka riga aka amince da su, ciki har da gwaje - gwaje huɗu akan hydroxychloroquine ko chloroquine.
Magungunan rigakafin ƙwayoyin cuta da aka sake amfani da su sun ƙunshi mafi yawan binciken na kasar Sin, tare da gwajin kashi tara na III akan remdesivir a ƙasashe da yawa da za a bayar da rahoto a ƙarshen Afrilu.
An gudanar da nazarin ci gaban asibiti don allurar rigakafin COVID-19 da kuma masu neman magani, har zuwa Afrilu 2020. Ana kimanta magungunan rigakafin cutar da ke akwai don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir / ritonavir da lopinavir / ritonavir haɗe da interferon beta.
Akwai shaidar farko game da ingancin remdesivir, har zuwa Maris 2020.
An lura da ci gaban asibiti a cikin marasa lafiya da aka bi da su tare da amfani da remdesivir.
Ana gudanar da gwajin asibiti na Phase III a Amurka, China da Italiya. Chloroquine, wanda a baya ake amfani da shi wajen maganin zazzabin cizon sauro, an yi nazari a China a watan Fabrairu na 2020, tare da sakamakon farko.
Duk da haka, akwai kira ga bita na takwarorinsu na bincike.
Hukumomin kiwon lafiya na Koriya da na Sin sun bada shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayar cuta ta Wuhan, yayin da take ba da shawarar kashi ɗaya na gram a kowace rana, ta lura cewa ninki biyu na wannan kashi yana da haɗari sosai kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa don hydroxychloroquine da chloroquine bisa ga zaɓin likitocin da ke kula da mutanen da ke da COVID-19. Jagororin na 7 na kasar Sin sun haɗa da interferon, ribavirin ko umifenovir don amfani da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar manyan allurai na ribavirin don hana SARS-CoV-2 in vitro.
An ba da shawarar yin ƙarin nazarin in vivo na Nitazoxanide bayan nuna ƙarancin hana SARS-CoV-2. Nazarin ya nuna cewa farkon farawa na furotin mai ƙwanƙwasa ta hanyar transmembrane protease serine 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan iyakoki waɗanda suka hana ƙungiyar likitanci rungumar waɗannan hanyoyin magani ba tare da ƙarin bincike ba. Oseltamivir baya hana SARS-CoV-2 in vitro kuma ba shi da sanannen rawa a cikin maganin COVID-19.
Cytokine storm na iya zama rikitarwa a cikin matakan ƙarshe na COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kaddarorin anti-cytokine storm. Tocilizumab an haɗa shi cikin jagororin magani ta Hukumar Lafiya ta China bayan an kammala karamin bincike.
Ana gudanar da gwajin kashi na 2 wanda ba a yi amfani da shi ba a matakin kasa a Italiya bayan nuna sakamako mai kyau a cikin mutane masu cutar mai tsanani.
A hade tare da gwajin jini na ferritin na jini don gano guguwar cytokine, an yi nufin magance irin waɗannan ci gaba, wanda ake tsammanin shine dalilin mutuwa a wasu mutanen da ke fama da cutar.
FDA ta amince da mai adawa da mai karɓar interleukin-6 bisa nazarin yanayin baya don maganin cutar cutar cytokine mai hana steroid wanda ya haifar da wani dalili daban, maganin kwayoyin CAR T, a cikin 2017.
Ya zuwa yanzu, babu wata hujja da aka yi ta bazuwar, da aka sarrafa cewa tocilizumab magani ne mai inganci ga CRS.
Ana binciken canja wurin tsarkakewa da kuma tsananin ƙwayoyin cuta da tsarin rigakafin waɗanda suka warke daga COVID-19 ke samarwa ga mutanen da suke buƙatar su a matsayin hanyar da ba rigakafin rigakafi ba.
An gwada wannan dabarar don SARS tare da sakamako mara tabbatacce.
Rashin tasirin kwayar cuta shine tsarin aiki da ake tsammani wanda maganin rigakafin jiki na iya shiga tsakani a cikin kariya daga SARS-CoV-2.
Sauran hanyoyin, kamar su cytotoxicity na tantanin halitta da ke dogara da antibody da/ ko phagocytosis, na iya yiwuwa.
Sauran nau'ikan maganin rigakafin rigakafi, misali, ta amfani da samfuran rigakafin monoclonal, suna cikin ci gaba.
Za a iya ƙara samar da maganin magani na mai warkarwa, wanda ya ƙunshi ruwan jini daga marasa lafiya da suka warke kuma ya ƙunshi ƙwayoyin cuta na musamman ga wannan kwayar, don saurin saurin.
Cutar Coronavirus, rukuni na cututtukan da ke da alaƙa da juna
Li Wenliang, likita a Babban Asibitin Wuhan, wanda daga baya ya kamu da cutar COVID-19 kuma ya mutu bayan ya wayar da kan jama'a game da yaduwar cutar.
